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Abstract
Cellular senescence is an innate physiological mechanism crucial in development, wound healing
and tumour suppression. It is characterised by an irreversible cell cycle arrest, resistance to apoptosis,
and an inflammatory secretome that remodels bystander cells, referred to as senescence-associated
secretory phenotype (SASP). SASP acts in an autocrine or paracrine manner to reinforce senescence,
transmit senescence to naive cells and activate immunosurveillance to remove cells of pathological
potential. In ageing organisms, senescent cells accumulate, resulting in SASP-driven chronic inflam-
mation, aberrant tissue homeostasis and immune functions, and age-related pathologies such as cancer.
Ageing also comes with an increased susceptibility to infectious diseases but the cellular basis for this
is unclear.
Salmonella Typhi causes more than 11 million cases of drug-resistant typhoid fever cases each
year that are spreading intercontinentally, making it a global health concern. The typhoid toxin
of Salmonella Typhi causes DNA damage, cell cycle arrest and cell distension, which are indicative
of senescence. Toxin-induced DNA damage is associated with mortality, typhoid fever symptoms
and chronic Salmonella carriage in animal models, which aids in pathogen shedding and disease
transmission. Therefore, dissecting the typhoid toxin virulence mechanism is of utmost importance.
Using molecular and cellular biology, this thesis substantiates evidence that the typhoid toxin in-
duces senescence in vitro marked by persistent DNA damage responses, increased senescence associated
β-galactosidase, p21 activity, diminished lamin B1, and paracrine senescence via toxin-induced SASP
(toxSASP). Interestingly, previous work in our lab demonstrated that toxSASP uniquely promoted
Salmonella infection, while aphidicolin (APH), i.e. another senescence inducer, did not. This finding
indicates that factors in the host secretome increase the susceptibility of bystander cells to Salmonella
infection but the identity of the SASP factors are unknown. Using unbiased LC-MS/MS and GeneChip
microarray transcriptomics, this thesis reveals toxSASP constituents which were divergent from other
senescence inducers, namely APHSASP and ETPSASP. Additionally, in vitro experiments implicate
potential crosstalk between TGFβ and Wnt5a signalling pathway in toxin-induced senescence phe-
notypes. Indeed, purified Activin A, a TGFβ ligand, and Wnt5A contributed to toxSASP paracrine
senescence. Furthermore, TGFβ receptors knockdown via siRNAs ameliorated Salmonella invasion
induced by toxSASP.
In conclusion, this study reveals the first proteomic characterisation of a SASP induced by a
bacterial toxin. The study represents a Salmonella hijacking mechanism via the TGFβ signalling
pathway, which represents a novel host-pathogen interaction that may be of significance to invasive
infections underlying typhoid fever and chronic carriage. This thesis is of broad significance as it reveals
a way by which bacterial pathogens can reprogramme multicellular infection niches by hijacking the
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Invasive infections of Salmonella
enterica
1.1 Introduction
The United Nations has set out 12 global challenges we need to address to achieve a better and
more sustainable future for all. UN sustainable development goal 3 is to end epidemics of neglected,
communicable and water-borne diseases by 2030. High on this list is typhoid fever, one of our oldest
killers, which affects many low-and middle-income countries where the most severely affected are
children (∼27%)1. World Health Organisation (WHO) reports that more than 2,000 children die each
day of diarrhoeal diseases, which is more than HIV, measles and malaria combined, making it the
second leading cause of deaths in children worldwide2. One of the top causes of diarrhoeal disease
is Salmonella. Salmonella enterica subspecies enterica (henceforth Salmonella) is a species of rod-
shaped Gram-negative bacteria that comprise more than 2500 serovars. Salmonella is transmitted
from contaminated food and water via fecal-oral route. It is estimated that 1.8 billion people use
a source of drinking water contaminated with faecal matter3, which increases the risk of typhoid.
With respect to human disease, Salmonella is grouped into i) typhoidal serovars which cause global
epidemics of invasive enteric fever, also known as typhoid and paratyphoid fever, and ii) non-typhoidal
serovars which result in a self-limiting non-invasive gastroenteritis.
1.2 Human diseases caused by Salmonella enterica
1.2.1 Non-typhoidal Salmonella
Non-typhoidal Salmonella (NTS) serovars (+2500) are zoonotic and have broad-host tropism4.
NTS causes ∼100 million causes of food poisoning and ∼150,000 deaths per year worldwide, making
it a global health concern. The most common NTS is Salmonella Typhimurium sequence type 19
(ST19), which infects humans and food-chain animals4. NTS results in self-limiting gastroenteritis
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that is usually restricted to the terminal ileum and the colon by initiating a localised inflammatory
response, i.e. non-invasive5, with relatively mild symptoms such as diarrhoea and fever.
1.2.2 Invasive non-typhoidal Salmonella
The increasing number of immunocompromised individuals (e.g. through the AIDS pandemic, or
the ageing population) has driven the evolution of NTS serovars that are adapted to the immunocom-
promised host where they cause a devastating invasive infection (iNTS disease; 535,000 cases/77,500
deaths in 2017)6. Individuals infected with iNTS typically present bacteraemia and a febrile illness
with a clinical presentation similar to typhoid fever (Section 1.2.3). The most dominant serovars
with an invasive potential are currently Salmonella Typhimurium and and Enteritidis7. The proto-
type iNTS serovars S. Typhimurium ST313 is on the rise, has antibiotic resistance, and is associated
with higher fatality rates than their non-invasive NTS counterparts, e.g. ST196,8. Unlike non-invasive
NTS, ST313 reduces inflammation, replicates in macrophages and results in systemic infections9
1.2.3 Typhoidal Salmonella
Enteric fever, or typhoid fever, is a systemic, lethal disease that is a result of an infection by the
typhoidal Salmonella serovars Typhi, Paratyphi (A, B, and C), and Sendai which are human-specific
pathogens and therefore unable to elicit disease in other animals4. Typhoid patients often suffer from
high-grade fever (>39°C), constant fatigue, abdominal pain, diarrhoea, hepatosplenomegaly, rash,
nausea, anorexia, constipation, headache and dry cough10,11. Salmonella can result in internal organ
damage such as intestinal perforation, the most severe complication observed in S. Typhi infections.
Typhoid fever is diagnosed in ∼10-20 million people worldwide and kills more than 200,000 people
per year12,13 (Fig.1.1), which presents a lower disease burden but higher mortality rate than NTS.
In addition, a recent Global Burden of Disease (GBD) study estimated that typhoid fever results
in approximately 10 million cases with disability-adjusted life-years (DALYs) in 20176. It is mainly
prevalent in countries with scarce sources for clean food and water particularly in regions such as
South Asia6, southeast Asia14, and sub-Saharan Africa15. The highest incidences of typhoid cases,
and mortality is amongst children below 15 years old (∼56% of the cases, ∼59% of the deaths), which
progressively decreases with age6. Infections with typhoidal Salmonella are not restricted to low- and
middle-income countries (LMICs) countries, but also spreads to high-income countries through travel
from endemic settings, or through chronic carriers of Salmonella who prepare food (Section 1.3,
Fig.1.1).
1.3 Chronic carriers of S. Typhi
During typhoid convalescence, 10% of individuals exhibit temporary Salmonella carriage (i.e. shed-
ding Salmonella for less than 12-months), while 1-5% develop a chronic S. Typhi infection (Salmonella
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Figure 1.1|The transmission cycle of Salmonella Typhi. Salmonella is transmitted through contam-
inated food and water. Some of the infected develop severe typhoid symptoms and die, but some recover,
retain the pathogen, and remain asymptomatic. Chronic carriers can then spread Salmonella undetected via
shedding the bacteria in faeces, which can contaminate food and water sources and infect otherwise healthy
individuals (e.g. sewage draining into drinking water).
carriage 12-months or more)16. Chronic carriage is not observed in NTS or iNTS infections, though
temporary carriage (∼ 55 days) is observed in 2% of cases16,17. In addition to these individuals, 25%
of individuals do not develop any acute symptoms of typhoid fever, but shed S. Typhi in stools indi-
cating asymptomatic chronic carriage16 (Fig.1.1). The most infamous chronic carrier was Typhoid
Mary who worked as a cook and passed the infection onto her customers in the 1850s, and Mr N the
milker who infected farm products18. Interestingly, incidences of S. Typhi chronic carriage increased
with age, and were more prevalent in females16,19.
It is thought that chronic infection develops following dissemination to the reticuloendothelial
system where Salmonella Typhi resides in the gallbladder20. From there, Salmonella can be excreted
through bile into the gastrointestinal tract triggering relapse or shed in stools, which contributes
to disease transmission16. Increasing evidence shows that Salmonella is evolutionarily adapted to
thrive in the gallbladder21,22,23. In vitro studies indicated that Salmonella divide preferentially in
gallbladder mimicking conditions23, and specifically to cholesterol coated gallstones24. Gallstones aid
in the formation of biofilms that protect bacteria from the immune system and allow them to thrive25,
making gallstones a suspected risk factor of persistent infection26.
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1.3.1 Salmonella and gallbladder cancer
A correlation between S. Typhi infections and gallbladder cancer is established27. The current
notion is that alongside gallbladder stones, S. Typhi is a major risk factor in gallbladder cancer26. In
Chile where S. Typhi is endemic, ∼44% of gallbladder cancer patients were positive for S. Typhi27.
The majority of chronic carriers can be treated with a 4-week antibiotic therapy (∼80% of the cases).
However, if patients have gallstones, antibiotic treatment in addition to cholecystectomy (i.e. the
removal of the gallbladder) might be necessary, to prevent complications and continued shedding of
bacteria, which is invasive and expensive28,29.
Salmonella is sufficient to induce carcinogenesis in mice and transform mouse embryonic fibroblasts
that are genetically predisposed to develop cancer, e.g with mutated p53, amplified c-Myc30. As yet,
the molecular basis for Salmonella-induced transformation is unknown. It is interesting to speculate
that a virulence factor (e.g. typhoid toxin; Section 1.8) encoded by Salmonella, might contribute to
oncogenesis.
The high fatality rate and the associated complications of invasive Salmonella, whether typhoidal
or non-typhoidal, beg for research to examine their virulence in an effort to prevent lethal outbreaks.
1.4 Diagnostics, current treatments and preventions
1.4.1 Diagnosis
All diagnoses of enteric fever or invasive Salmonellosis begin with examining clinical signs and
symptoms. However, systemic infections of both typhoidal Salmonella and iNTS, are often miscon-
strued for other febrile diseases such as dengue fever and malaria8. Symptoms can even include
anaemia, pneumonia-like symptoms, and in some cases absence of diarrhoea, which could deflect from
suspecting Salmonellosis. As a result, inappropriate treatments are administered to the patients and
Salmonella is not directly tackled.
Typical diagnostics examine stool, blood or urine which measure shedding of Salmonella 31. The
most commonly used measures are bacterial cultures and Widal test32. Bacterial cultures are carried
out with blood samples from patients and grown in controlled nutritious LB broth to examine for
Salmonella growth. Widal tests utilise antigens from killed Salmonella and examine reactivity of cir-
culating antibodies from patients sera with these antigens. Both tests are currently the gold standard
and do not require expensive special lab equipment. However, they lack sensitivity, due to the low
titre of Salmonella found in blood during bacteremia, or due to antibiotics that have been used prior
to the test. In contrast, bone marrow test is the most sensitive as Salmonella Typhi has been reported
to invade preferentially and resist antibiotic treatments in bone marrow cells33,34. However, it is very
invasive, and requires trained specialists and state-of the art sterile medical equipment that is not
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available in developing countries. Surveillance programmes and academic studies exploit genomics,
proteomics, transcriptomics, in vivo-induced antigen and immunoaffinity proteomics-based technolo-
gies, which are fuelling novel diagnostic approaches though these may be better suited to surveillance
monitoring rather than point-of-care diagnosis35.
1.4.2 The rise in antibiotic resistant Salmonella
Untreated, typhoid fever historically had a mortality rate of up to 20% but this declined with
the introduction of chloramphenicol in the 1940s12,13,36,37. With the appropriate antibiotic, mortal-
ity can be as low as 1%12,37. Antibiotics are usually the immediate treatment for patients infected
with typhoidal Salmonella 4. However, antibiotic treatment of NTS is restricted to immunocompro-
mised patients and infections that have become invasive, due to the fact that it would prolong NTS
excretion4.
The emergence of multidrug-resistant (MDR) Salmonella has become a global health concern due
to its potential to increase mortality to the alarming rates observed in the 1940s37,38,39. Additionally,
MDR results in longer hospitalisation, force the use of more expensive drugs and hence increase health
care costs in several countries40,41.
Whole genomic sequencing of thousands of isolated S. Typhi revealed that the most dominant cir-
culating Salmonella strain is H58, which is an MDR strain that is thought to have originated in South
Asia and is now being transmitted intercontinentally to Africa and Southeast Asia42. Antimicrobial
resistance (AMR) can also develop via gene transfer facilitated by transposon or plasmid exchange, or
by chromosomal mutations43. In the case of H58 strain, AMR genes were initially associated with a
self-transferrable IncHI1 plasmid that conferred multiple AMR genes resistant to previously prescribed
antibiotics such as chloramphenicol, co-trimoxazole and ampicillin, making it a global threat42,44,45.
A study by Wellcome Trust highlighted the disturbingly rapid spread of H58 typhoid cases demon-
strated by the increase in AMR typhoid cases in Malawi from ∼7% to 97% between 2010 and 2014
only45. Whilst AMR arises naturally, it can also arise due to the misuse of antibiotics, for example
through incomplete therapies, incorrect doses or incompatible antibiotics4,46.
Currently, the first-line of antibiotics are fluoroquinolones, which block bacterial DNA replication
via inhibiting the supercoiling activity of DNA gyrase. However, in 2017, the World Health Organi-
sation declared fluoroquinolone-resistant Salmonella a high priority threat due to its prevalence and
severity of the disease they cause47. The antibiotic resistance arose as a result of a mutation in the
gyrase enzyme that has reduced its affinity to the drugs, and hence ameliorated their inhibition.
With increasing antimicrobial resistance, commonly used treatments are less effective. Thus, we




Given the rise in MDR Salmonella, vaccines have been developed using various methods in an
attempt to control outbreaks, and build herd immunity. Currently, there are no vaccinations for
invasive Salmonella except for S. Typhi. There are two vaccines typically used: i) a live attenuated
Ty21a and ii) unconjugated Vi capsular polysaccharide (Vi CPS), which is a capsule that coats S.
Typhi and protects it from the host’s immune system48 (described in Section 1.7.2.1). Neither
vaccinations are authorised for use in children younger than 2 years old, who represent a huge portion
of the typhoid burden (∼30%). Recently, WHO authorised the use of a new typhoidal conjugated
vaccine (TCV), where Vi capsule is conjugated with tetanus toxoid as a carrier protein49, which has
been shown to be safe and increase efficiency in children older than 6 months in phase III clinical
trials1,50,51. The characteristics of each vaccine is summarised in Table 1.1.
Vaccines




• developed using non-specific
mutagenesis
• Vi capsule absent
• allows for cross-reactivity
with other typhoidal strains
that do not express Vi
e.g. Paratyphi
• 7 years protection
• 3-4 doses
• Not authorised for <6 years
• Difficult to swallow for children
50-80%
Authorised Vi CPS48
• unconjugated Vi capsular
polysaccharide
• intramuscular injection








• 2 years protection
50-80%
In development TCV
• Vi capsule conjugated with
tetanus toxoid as a
carrier protein49
• intramuscular injection
• safe in children
>6 months1,50,51
• 3 years protection
(less than Ty21)
• Still in trials
80%
Table 1.1|Effective typhoidal vaccines currently authorised or in development.
Modelling predicts that vaccination alone is insufficient to eradicate typhoid52, and thus inte-
grated control strategies are required with improved antibiotic therapies, diagnostics, and education
programmes. Therefore, there is still current need to develop existent or alternative strategies to treat
and prevent invasive Salmonella from establishing disease. To do this, the virulence of Salmonella
and its pathogenesis is currently a major focus of the field.
1.5 Pathogenesis of Salmonella
1.5.1 Bacterial entry into host cells
Both typhoidal and NTS serovars enter the body via ingestion of contaminated food and/or water
(Fig.1.1). The first contact with the host is with non-phagocytic cells, such as gut epithelial cells
(Fig.1.2). They adhere to the surface of gut epithelial cells via adhesins, which facilitate bacterial
attachment to the host cell4,53. The Salmonella genome contains pathogenicity islands that encode
important virulence factors for cellular invasion54. Notably, expression of Salmonella pathogenicity
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Figure 1.2| Pathogenesis of invasive and non-invasive Salmonella. Salmonella can infect gut epithelial
cells, macrophages, M cells, and dendritic cells. Invasive Salmonella breach the gut epithelial barrier, evade
any immune responses, and infect macrophages or remain free in the blood stream (i.e. bacteraemia), where
it spreads to sterile systemic sites such as the bone marrow, liver, and/or spleen (left panel). In contrast,
non-invasive Salmonella elicits a localised inflammatory response marked by neutrophil transmission (right
panel).
island 1 (SPI1) is activated in the high salt environment of the host gut and encodes a needle-
like assembly protein, the type 3 secretion system (T3SS1), that delivers virulence effector proteins
directly into the cells, forcing Salmonella internalisation into host cells55 . The virulence effectors then
hijack the actin cytoskeleton indirectly (e.g. SopE activation of Rho GTPases) or directly (e.g. SipA
binding of actin filaments), which promote membrane ruffling and macropinocytosis of Salmonella 55
(Fig.1.3).
1.5.2 Survival in host cells
Intracellular Salmonella then resides in a phagosome-like compartment known as the Salmonella
containing vacuole (SCV) within cells of the intestinal epithelium56. The SCV enters the lysoso-
mal pathway and the acidification of the SCV activates expression of Salmonella pathogenicity is-
land (SPI2) that encodes T3SS2 which delivers virulence effectors that sustain intracellular survival
(Fig.1.3). For example, Salmonella-induced filaments (Sif) redirect nutrients into the vacuole to
allow for a nutrient rich niche suitable for replication57,58. Additionally, SifA and SopD2 produced by
Salmonella maintain the vacuolar membrane and its integrity59. Mutant SifA S. Typhimurium led
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Figure 1.3| Salmonella entry into the cell. Salmonella utilises its needle-like type 3 secretion system
(T3SS) encoded by SPI-1 to inject effectors that polymerise actin and promote Salmonella engulfment. Initially
Salmonella resides in an endosome which is referred to as a Salmonella containing vacuole (SCV). Once in the
SCV, Salmonella utilises T3SS encoded by SPI-2 to release effectors necessary for maintenance of the SCV.
to the bacterial escape into the cytosol of macrophages and promoted Salmonella killing60(Fig.1.3).
Unlike other phagosomes, SCV evades lysosomal degradation, which promotes its survival61,62. In-
terestingly, the T3SS2 effector SifA sequesters Rab39-mediated retrograde trafficking of SCV into
lysosomes thereby preventing lysosomal degradation63. Next, Salmonella alongside the SCV divide,
until there is one bacterium per SCV in the host cell64 (Fig.1.3).
1.5.3 Interactions with intestinal innate immunity key to dissemination
The distinct diseases caused by NTS and typhoidal Salmonella are determined by a critical inter-
action with intestinal innate defences. For example, host cell inflammasomes sense virulence factors
of NTS (e.g. flagella, T3SS of prototype NTS serovar S. Typhimurium ST19) triggering pyropto-
sis of infected epithelial cells and macrophages that recruits neutrophils. As a result, neutrophils
kill NTS, prevent dissemination and restrict disease to a localised non-invasive infection in the in-
testinal mucosa (Fig.1.2)65,66,67,68. In contrast, typhoidal serovars (e.g. S. Typhi, S. Paratyphi A)
evade inflammasome defences and disseminate within infected macrophages to cause invasive infec-
tions69. Similarly, iNTS S. Typhimurium ST313 also evades the inflammasome, which is thought to
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contribute to immune evasion and dissemination from the intestinal mucosa70. Immune evasion by
invasive serovars of typhoidal and iNTS Salmonella is partly facilitated by degradation of genes that
encode pro-inflammatory virulence factors, which are actively expressed in the non-invasive serovar
NTS serovar S. Typhimurium ST1971.
1.5.4 Systemic infection
Unlike NTS, typhoidal Salmonella usually do not elicit an inflammatory response at the early stages
of infection. Whilst S. Typhimurium has evolved to flourish in inflammatory conditions to outcompete
the gut microbiota, it is thought that S. Typhi lost that ability to thrive systemically4,72,73. The lack
of an inflammatory response allows typhoidal Salmonella to evade the immune system and become
systemic where it reaches liver, gallbladder and spleen4. For the typhoidal strain and in keeping with a
lack of inflammation, there is no neutrophil transmission across the intestinal epithelium in comparison
with NTS which are restricted by infiltrating neutrophils (Fig.1.2)74. Invasive strains such as S. Typhi
disseminate within mononuclear phagocytic cells including macrophages or dendritic cells, via three
routes75: (i) Salmonella can infect macrophages resident in the underlying gut-associated lymphoid
tissue (GALT) that contain immune effector sites such as Peyer’s patches, which are distributed across
the lamina propria within the intestinal mucosa, or (ii) Salmonella can drain from the Peyer’s patches
into mesenteric lymph nodes (MLNs) where they can infect macrophages and other mononuclear
phagocytes, and finally, (iii) free Salmonella can invade the bloodstream from the MLNs causing a
transient primary bacteraemia characteristic of typhoid fever. In the blood, Salmonella moves out
of the circulation by mononuclear phagocytes. Regardless of the mechanism, infected macrophages
migrate to organs of the reticuloendothelial system (e.g. liver, spleen) where Salmonella survives
intracellularly, as described in Section 1.5.256,63 (Fig.1.3). S. Typhi resides at these systemic sites
until onset of typhoid fever (8-14 days), which is typically accompanied by sustained, albeit low level
(1–10 organisms/mL), secondary bacteremia lasting several weeks76 (Fig.1.2).
1.6 Modelling Salmonella infection and typhoid fever
Given that S. Typhi is human-specific, there is no animal model that faithfully recapitulates
typhoid fever in humans. S. Typhimurium causes human disease but is a pathogen that causes a
systemic typhoid-like infection in mice, which has been exploited to provide information on Salmonella
invasion, transmission and dissemination77,78,79. However, there are a number of important differences
between S. Typhi and S. Typhimurium (Fig.1.4). For example, (i) SPI2 is required for intracellular
survival of S. Typhimurium but not S. Typhi80, (ii) S. Typhimurium and S. Typhi genomes share 11
common SPIs but some are specific to S. Typhi (SPI-7, 15, 17, and 18) or S. Typhimurium (SPI-14)71,
and (iii) S. Typhi has unique virulence factors implicated typhoid, e.g. Vi capsule, typhoid toxin81.
Much attention has been focussed on developing animal models that are permissible for S. Typhi.
For instance, Toll-like receptor 11 (TLR11) is present in mice but not in humans and recognises the
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Figure 1.4| Structural comparison between S. Typhimurium and S. Typhi. Similarities between
both serovars are indicated by blue text and differences are indicated by red text. The small plasmid in S.
Typhi depicts genomic degradation (Inspired by diagram from de Jong et al 201271).
Salmonella flagellin, which is a pathogen-associated molecular pattern (PAMP). Knocking out TLR11
disrupts PAMP detection allowing systemic S. Typhi and S. Typhimurium infections82. Having
allowed S. Typhi to enter the vascular system, effects on the liver, gall bladder and other usual targets
of the pathogen could be studied in mice.
Another approach was to humanize mice by engrafting human immune cells including B cells,
NK cells, monocytes, CD4+ and CD8+ cells into immune-deficient mice. The engraftment allowed
S. Typhi to replicate normally in mice and assisted in modelling long-term persistent infection77,83.
After a few days, the infection becomes similar to human typhoid and leads to lethality.
1.7 S. Typhi adaptation to the human host (Fig.1.4)
1.7.1 Genomic degradation
S. Typhi is a human-restricted pathogen while S. Typhimurium infects a broad-range of animal
hosts4. 90% of genes are identical in S. Typhi and S. Typhimurium ST1984. Of the 4,000 genes in
S. Typhi, 200 are functionally disrupted but these genes are actively expressed in S. Typhimurium
ST1971. S. Typhi’s genome degradation is thought to contribute to its human host restriction. Sim-
ilarly, S. Typhimurium ST313, which was identified in 2009 as causing a typhoid-like bacteraemia in
immunocompromised HIV-infected individuals, is also undergoing genome degradation in genes that
are expressed in S. Typhimurium ST19 but degraded in S. Typhi85. Some of the virulence factors
that were degraded in S. Typhi include motility, chemotaxis factors and the type III secretion system
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effectors that are usually found in S. Typhimurium and have been shown to promote infection of an-
imal hosts86. One such factor is GtgE, a type III secretion system effector, found in S. Typhimurium
but not S. Typhi. GtgE degrades Rab32, which is responsible for lysosomal biogenesis and bacterial
killing in animals87. Therefore, GtgE-mediated Rab32 degradation allows the survival of intracellular
S. Typhimurium in deficient lysosomes within animal hosts. Spanò and Galán (2012) demonstrated
that the expression of GtgE in engineered S. Typhi enabled the normally human-specific pathogen to
survive in a mouse and thus demonstrated an example of how host specificity is controlled87.
1.7.2 Gene Acquisition
1.7.2.1 Vi capsule and immune evasion
S. Typhi also encodes unique virulence factors, e.g. Vi antigen. Vi is a polysaccharide antigen that
forms the capsule surrounding S. Typhi (Fig.1.4). It is thought that Vi masks S. Typhi from the
immune system, inhibiting an immune response in comparison with S. Typhimurium88. Infecting mice
with Salmonella Typhi lacking the Vi capsule allowed host immune deposition of complement proteins
(C3) on Salmonella, resulting in Salmonella clearance from mouse tissues89. However, typhoidal
serovars S. Paratyphi and S. Sendai do not express Vi, but can still cause enteric fever. Additionally,
S. Typhi with Vi mutation still causes a typhoid-like illness90. Therefore, it is likely that virulence
factors of S. Typhi work in combination to cause typhoid fever.
1.7.2.2 The typhoid toxin.
A major focus of the field has been understanding how S. Typhi causes invasive typhoid fever while
the highly-related NTS serovars cause non-invasive gastroenteritis. Genomic analysis of S. Typhi and
S. Typhimurium revealed a novel toxin encoded only in S. Typhi91 (Fig.1.5a, 1.5c). Similarly, other
typhoidal strains encode the typhoid toxin such as S. Paratyphi which highlights its importance92.
Although the typhoid toxin is largely absent in 2000+ NTS serovars, 15 NTS serovars were found
to encode typhoid toxin homologues, the best-characterised being S. Javiana, which encodes Javiana
toxin93,94.
1.8 The role of the typhoid toxin in disease
At the outset of my PhD, the typhoid toxin had been identified as a novel chimeric exotoxin secreted
by typhoidal Salmonella 81,95,96. In a seminal Nature paper in 2013, intravenous injection of purified
typhoid toxin into a mouse was shown to induce the deadly symptoms of typhoid fever including
100% lethality, which followed weight loss and decreased number of monocytes and neutrophils81,97.
In contrast, the typhoid toxin facilitated host survival in a mouse model infected with S. Typhimurium
engineered with the toxin islet78. The toxin suppressed intestinal inflammatory responses, promoted
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host survival and established chronic bacterial carriage whereby only animals infected with toxigenic
Salmonella were viable at 6 months. Similarly, the NTS strain, S. Javiana, encodes the Javiana
toxin with an identical CdtB subunit to the typhoid toxin. Mice infected with wild-type S. Javiana
exhibited reduced pathology, intestinal inflammatory responses, and increased systemic spread relative
to infection with S. Javiana ∆CdtB98,99. These mouse infection studies indicated that the toxin plays
an immune-evasive role important in suppressing innate immune responses and establishing systemic
infections, which contrasted with studies using purified toxin that indicated a role in acute typhoid
symptoms. Indeed, human infection challenge with wild-type S. Typhi and the toxin null mutant
showed that the toxin was not involved in initiating acute typhoid fever but instead reduced human
pathology and played a significant role in systemic phenotypes such as bacteraemia100. The toxin-
induced phenotypes during infection, i.e. survival, bacteraemia and chronic carriage78,99,100, and the
increased mortality observed with intravenous injection of the toxin81, represent the conflicting disease
outcomes of typhoid fever patients (Fig.1.1).
Since its discovery the typhoid toxin has been considered one of the main virulence factors of S.
Typhi and became at the forefront of the research on typhoid fever. This thesis specifically addresses
the effects of the typhoid toxin on host human cells. The next part of this chapter described the
typhoid toxin in more detail.
1.9 Typhoid toxin structure and function
1.9.1 AB toxins
The typhoid toxin belongs to a large family of potent proteins known as the AB toxin family81,101,
which encompasses many plant and bacterial toxins. The family’s name is derived from their composi-
tion of two subunits, A and B102. The “A” subunit is for “active” and usually refers to enzymatically
active subunits that exert an effect on host cells. The “B” subunit refers to proteins which mediate
“binding” to the receptor. The typhoid toxin was discovered by virtue of its similarity to cytolethal
distending toxins (CDTs). CDTs are tripartite proteins (i.e. consist of 3 subunits) secreted by a
variety of Gram-negative bacteria including Haemophilus ducreyi, Escherichia coli and Shigella 97 and
usually adopt an AB2 structure. The three subunits are CdtA, CdtB and CdtC
103, where CdtB is the
A subunit, and CdtA and CdtC are the B subunits. However, interestingly Salmonella Typhi did not
encode CdtA and CdtC but still induced toxigenic effects dependent upon CdtB91. In 2008, Spano
and colleagues found that the CdtB of typhoid toxin formed a complex with PltA and PltB96, which
are homologues of pertussis toxin (Fig.1.5a, 1.5c), an AB5 toxin (i.e. 1 PltA is the A subunit bound
to 5 PltB) that contributes to whooping cough during Bordetella pertussis infection104.
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Figure 1.5|The typhoid toxin synthesis and transport. a, The typhoid toxin encoding island depicting
the three subunits and a murmidase, ttsA. b, Illustration of the Salmonella membrane showing assembly of
the toxin subunits in the periplasm. Potential holins and ttsA collaborate to allow for the holotoxin to be
secreted out of Salmonella. c, The 3D structure of the typhoid toxin81. d, Only when Salmonella is in the
SCV, does it secrete the typhoid toxin. The toxin is then sorted into vesicle carrier intermediates via its
PltB subunit that binds to the Neu5Ac receptors, trafficked to the membrane and exocytosed. e, Retrograde
trafficking of the typhoid toxin in an autocrine and/or paracrine manner.
1.9.2 Evolution of the structure of the typhoid toxin
The typhoid toxin is a unique chimeric toxin that adopts an A2B5 architecture
81,92. The “A”
subunits are composed of PltA (pertussis toxin) and CdtB (cytolethal distending toxin), which are
usually independent bacterial toxins105. The “B” subunit is composed of five PltB (Pertussis-like
toxin B) subunits, a homologue of one of the components of the heteropentametric B subunits in
pertussis toxin (Fig.1.5a, 1.5c).
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1.9.3 CdtB of the typhoid toxin
In the typhoid toxin, the CdtB has structural and functional homology to mammalian DNase97.
Early studies characterised the function of CdtB through experiments using other bacterial CDTs
that constitute CdtB homologues97.
Structure alignment of H. ducryei CdtB with DNase I revealed two conserved catalytic histidines
(H160 and H274) critical for toxicity. Similar to DNase, wildtype CDT showed cell cycle arrest
and plasmid relaxation in vitro. In fact a point mutation on the catalytic position histidine 160 to
glutamate (i.e. H160Q or toxHQ) abolished toxicity in vitro 97. However, in comparison to bovine
DNase I, CdtB only retains 0.01% activity in vitro, which has been attributed to the presence of
Valine at position 118 in CdtB in place of a glutamate in DNase97. In addition, three DNA substrate
binding residues, Arg 144, Asn 201, Arg117 were found in CdtB at the equivalent 3D positions in
DNase (Arg11, Asn170, and Arg41 respectively)97. Triple-mutant of these domains diminished toxic
activities but did not abolish it, providing insight into CdtB and DNA interaction.
The CdtB of typhoid toxin showed ∼50% sequence identity to the CdtB of H. ducryei whereby
the catalytic and DNA binding residues were conserved81. Regardless of the structural differences
to DNase, comet assays performed in vivo and in vitro indicate that the typhoid toxin causes DNA
fragmentation via its CdtB subunit106,107.
Indeed, when the typhoid toxin was applied to cultured cells, it resulted in a DNA damage re-
sponse, cell cycle arrest and cell distension81,96,106, which have become the established readouts for
assaying toxicity. Interestingly, all observed effects of the typhoid toxin described in Section 1.8
were dependent on eliciting a DNA damage response (DDR) by the CdtB nuclease activity. Deleting
or rendering the CdtB subunit inactive via H160Q point mutation, reversed all these effects of the
typhoid toxin. This implicates the DNase activity of the typhoid toxin in the disease phenotypes of S.
Typhi. Most recently, our lab106 implicated the CdtB-induced DNA damage response in senescence
(discussed in Chapter 2), which enhanced Salmonella infections in host human cells.
CdtB is bound to PltA by disulphide bonds mediated by C-terminal cysteines in PltA (Cys214) and
CdtB (Cys269) (Fig.1.5c)81,105. These cysteine residues are specific to the typhoid toxin subunits and
missing from their respective homologues in other species, i.e. pertussis toxin in Bordetella pertussis,
and CDTs in a broad range of Gram negative bacterial pathogens. When the toxin is exposed to a
reducing environment, e.g. the cytosol of the cell, the disulphide bond is broken and CdtB is free to





PltA has ADP-ribosyl transferase activity with unknown targets. When intestinal epithelial cells
were infected with a PltA mutant S. Typhi, the toxin lost its intoxication ability. Mutating its catalytic
residue however showed no difference to the wild type toxin, demonstrating that PltA is only required
for CdtB-mediated toxicity, i.e. by linking CdtB to the receptor binding subunit PltB (Fig.1.5c)96.
1.9.5 PltB subunit
The typhoid toxin has five PltB subunits arranged in a pentameric structure with a central channel.
PltB subunits are thought to have a binding site that bind oligosaccharides in a location similar to
subunits in other toxins that are known to bind glycoproteins81. The linear arrangement of the
subunits within the typhoid toxin dictate that there would be no interaction between CdtB and PltB,
since PltA is located between these two subunits (Fig.1.5c).
1.10 Production and secretion of the typhoid toxin
S. Typhi is thought to invade intestinal epithelial cells, M cells, and immune cells such as macrophages
by adhering to their surface and getting internalised. It is only when S. Typhi invades human cells and
resides in the SCV does it start to express the typhoid toxin from ∼3h post-infection91,96(Fig.1.5d).
The genome islet of the typhoid toxin encodes the toxin subunits pltB, pltA and cdtB plus the
sty1889 gene, also known as ttsA (Fig.1.5a). The proximity of ttsA to the genes that code for the
toxin indicated functional relevance. TtsA is a muramidase and belongs to a class of bacteriophage
endolysins, which when knocked out led to the disruption of toxin secretion95. Although bacteriophage
muramidase activity usually leads to bacterial lysis, it is thought that TtsA has been adapted to secrete
the typhoid toxin in S. Typhi. In this context, it is thought that TtsA is transported by unidentified
holins that form a channel through the inner bacterial membrane, where it leads to small holes in the
bacterial membrane (particularly the peptidoglycan) to allow for toxin to be released92(Fig.1.5b).
Each PltB/PltA/CdtB subunit peptide has a secretion signal that allows its secretion via sec machinery
from the bacterial cytoplasm into the periplasm between the inner and outer membrane of Salmonella.
The toxin is then assembled in the periplasm before being secreted into the SCV92 (Fig.1.5b).
Once the toxin is synthesised and secreted from the pathogen, it traffics via small carrier inter-
mediate vesicles derived from the SCV (Fig.1.5d). As the SCV is a compartment created from the
host cell membrane, it was hypothesized that the toxin is sorted via its receptor-binding subunit PltB.
Indeed mutating the PltB prevented the packaging of the toxin in the vesicle intermediate, and the
subsequent exocytosis, providing yet another role for PltB in toxin packaging in the host cell108. Next,
the carrier intermediates are targeted to the invaded cell membrane where they fuse and exocytose
the toxin. The toxin then either acts on the same host cell where the Salmonella resides (autocrine)
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or on a neighbouring cell (paracrine)96.
1.11 Typhoid toxin interactions with cell surface receptors
Co-immunoprecipitation of purified typhoid toxin revealed that all toxin receptors were glycosy-
lated109, which allows the toxin to bind to diverse receptors on different cell types. Mutations affecting
the N-glycans of these receptors rendered cells more resistant against the toxin. Protein-protein in-
teraction arrays81 and glycan microarray experiments109 found that the toxin preferentially binds
to receptors associated with the glycan consensus Neu5Ac on glycoproteins which is predominant in
humans (Fig.1.5c, 1.5d). In contrast, other mammals express sialylated glycans terminated with
Neu5Gc instead109. Human cells that were grown in Neu5Gc rich media conferred resistance to the
toxin, indicating that Neu5Ac might be a factor that confers toxin specificity to humans109. The
expression of either Neu5Ac or Neu5Gc in humans is dictated by the CMAH gene. In humans CMAH
is absent leading to the up-regulation of Neu5Ac, while other mammals, such as chimpanzees express
CMAH more prominently, resulting in the up-regulation of Neu5Gc.
Consistent with the fact that chimpanzees express Neu5Gc, S. Typhi only caused mild symptoms
that are similar to the NTS110. On the other hand, mice express Neu5Ac in most of their tissues
due to low level activation of Neu5Gc, and demonstrate typhoid fever symptoms upon intoxication,
making them a suitable model to examine the toxin in vivo.
1.12 Internalisation of toxin in the host cell.
The process of the toxin internalisation was only recently examined via fluorescently tagged ty-
phoid toxin111. After binding to the host cell receptors, the typhoid toxin undergoes receptor-mediated
endocytosis, retrograde trafficking into the Golgi apparatus, and then trafficks to the ER where re-
ductases break the disulphide bond between the CdtB and PltA subunits (Fig.1.5e). Genome-wide
screen using CRISPR/cas9 technology revealed that the release of the subunits into the cytosol is
mediated by proteins involved in the Endoplasmic-reticulum-associated protein degradation (ERAD)
pathway that usually targets misfolded proteins. This internalisation process is analogous to other
AB5 toxins
112,113,114,115,116, whereby the toxin is disassembled into its functional subunits using the
host cell’s own machinery. As a result, free CdtB is released into the cytosol where it targets the
nucleus and causes DNA damage, cell cycle arrest and cell enlargement81,106. The CdtB DNAse
activity was required to achieve the conflicting diseases outcomes i.e. mortality, and survival of the
host, described in Section 1.8.
Prior to discussing the DNA damage induced by the toxin, it is prudent to introduce DNA damage






One of the most vital components of every eukaryotic cell is its nuclear DNA. DNA is a complex
macromolecule in the form of a double helix that is responsible for encoding all proteins necessary for
survival and the function of the cells and organisms. A double membraned nuclear envelope surrounds
DNA to organise and protect it from damage. Everyday our genomic DNA is subjected to thousands
of intrinsic (e.g. reactive oxygen species as a result of metabolism) and extrinsic (e.g. UV radiation)
inducers of DNA damage. Therefore, it is necessary for the cell to resolve the damage in order to
sustain its survival and functional integrity, which is achieved via a DNA damage response (DDR).
The DDR stalls or arrests the cell cycle to prevent the propagation of corrupted genetic information
into daughter cells. This is important to prevent aberrant phenotypes such as cancer cell formation.
Throughout the past few decades, scientists unveiled evolutionarily conserved mechanisms to repair
the damage that occur, which have become the centre of many research fields particularly oncology
and gerontology. This chapter will focus on the DDR mechanisms and the resulting cell fate if the
DNA damage is unresolved, with particular focus on senescence responses.
2.2 Cellular organisation of DNA
Most human cells, excluding spermatozoa and ova, are diploid, i.e. contain two copies of 23 chro-
mosomes per nucleus, containing ∼3 billion base pairs117. In order to compact the lengthy DNA
in the small nuclear structure, the double helix is coiled around proteins known as histones forming
a nucleosome118. Each nucleosome consists of a core octamer made of two copies of each histone:
H2A, H2B, H3, H4, to which the DNA coils around. Histones are positively charged which allow
tight binding to the negatively charged DNA119. The formation of multiple nucleosomes results in
the commonly known structure, chromatin, which forms chromosomes120. Histones are susceptible to
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Figure 2.1|The cell cycle. Illustration of the various stages of the cell cycle. At certain stages, the cell
deploys checkpoints to ensure that DNA replication is error free via recruitment of cyclins and cyclin dependent
kinases (CDK). If damage occurs, CDK inhibitors, such as p16, p15, p21, and p27 ensure cell cycle arrest until
damage is repaired.
post-translational modifications such as ubiquitination, methylation, acetylation and phosphorylation,
which play a pivotal role in the chromosome structures, chromatin remodeling and transcription121.
Chromatin is subdivided into euchromatin, which are gene-dense and accessible for transcription,
and heterochromatin, which are inaccessible and hidden from transcription machinery120. The com-
plex organisation of DNA allows for diverse regulatory processes involving cell division, DNA repair
pathways and epigenetic changes that dictate cellular fates.
2.3 The cell cycle
Undifferentiated cells undergo DNA replication to generate copies of the same genetic material
and allow for cell division, which is essential in processes such as embryogenesis, wound healing
and regeneration. The cell goes through a cell division cycle that is subdivided sequentially into
G1, S, G2, (collectively interphase) and M phase (Fig.2.1). DNA replication occurs during the S
(or synthesis) phase, which is preceded by a gap phase (G1) that prepares for DNA synthesis and
succeeded by another (G2) which prepares the cell for cytokinesis and cell separation122. When a
cell becomes differentiated or adopts what is known as ‘quiescence’, the cell exits the cell cycle and
enters a G0 phase (Fig.2.1). The cell cycle is a carefully regulated process governed by ‘checkpoints’
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Figure 2.2|DNA damage pathways activated upon single-strand or double-strand DNA damage.
Simplified drawing depicting sensors, transducers, mediators and differential outcomes of each pathway. Upon
DNA damage all the three signalling pathways can converge to repair DNA damage or decide cell fate.
that ensure that replication is error-free. These checkpoints lie between G1/S or G2/M phase and are
monitored by cyclins and their substrate cyclin-dependent kinases (CDK) that start a phosphorylation
cascade promoting progression through the cell cycle. Occasionally, where DNA damage occurs, CDK
inhibitors such as p21, which is a target of p53, prevent the formation of cyclin-CDK complex, lead to
cell cycle arrest and begin a DNA damage response123 (Fig.2.1). Another cell cycle modulator is p16,
which inhibits CDKs and cyclins (e.g. CDK4 and cyclin D), thereby preventing the phosphorylation
of retinoblastoma tumour suppressor protein (Rb). Rb forms a complex with E2F an elongation factor
required for cell division, and arrests the cell cycle at G1 phase124.
2.4 The DNA Damage response
Depending on the form and extent of DNA damage, our cells elicit an appropriate DNA damage
response to maintain normal function and survival. One of the most significant forms of DNA damage
include single strand breaks (SSB), which if unresolved can develop into double strand breaks (DSB),
thus resulting in genomic instability125. Master regulators of the DDR are the phosphatidylinositol-3-
kinase related kinases (PIKK): Ataxia Telangiectasia Mutated protein (ATM), Ataxia Telangiectasia
and Rad3 related protein (ATR), and DNA-dependent protein kinase (DNA PKcs) (Fig.2.2). In
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response to DNA damage breaks, histone H2AX is phosphorylated by kinases to phospho-H2AX (i.e.
γH2AX) at position serine 139126. γH2AX then acts as a signal hub for recruitment of repair pro-
teins127, transcription factors or cell cycle regulator to mediate repair128,129. Though redundancy
exists, ATM, ATR and DNA-PKcs principally phosphorylate H2AX in response to two distinct types
of DNA damage: ATM and DNA PKc recognise DSB while ATR responds to SSB at DNA replica-
tion forks130,131,132,133. Recognition of DNA damage activate PIKK134, which then recruit mediator
proteins by phosphorylating diverse substrates to (i) pause the cell cycle, (ii) mediate repair, and (iii)
decide on cell survival135(Fig.2.2).
2.4.1 Single-strand break repair pathway
SSBs are by far the most common form of DNA damage that occur in the mammalian cell, usually
due to intrinsic stresses by metabolites such as reactive oxygen species (ROS)136. It can also occur
as a result of a malfunctioned replication fork. For instance, during S-phase, DNA topoisomerase 1
nicks one DNA strand, to relax and unwind the double helix transiently, allowing access of replication
machinery. As a result, a single-stranded DNA (ssDNA) forms. However, if topoisomerase fails to
reseal the ssDNA, for example by colliding with DNA polymerases or RNA transcription machinery,
this can result in a SSB and replication fork stalling, known as replication stress137.
To prevent SSB formation, Replication Protein A (RPA), a tripartite protein consisting of 60KDa,
32KDa, and 14 KDa subunits138, binds and coats exposed ssDNA. Next, ATR-interacting protein
(ATRIP) recognises ssDNA-RPA complexes and results in the recruitment and autophosphorylation
of ATR139,140 (Fig.2.2, left panel). Activated ATR subsequently phosphorylates RPA at serine 33
(RPApS33) and threonine 21 (RPApT21)141 to mediate DNA synthesis and repair139. Next, ATR
mediates repair locally and prevents further global replication firing until the SSB is repaired, by
phosphorylating its substrate CHK1 which diffuses to exert action in the nucleus142. The ATR ki-
nase signal is then amplified by a trimer complex known as 9-1-1 (RAD9, RAD1 and HUS1) and
TOPBP1143,144. CHK1 is a checkpoint surveillance protein which controls the cell cycle through
recruitment of p53145,146, which is a transcription factor that activates cyclin-dependent kinase in-
hibitors such as p21147. As a result, replication is halted until the damage is resolved. Inhibiting ATR
leads to failed repair locally and causes unscheduled global replication origin firing resulting in the ac-
cumulation and persistence of ssDNA across the genome. This was termed “replication catastrophe”,
where the finite pool of RPA is exhausted by excess substrate ssDNA that can become unprotected
resulting in fork collapse, double-strand breaks and permanent exit of the cell cycle148.
2.4.2 Double-strand break repair pathway
The production of DSB is the most lethal form of DNA damage a cell can encounter. Its effects
can sometimes be deleterious of genes that might be important for cell survival149. They can form as
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a result of collapsed replication forks or other exogenous sources such as the chemotherapeutic agent,
aphidicolin (APH), that inhibits DNA polymerase α activity and results in replication stress (Glover
et al 1984).
At the site of DSB, the MRN complex which constitutes (Mre-11 Rad50, Nbs1) detects the dam-
age and recruits ATM150 which is the main driver of DSB repair signalling (Fig.2.2, right panel).
Experiments with APH-induced replication stress revealed that the activation of ATM is also partially
dependent on ATM-interacting protein, ATMIN129. ATM is activated by auto-phosphorylation and
subsequently activates various effectors such as CHK2, another cyclin and checkpoint regulator. In
contrast to ATR, ATM leads to recruitment of the p53-binding protein, 53BP1 which tethers ATM
to the double strand breaks and initiates a recruitment cascade for DSB repair. Similar to ATR,
ATM-dependent activation of 53BP1 can also prime the activation of p53 which results in cell cycle
arrest, making 53BP1 a tumour suppressor protein151. During DSB repair, ssDNA forms which can
activate ATR signaling in conjunction with ATM kinase activity at the same damage site152. When
ATM was knocked down in irradiated cells, low levels of γH2AX were detected. Blocking DNA-PKc
but not ATR via wortmannin abrogated the low level of DNA damage observed in ATM knockout
cells, indicating that DNA-PKc is secondary to ATM as a sensor of DSB128. DNA-PKcs autophospho-
rylates after binding to Ku proteins, which are sensors of DSB to initiate repair. Whilst DNA-PKc
plays an important role in DSB repair, its activity dominated over ATM particularly in apoptotic
cells131 (Fig.2.2, right panel).
Although the cell has a DNA damage contingency plan in place, extensive DNA damage might
not always be successfully repaired. At this stage, the cell must eliminate the problem to prevent
aberrant DNA replication and oncogenic phenotypes. The cell either adopts apoptosis or senescence.
2.4.3 Apoptosis
Apoptosis is non-inflammatory programmed cell death which is initiated after extensive, unrepaired
DNA damage153. Apoptotic cells are marked by DNA fragmentation, chromatin condensation, and
nuclear shrinkage due to a cascade of signalling involving activation of caspases that carry out mass
proteolysis. In terms of DDR, studies showed that the phosphorylation of H2AX by DNA-PKcs, but
not by ATM, is required for apoptosis131. In early apoptosis, γH2AX which is typically observed as
foci, migrates to the periphery of the nucleus, forming an ‘apoptotic ring’, while maintaining a pan
distribution of H2AX154. Localised with this ring are ATM, Chk2 and DNA-PKc. In late stages of
apoptosis, γH2AX becomes distributed across the whole nucleus. If the DNA damage is persistent





Senescence is a phenomenon whereby the cell exhibits several key features, namely irreversible cell
cycle arrest, resistance to cell death signalling and production of a characteristic secretion profile called
the senescence-associated secretory phenotype (SASP)155. The cell decision between senescence and
apoptosis is an unclear process. Recent findings implicate High mobility group box-1 (HMGB1) and
the degree of p53 activation as a contributing factor to these cell fates. Indeed after treating cells with
the topoisomerase 2 inhibitor doxorubicin, senescent cells showed elevated HMGB1 and p21, whilst
apoptotic cells showed diminished levels of both proteins156. Although senescence and quiescence
are terms that are sometimes misused interchangeably, they vary molecularly and morphologically.
Quiescence is a reversible cell-cycle arrest state that can be triggered due to lack of nutrients (such
as serum-starvation) or differentiation. Given favourable environmental or molecular signals, the cell
can resume the cell cycle. In contrast, senescence is an irreversible stress-response that normally
accumulates during the ageing process of an organism or induced by extensive DNA damage157.
At the outset of my PhD, we discovered that the typhoid toxin induction of DNA damage via the
CdtB subunit resulted in a senescence-like response106. Therefore, before describing these results,
the rest of the literature review will discuss hallmarks of senescence, the benefits and drawbacks of
senescence, and provide insight into host-pathogen interactions with cellular senescence.
2.5 Characteristics of cellular senescence
As the development of cellular senescence is temporal and occurs in stages, there is not a single
gold standard universal marker of senescence to this day. To identify senescent cells, researchers utilise
various markers of senescence in combination. These include morphological changes, DDR pathways,
metabolic changes and other molecular changes155(Fig.2.3).
Permanent cell cycle arrest. The most established marker of senescence is irreversible cell
cycle arrest often mediated by a sustained p53 activity and activation of different CDK inhibitors
such as p21WAF/Cip1, p16INK4A, and p15INK4b 158,159. This is supported by colony forming assays and
experiments showing that senescence cells are unable to incorporate thymidine analogues (e.g. EdU)
added to cell culture media, signifying inability to divide160.
Morphology and lysosomal activity. Senescent cells typically display an enlarged, flattened,
and granular phenotype, which is easily observed using light microscopy. Perhaps the most commonly
used marker is the up-regulation of the lysosomal marker senescence-associated β-galactosidase activ-
ity (SA-β-gal)161. However, the limitation of SA-β-gal is that quiescent cells can sometimes display
SA-β-gal. For example, healthy macrophage cells show intrinsically high levels of SA-β-gal in the
absence of genotoxic stresses during polarisation in response to immune signals162. Alternatively,
∗Fig.2.3 was published as part of Humphreys et al 2020 (Cells). Access via this link.
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Figure 2.3| Hallmarks of senescence. The figure demonstrates different types of senescence and the most
common features of senescent cells. ∗
lipofuschin, which is an aggregate of proteins and lipids that represents residues of lysosomal diges-
tion, is used58.
DDR and nuclear structure. As previously described, senescent cells can display a chronic DDR
marked by persistent γH2AX foci and downstream effectors such as ATM and ATR. However, DDR
is often triggered independently of a senescence response, and in some cases, is absent in senescent
cells. Therefore, this marker is not used solely to identify senescent cells163. Nuclear size can also
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increase, and senescent cells sometimes display multi-nucleation that is a result of failed mitosis in
G2/M phase (i.e. presence of 2 copies of each chromosome; 2N to 4N)164,165.
Lamin B1 down-regulation. Other nuclear changes that occur in senescence is the down-
regulation of the nuclear envelope protein, lamin B1. This was observed in various types of senes-
cence including irradiated cells, constitutive ras-oncogene activation and replicative senescence166. In
contrast, over-expressing lamin B1 improved proliferation rate and delayed onset of senescent pheno-
types167. Interestingly, loss of lamin B1 was also reported to be essential for the development of a
full senescent phenotype168. In addition, it resulted in global chromatin remodelling and cytoplasmic
chromatin fragments (CCF)169.
Chromatin remodelling. In normal cells, chromatin is composed of euchromatin, which allow
for transcription, and heterochromatin, which is hidden from transcription machinery120. One of the
observable changes in chromatin structure of senescent cells is the generation of senescence-associated
heterochromatin foci (SAHF), which is mainly reported in oncogene-induced senescence170,171. SAHF
constitutes repressive histone marks such as methylation H3K9me3 that is different from facultative
heterochromatin mark H3K27me3172. SAHF formation results in repressing proliferative genes, such
as E2F, and prevents accessibility of DDR proteins causing resistance to apoptotic pathways172.
Anti-apoptotic properties. In addition to suppressing extensive DDR, senescence cells display
increased signalling of pro-survival genes such as BCL2 which is activated due to up-regulation of
transcription factor NFκB173. As a result, senescent cells can resist cellular death and survive for an
extended duration regardless of initial DNA damage induction.
Senescence Associated Secretory Phenotype (SASP). SASP is a cohort of molecules, typi-
cally inflammatory molecules, growth factors, cytokines and chemokines that are secreted by senescent
cells. SASP constituents vary depending on the senescence inducer and the cell type174. Therefore, a
‘gold standard’ SASP signature is still not discovered, especially in vivo. However, a recent library of
its constituents, namely “SASP Atlas”, revealed core SASP proteins that were secreted by senescent
epithelial and fibroblast cells using different senescence induction methods, and matched with blood
plasma analysed from an ageing population174. The top candidates included GDF15, SERPINs and
MMP. Interestingly, senescent fibroblasts that resume cell proliferation due to an inactivation in p53,
still retain most SASP constituents, which indicates that SASP is a more permanent characteristic of
senescence than cell cycle arrest175.
2.6 Senescence - The Bright and Dark Sides
Senescence has been typically acknowledged as an anti-tumorigenic phenomenon and represents
a defence mechanism against pathologies that require cell proliferation. Normally, senescent cells
accumulate as the organism ages, resulting in age-related pathologies such as osteoarthritis, diabetes,
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Alzheimer’s and cardiovascular diseases176. Indeed, transplanting senescent cells in young mice led to
physical weaknesses as measured by their grip endurance, maximal speed and hanging endurance177.
In contrast, ablating senescent cells (via senolysis) improved their health and strength, and prolonged
the life span of ageing mice177. Since senescence has anti-tumorigenic properties, but is the basis of
age-related diseases, is senescence beneficial or detrimental?
Different types of senescence have been identified: i) replicative senescence ii) oncogene-induced
senescence, iii) genotoxin-induced senescence, iv) developmental senescence, v) tissue repair senes-
cence, and vi) paracrine senescence.
Replicative senescence (RS). This type of senescence was the basis of the discovery that cells
undergo a finite amount of cycle before they undergo permanent cell cycle arrest178. At every chro-
mosomal replication, telomeres, which are nucleotide sequences found at the end of each chromosome,
get shorter. This process is known as telomere attrition and is due to incomplete chromosomal replica-
tion. Since telomeres are non-coding they prevent deletion of important genes within the chromosome.
However, critically short telomere lengths are detected as DNA damage and elicit a DDR that activates
a senescence-like response to prevent further replication and damage to coding genes143,179.
Oncogene-induced senescence (OIS). Independent of RS, OIS is triggered upon activation of
aggressive oncogenes, such as RAS180. Oncogene activation results in replication stress, the formation
of multiple DSB and the activation of DDR181. It is thought that OIS together with RS is adopted
to prevent the uncontrolled cell division and the carcinogenesis of normal cells by arresting the cell
cycle in G1 phase182.
Genotoxic-induced senescence (GS). Similarly to OIS, GS is elicited by subjecting cells to
external DNA damage inducing agents such as irradiation, chemotherapeutic drugs (e.g. aphidicolin or
etoposide, a topoisomerase II inhibitor), and bacterial toxins, or internal agents such as ROS generated
due to aberrant metabolism183,184. DNA damage induction results in DSBs which orchestrate a
stabilised DDR leading cells into senescence184,185.
Developmental and tissue repair senescence. These two types are not as well-addressed as
RS, OIS, and GS. It is evident that senescence is an intrinsic mechanism used in non-disease contexts
as well, for example, during embryogenesis. Given their high secretion profile, it is thought that SASP
might contribute to cell fate and stem cell control. Similarly in wound healing, secretion of growth
factors such PDGFAA recruit immune cells that aid the process of tissue regeneration186.
Paracrine senescence. Also known as transmissible senescence, this type of senescence is in-
duced via secretions of senescent cells, SASP, that transmit senescence to neighbouring cells that are
otherwise healthy. It is usually less potent than primary induced senescence but can confer beneficial
and detrimental effects, which are discussed in the following sections155,187.
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2.7 Senescence Associated Secretory Phenotype (SASP) – Friend
or Foe?
SASP is capable of altering the tissue microenvironment by inducing transmissible senescence in
surrounding näıve cells188. SASP can be composed of soluble factors that act on receptors, non-
soluble factors secreted via exosomes, and secreted proteases. Proteases can then cleave membrane
bound receptors, break down the extracellular matrix or inhibit secreted soluble molecules thereby
modulating the tissue microenvironment189. Many of the benefits and drawbacks of senescence in
the literature have been mainly attributed to the composition, timing and duration of SASP190.
Paradoxically, SASP is a sword with two-edges depending on organismal context. It can be beneficial,
e.g. in tumour suppression, wound healing and immune clearance or it can be detrimental, e.g. chronic
inflammation and cancer promotion191.
2.7.1 SASP as a friend
SASP is important to maintain normal physiological functions of mammals and other organisms.
As described in developmental and tissue repair senescence in Section 2.6, SASP is imperative from
embryonic stages into adulthood. In embryos, SASP recruits immune cells that eliminate senescent
cells in order to balance cell populations in each organ. In p21 knockout mice, that are incapable of
undergoing senescence, apoptosis compensates, albeit resulting in embryonic deformities192. SASP
can also cue for tissue development via growth factors essential for organogenesis such as TGF and
FGF193.
Progressing into adulthood, SASP has a clear impact on important homeostatic processes such as
wound healing. At the site of wound infliction in mice, senescent fibroblasts and endothelial cells were
observed. Interestingly, double knockout mice (p21/p16) displayed a lack of PDGF-AA, which is a
prominent SASP factor, resulting in delayed wound closure191. In addition, SASP was shown to limit
liver deterioration following injury. In mice primed to develop liver fibrosis, senescent cells enhanced
degradation of the extracellular matrix and immune cell recruitment, via SASP, which were essential
in liver repair194.
Furthermore, SASP can reinforce senescence in an autocrine manner via chemokine signalling,
to prevent tumorigenesis195. Chemokine signaling recruits immune cells such as natural killer cells,
neutrophils, monocytes, macrophages, dendritic cells, B cells and T cells to eliminate senescent cells
and prevent their chronic accumulation196,197, which is essential in development and wound healing.
Interestingly, although SASP has important functions in physiologically healthy organisms, it can
have detrimental effects if senescent cells accumulate and SASP becomes chronic.
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2.7.2 SASP as a foe
In an ageing organism, senescent cells accumulate, for example due to telomere attrition (discussed
in Section 2.6), resulting in immuno-senescence, i.e. senescence of immune cells and a chronic pro-
inflammatory SASP known as ‘inflamm-aging’198. Inflammaging was correlated to many age-related
diseases such as cardiovascular disease, Alzheimer’s and cancer190,199.
SASP has been implicated in the development, invasion and metastasis of many cancers including
breast cancer and melanoma amongst others189. When senescent fibroblasts were incubated with
pre-malignant cells, tumorigenesis was induced200. When they were incubated with malignant cells,
cancer progression was accelerated201. As SASP is rich in pro-angiogenic factors such as vascular
endothelial growth factors (VEGF), tumours in vivo were highly vascularised in presence of senescent
cells compared to non-senescent cells. Given the pro-tumorigenic effects of SASP, its impact drives
chemo-therapy resistance in vivo 184,202.
Although short-term exposure to SASP was described as beneficial in wound healing, chronic SASP
on the contrary ameliorates it. SASP transmits senescence to stem and progenitor cells required for
differentiation, and thereby preventing their normal function of tissue regeneration203.
2.8 The complex regulation of SASP
SASP regulation involves a complex interplay of intrinsic and extrinsic signaling pathways. The
most recognized transcription factors involved in a pro-inflammatory SASP are CCAT/Enhancer
Binding Protein (C/EBPβ) and NFκB204.
C/EBPβ, is a transcription factor able to promote expression of inflammatory SASP proteins such
as IL-1β, GROα and IL-6195. Indeed, studies have shown that C/EBPβ binds to IL-6 promoter in
OIS205. Interestingly, the action of C/EBPβ is further modulated by an alternative isoform, C/EBPγ
which heterodimerizes with C/EBPβ to suppress SASP gene transcription206. Furthermore, sustained
DDR in senescent cells were shown to increase NFκB signaling activity that was activated by IL-1β
expression207 and enhanced by p38 MAPK signaling208. Indeed, inhibiting NFκB signaling via met-
formin resulted in a significant reduction of CXCL5, IL-6 and IL-8209. Conversely, JAK2/STAT3
activation resulted in secretion of anti-inflammatory proteins such as IL-10 and IL-13. Inhibiting
JAK2/STAT3 signaling pathways in PTEN-null mice, favoured an NFκB-induced inflammatory phe-
notype and immune cell filtration210.
SASP is also regulated on an epigenetic level via chromatin remodelling, triggered by lamin B1
downregulation169. For instance, senescent cells lose the repressive histone modification H3K27me3
which results in activation of SASP genes169. Additionally, the nuclear protein, HMGB2 is enriched
in OIS cells, and excludes relevant SASP genes from SAHF to allow for their transcription during
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Figure 2.4| Senescence and host-pathogen interactions. Illustration of the diverse interactions between
viruses/bacteria and senescent host cells.∗
senescence211, and promoted by NFκB and p38 MAPK signalling212.
2.9 Senescence and Host-pathogen interactions
Given the regulation of inflammation and immune system in senescence, it is not surprising that
there are emerging roles for senescence in viral and bacterial pathogenesis. In some cases, pathogens
can subvert senescence in their favour, while in other cases senescence is a host-defence mechanism
against pathogens or a driver of pathogen-associated oncogenesis. This section will highlight some
examples of senescence as a host-defence mechanism and other examples as a pathogen-subversion
mechanism in favour of infections213 (Fig.2.4).
∗Fig.2.4 was published as a graphical abstract for Humphreys et al 2020 (Cells). Access via this link.
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Viruses can induce senescence via replication stress. Chronic viral infections can lead to
immunosenescence, a process whereby immune cells show decreased function and adopt senescence213.
For instance, human cytomegalovirus (HCMV) is a double stranded DNA virus that causes herpes and
results in latent infections. Continuous antigen exposure of HCMV results in T lymphocytes clonal
expansion, possibly leading to telomere shortening and replicative senescence214,215,216. It is thought
senescence might be induced to allow these cells to sustain viral burden and prevent apoptosis. This
is indeed the case for the human hepatitis C virus (HCV) where chronic infections of the liver are
common, and leads to liver fibrosis and cirrhosis217. Memory T-cells exhibited significantly shorter
telomeres compared to uninfected individuals, which is indicative of immunosenescence (Fig.2.4, top
left panel)218. This phenomenon aids the promotion of chronic viral infections219.
Bacteria can induce senescence via genotoxic stress. Increasing evidence shows that bac-
teria have evolved virulence mechanisms to induce premature senescence. This could be via eliciting
a chronic inflammatory response indirectly via pathogen-associated molecular pattern (PAMPs) such
as lipopolysaccharide (LPS)220 or via the secretion of genotoxins (Fig.2.4, bottom left panel)106,221.
One example includes E. coli, a Gram-negative bacterium that produces colibactin, a genotoxin. Col-
ibactin causes DNA interstrand crosslinks, resulting in DNA SSB and subsequent DSB fromation221
thereby activating ATR and ATM signalling, respectively221. Extensive damage led to apoptosis,
whilst other intoxicated cells survived and demonstrated senescence markers such as SA-β-gal, SAHF,
and inflammatory SASP. However, colibactin-induced SASP, triggered the proliferation of bystander
cancer cells and promoted oncogenesis (Fig.2.4, bottom right panel)222.
Of more relevance to the typhoid toxin are cytolethal distending toxins (CDTs), which were de-
scribed in Chapter 1, Section 1.9. Briefly, CDTs possess a DNase homologue called CdtB that
induces SSBs and DSBs. CDT-intoxicated cells display distended flattened morphology similar to what
is observed in senescence. There are very few examples in the literature of CDT-induced senescence.
Namely, cells infected with H. ducreyi, a Gram-negative bacterium that secretes CDT, demonstrate
persistent γH2AX, 53BP1 signalling, and SASP that comprises cytokines such as IL6, IL8, IL24.
Interestingly, in vivo experiments with CdtB showed increased tumour invasion and endoreplication,
which are key in cancer progression (Fig.2.4, bottom left panel)223.
2.10 Is senescence a host defence mechanism or a pathogen-
induced virulence mechanism?
Elderly individuals are the most vulnerable age group to infections by bacteria and viruses224,225.
Indeed, experiments with influenza virus and varicella zoster virus show that senescent cells allowed
for enhanced viral infection as measured by increased virus titre and gene expression (Fig.2.4, top
right panel)226. Similar to viruses, aged organisms are more susceptible to many bacterial infections.
Experiments in vivo show that aged mice are more susceptible to S. Typhimurium which causes
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Figure 2.5| The typhoid toxin proposed mechanism of disease. This diagram demonstrates how
Salmonella hijacks the host human cells via SASP to enhance invasion in bystander cells. This model was
developed based on Ibler et al 2019106 findings alongside some of the results presented in the first results
chapter.
gastroenteritis227. Another example include the increased susceptibility of senescent cells in vitro
and in vivo to Streptococcus pneumoniae which is thought to invade better due to the inflammatory
profile of senescent cells228. These examples describe pathogens that exploit senescence in their favour
(Fig.2.4, top right panel). On the other hand, double stranded DNA viruses, such as human papilloma
virus, inhibit senescent phenotypes by degrading p53 to combat protective senescence-induced cell
cycle arrest resulting in cervical cancer (Fig.2.4, bottom left panel)229.
In contrast, viruses that exploit the human host cell replication machinery to divide would be
incapable to replicate if it resides in a senescent cell. For instance, vesicular stomatitis virus, a
negative-sense single-stranded RNA virus, displayed a reduced titre of the virus in senescent MEFs
cells in vitro or in lungs of chemically-aged mice in vivo after administering bleomycin, a senescence-
inducer230. Unlike viruses, bacteria are self-sufficient and do not require the host replication machinery
to survive and replicate. So is the senescence phenotype induced by the genotoxic effects of bacterial
toxins, such as colibactin and CDTs, a mechanism of host-defence or pathogen subversion?
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2.11 The typhoid toxin of Salmonella proposed mechanism of
disease
At the outset of my PhD, injected toxin had been shown to induce typhoid fever in a mouse81 but
how the typhoid toxin contributed to invasive infections was unclear. Given the DNase activity of the
typhoid toxin of Salmonella, my lab colleague, Dr Angela Ibler examined the DNA damage response
induced in a CdtB-dependent manner. Interestingly, she discovered a novel DNA damage phenotype,
which was termed as RING (a response induced by a genotoxin) marked by the localisation of γH2AX
at the nuclear periphery (discussed and examined in Chapter 3), which was similar to the apoptotic
ring. However, RING cells survived and the phenotype was persistent for at least 48h post intoxication.
This non-canonical response was marked by induction of ssDNA breaks, activation of ATR signalling
and exhaustion of the RPA response resulting in replication fork collapse and replication stress. In
addition, canonical DDR was also elicited and marked by γH2AX foci which was ATM-dependent. As
a result of toxin-induced DDR, cells showed a senescence-like phenotype including cell cycle arrest, cell
enlargement, and unidentified SASP that transmitted cells to and enhanced Salmonella invasion in
naive bystander THP1 monocytes and fibroblast-like HT1080 cells. Interestingly, conditioned media
from another chemical senescence inducer, aphidicolin, did not enhance invasion, indicating a specific
phenotype induced by the typhoid toxin. This suggests that Salmonella has evolved a senescence
hijack mechanism to modulate the microenvironment in favour of infection and potential persistence106
(Fig.2.5).
2.12 Aims and hypothesis
Given the molecular role of the toxin, this thesis aims to:
1. Further characterise the senescence-like phenotype induced by the toxin.
2. Identify the toxin-induced host secretome underlying senescence responses.
3. Resolve the SASP factors mediating transmissible senescence and Salmonella invasion
I hypothesise that the typhoid toxin induces a unique SASP that reprograms the infection niche in
favour of Salmonella invasion. Understanding the senescence-like stress response induced by the toxin
and identifying SASP molecules that are potentially toxin-specific are key to i) elucidate on the role
of typhoid toxin during infection, ii) provide insight into potential biomarkers of chronic carriers, and
iii) identify potential targets for therapeutic intervention. Since this project also includes studying
DNA damage, senescence and Salmonella, it will not only contribute to the knowledge-base of aging-









damage and senescence responses
Uniting the diverse phenotypes observed in vivo, systemic spread of Salmonella 78,99, suppressed
inflammation78,81,99,231, bacteraemia100, and chronic Salmonella carriage78 is the key role of the
toxin’s nuclease activity and the host DDR. Thus, understanding how the toxin manipulates host cell
DDR has the potential to reveal important host-pathogen interactions and shed light on the role of
the typhoid toxin. Upon starting my PhD, my laboratory colleague Dr Angela Ibler had discovered
that purified recombinant typhoid toxin induced the RING phenotype106. I was first tasked with
substantiating these findings in different cell lines using recombinant typhoid toxin and examining
whether they occur during Salmonella infection. Next, I investigated the cell fate of intoxicated cells,
which centred on a senescent-like response that became the focus of my PhD.
3.1 The purification of the typhoid toxin
Different techniques have been adopted to examine the typhoid toxin activity in vitro and in vivo.
For instance, cell cultures or animal models were infected with S. Typhi or S. Javiana, or with S.
Typhimurium engineered to encode the typhoid toxin78,79,107. Using Salmonella best reflects a natural
infection but resolving whether damage has occurred from intoxication, infection or a mixture of both
in the same cell makes interpretation more challenging. To uncouple the toxin from other Salmonella
virulence factors, Salmonella can be induced to express and secrete the typhoid toxin when cultured
in minimal media that mimics the Salmonella-containing vacuole, e.g. pH 5.8, but the yields are
very low232. However, the most common method is the heterologous expression of recombinant toxin
in E. coli 81,94,106,109,111. The approach has been used effectively to study the typhoid toxin in our
laboratory and has been broadly adopted in the field.
To purify the typhoid toxin, E. coli C41 was transformed with the T7 expression vector pETDuet1-
pltB-HIS/pltA-MYC/cdtB-FLAG. E. coli C41 is engineered with T7 RNA polymerase whose expres-
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Figure 3.1| Toxin purification and concentration measurement. a-b, Commassie stains of each
fraction of the purification of a, toxinWT and b, toxinHQ. Uninduced and induced fraction depict E. coli
before and after IPTG treatment. Soluble and insoluble fractions are proteins in bacteria after lysis. FT=flow
through of the soluble fraction through the Ni-NTA column. Wash fraction is the buffer used to wash the
column before eluting bound proteins to the Ni-NTA beads. Arrows indicate the different subunits of the
toxins. c, Western blot of the toxinWT subunits with anti-FLAG (CdtBFLAG), anti-Myc (PltAMyc), anti-His
(PltBHis). d, Purified GST-CdtB of known concentrations was used to create a standard curve to extrapolate
the concentration of the toxinWT fraction using intensities measured in ImageStudio.
sion is induced using IPTG that drives expression of wild-type (toxinWT) subunits: CdtB-FLAG,
PltA-Myc, and PltB-His. In contrast to Salmonella , which encodes TtsA that facilitates toxin secre-
tion95, the toxin is not secreted by E. coli and accumulates in the periplasm. Therefore, the holotoxin
was purified from lysed E. coli using NiNTA affinity chromatography of PltB-His. As a consequence,
any CdtB present should be bound to PltB via PltA.
The purification efficiency was examined using Coomassie stained gels (Fig.3.1a). The typhoid
toxin subunits, CdtB, PltA and PltB were faintly observed at the relevant protein sizes, after induction
with IPTG and elution from columns. Additionally, western blot against FLAG, Myc and His tags
confirmed that the holotoxin has been purified (Fig.3.1c). As expected, the yield was low, which
is evidenced by the high abundance of E. coli contaminants, and only a crude preparation of toxin
was harvested (Fig.3.1a-b). Indeed, researchers have previously omitted affinity chromatography
and opted to use a whole extract instead103,233. To control for E. coli contaminants, such as LPS,
in downstream host-pathogen interaction experiments, mutant toxin H160Q (toxinHQ) was purified
from E. coli expressing pETDuet1-pltB-HIS/pltA-MYC/cdtB-H160Q- FLAG (Fig.3.1b) to examine
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Figure 3.2| Intoxication and the DNA damage response (DDR). a, Schematic demonstrating the
methodology used to intoxicate cells. b, Immunofluorescence of toxin pltA subunit (anti-myc, red) inside the
cells marked by tubulin (green) and DAPI (blue) after a 2h treatment in HT1080 cells. c, DNA damage
response in HT1080 cells marked by γH2AX (magenta). d, Quantification of γH2AX RINGs in three dif-
ferent cell lines after 24h after toxin wash for HT1080 (3 biological replicates; ∼600-1000 nuclei/condition),
HAP1 (6 biological replicates; ∼150-1000 nuclei/condition) and CACO-2 (2 biological replicates; 550-1800
nuclei/condition) Each circle is a biological replicate for HT1080 and HAP1, and a field of view for CACO-
2. e and f, Representative immunofluorescence images of the DDR of HT1080 to infection at 24h with e,
Salmonella Javiana (MOI 16) d, Salmonella Typhi (MOI 8) expressing the wild-type toxin or mutant toxin
with the deleted active subunit, CdtB subunit (∆CdtB). Nuclei are displayed as white outlines, Salmonella
in green and γH2AX in magenta. c, e and f, Arrows indicate nuclei with γH2AX RINGs (magenta arrow),
and γH2AX foci (white arrow) phenotypes g, Quantification of H2AX RINGs in f at 24h and 48h of infection
from one biological replicate. Each circle represents a field of view (∼400 nuclei/condition). Scale bars denote
50 µm (b) and 100 µm (c, e and f). Two-way ANOVA with Sidak multiple comparisons test was carried
out to test for statistical significance (d and g). Error bars indicate SEM.∗
the effect of CdtB DNase activity. Subsequently, the toxin concentration was estimated by creating
a standard curve using western blot intensities of known concentrations of purified GST-CdtB-FLAG
and extrapolating the concentration of purified typhoid toxin’s CdtB intensity (Fig.3.1d).
∗Fig.3.2d, f and g were published as part of Ibler et al 2019 (Nat Comms). Access via this link.
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3.2 The typhoid toxin induces the novel DNA damage phe-
notype, RINGs.
Previously, human HT1080 fibrosarcoma cells, which have wild-type p53 alleles, have been used
to study diverse DDRs including responses to the typhoid toxin106,234,235. Thus, HT1080 cells were
intoxicated using established protocols to confirm that the purified typhoid toxin was functional106.
Briefly, the toxin was pulsed on cells for 2 hours to allow for its endocytosis, before washing the cells
with PBS to remove any extracellular toxin. The cells were then chased in fresh complete growth media
for the remainder of the experiment (Fig.3.2a). After 2h pulse, PltA subunits were observed inside
the cells, particularly at the perinuclear microtubule organising centre where endosomes accumulate
(Fig.3.2b), providing evidence of toxin uptake.
Consistent with Ibler et al 2019, 2h incubation with toxinWT induced γH2AX foci and RING at
24h (Fig.3.2c; white and magenta arrows respectively)106. The induction of RINGs was reproducible
in different cell lines including HT1080, HAP1 (haploid) and Caco-2 (colorectal adenocarcinoma) cells
(Fig.3.2d; ∼25%, ∼20% and ∼60%, respectively)106. This DNA damage response was not observed
for untreated and toxinHQ. To examine whether the same DNA damage phenotype is observed during
infection, cells were infected with S. Javiana and S. Typhi encoding the wild-type toxin (WT) and
toxin with deleted CdtB subunit (∆CdtB) then assayed for DNA damage at 24h. S. Javiana and
S. Typhi both induced γH2AX in a CdtB-dependent manner. However, unlike S. Javiana, which
only demonstrated γH2AX foci (Fig.3.2e white arrows) S. Typhi displayed the RING phenotype
(Fig.3.2f, magenta arrows) observed with the purified recombinant typhoid toxin (Fig.3.2c). RING
positive nuclei increased from ∼20% to ∼60% after 48 h infection or intoxication (Fig.3.2g). Inter-
estingly, γH2AX was induced in non-infected cells surrounding both S. Javiana- and S. Typhi-infected
cells supporting the fact that the toxin is secreted from infected cells and can act in a paracrine fashion
(Fig.3.1e-f).
3.3 The typhoid toxin induces replication stress leading to
RPApT21 exhaustion.
The typhoid toxin has been previously implicated in cell-cycle arrest in G2/M phase91,92. There-
fore, it was hypothesised that it induces DNA damage in a replication-dependent manner (e.g. during
S-phase). To test this hypothesis, cells were serum-starved to arrest their cycle at G1, before intoxicat-
ing in serum-free growth media and assaying for DNA damage. Immunofluorescence of intoxicated cells
abolished RING formation in serum-starved cells, but instead demonstrated predominantly γH2AX
foci phenotype that was independent on replication (Fig.3.3a, white arrows; 3.3b). Since RINGs
appeared to be replication-dependent, and the CdtB’s nickase activity was hypothesised to cause ss-
DNA breaks97,236,237,238, replication stress was examined. During replicative stress, RPA binds and
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Figure 3.3| DNA damage response in replicating and cell-cycle arrested HT1080 cells. a, Rep-
resentative immunofluorescence images of nuclear outlines of intoxicated cells at 24h with γH2AX (magenta)
and the replication stress marker, RPApT21 (white) with serum (replicating) and serum-starved (arrested).
Arrows indicate nuclei with γH2AX RINGs (magenta arrow), and γH2AX foci (white arrow) phenotypes.
Scale bars denote 50 µm. b-d, Quantification of b, RING positive nuclei (∼300-600 nuclei/condition), c,
RPApT21 foci positive nuclei (∼350-600 nuclei/condition), and d, nuclei that display RPApT21 with either
γH2AX RINGs or foci from all conditions at 24h (∼1500 nuclei/phenotype) across two biological replicates
(circles on the graph). Error bars indicate SEM. Two-way ANOVA with Sidak multiple comparisons test (b
and c) and an unpaired t-test (d) were used to test for statistical significance.∗
persists on ssDNA of stalled replication forks and recruits ATR to signal a DNA damage checkpoint,
and phosphorylates RPA at theronine 21 position (RPApT21)148. Indeed, toxinWT led to an increase
in RPApT21 positive nuclei (Fig.3.3a, 3.3c), that specifically localised with RING-positive nuclei
(Fig.3.3a, 3.3d; magenta arrows), which was not the case with toxinHQ and untreated cells. These
results support that the toxin induces replication stress.
3.4 Intoxicated cells demonstrate a senescence-like phenotype.
It was previously shown that the exposure of cells to cytolethal distending toxins leads to apoptosis
and senescence239,240,241, but the fate of cells targeted by the typhoid toxin is unclear. When cell
proliferation was examined in toxinWT-treated cells, no colonies were observed, unlike untreated and
toxinHQ treated cells (Fig.3.4a, top panel), which confirmed previously reported toxinWT-induced
cell-cycle arrest91,92. Upon higher magnification imaging of the plates, intoxicated cells appear to
have survived. They displayed astonishing enlargement and distension of cells, which is a typical
morphology induced by cytolethal distending toxins (Fig.3.4a, exemplified by cells in the bottom
panel) and a hallmark of senescence155,163. The result in Fig. 3.4a favoured the hypothesis that the
typhoid toxin induces senescence rather than apoptosis. To investigate this further, cells were assayed
for the lysosomal senescence-associated beta-galactosidase activity (SA-β-gal). If cells have elevated
∗Fig.3.3a, (top panel) and d were published as part of Ibler et al 2019 (Nat Comms). Access via this link.
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Figure 3.4| Senescence-like phenotype induced by the typhoid toxin in HT1080 cells. a, Clono-
genic assay to examine cell division by intoxicated cells and imaged on day 8 post-intoxication (top panel), and
the magnified plates using 20X objective (bottom panel). b, Representative images of intoxicated cells histo-
logically stained for senescence-associated β-galactosidase activity at 96h post-intoxication. c, Quantification
of b from 2 biological replicates (circles represents 3 technical replicates; 300-750 nuclei/condition). d, Rep-
resentative image of SpiDER gal localising with RING positive nuclei. e, Representative images of the DNA
damage responses to titrated toxinWT concentrations marked by γH2AX at 24h. f, Representative images of
a senescence response to titrated toxinWT concentrations marked by SA-β-gal at 96h. g, Quantification of e.
Each circle is a field of view (1 biological replicate, ∼200-500 nuclei/condition). h, Quantification of f. Each
circle is a field of view (1 biological replicate,∼80-200 cells/condition). One-way ANOVA test was used with
Tukey’s multiple comparison carried out for g. Unpaired t-test was used for h. Asterisks indicate significance
compared to untreated counterpart unless otherwise indicated by brackets. Error bars indicate standard error
of the mean (SEM). All toxin concentrations are at 20 ng/ml unless indicated. Scale bars are 50 µm (e), 100
µm (a, b and d), 300 µm (f).∗
SA-β-gal activity, cells can convert the substrate (X-gal) into a blue precipitate under sub-optimal
pH6, in contrast to physiological β-gal which is active at pH4242. As predicted, toxinWT-treated
cells showed a statistically significant increase in the percentage of SA-β-gal positive cells 96h post
intoxication compared to the negative control (Fig.3.4b, 3.4c), which was reproducible in other cell
lines including retinal epithelial RPE-1 cells (Fig.3.6g) and IMR90 lung fibroblast cells (Fig.3.7b,
3.7g; marked by reduction of EdU positive nuclei). SA-β-gal in intoxicated cells was also observed
by fluorescence microscopy (Fig.3.4d), which also revealed SA-β-gal in RING-positive cells. Thus,
the typhoid toxin induces several traits characteristic of senescence, namely (i) cell cycle arrest, (ii)
cellular distention, and (iii) increased lysosomal SA-β-gal activity.
To further examine the DDR responsible for the senescence phenotype, SA-β-gal and γH2AX were
investigated with different concentrations of toxin. Titration of the toxin from 20 ng/ml to 0.05 ng/ml
reduced the proportion of RING-positive cells, which corresponded with an increase in γH2AX foci
∗Fig.3.4d, and part of g were published as part of Ibler et al 2019 (Nat Comms). Access via this link.
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Figure 3.5| Time course of the DNA damage response and replication stress to the typhoid
toxin from early to late senescence. a, Representative images of a time-course experiment of DNA
damage responses marked by γH2AX (magenta) and replication stress marker RPApT21 (white) stained at
24h intervals. Arrows indicate nuclei with γH2AX RINGs (magenta arrow), and γH2AX foci (white arrow)
phenotypes. b, Percentage of γH2AX RINGs positive nuclei. Each circle represents a field of view (2 biological
replicates, ∼140- 1300 nuclei/condition) c, Percentage of nuclei positive for phosphorylated RPA (RPApT21).
Each circle represents a field of view (2 biological replicates, ∼170-920 nuclei/condition). d, Percentage
of γH2AX foci positive nuclei. Each circle represents a field of view (2 biological replicates, ∼140-1300
nuclei/condition). e, Number of γH2AX foci per nucleus including foci in RING cells. Each circle is the
average number of foci/nucleus per field of view (2 biological replicates, ∼140-1300 nuclei/condition). f, Size
of γH2AX foci induced. Each circle is the average size per field of view (2 biological replicates ∼3000-22000
foci measured/condition). g and h, Number and size of foci/nucleus in SA-β-gal positive and negative cells
by senescence inducers. Each circle depicts a nucleus after outliers were removed using GraphPad ROUT
(Q=1%). i, Nuclear sizes changes across 4 days. Each circle is the average nuclear size per field of view (3
biological replicates, ∼160-1500 nuclei). Quantification was using CellProfiler (b, d-g) and the MATLAB
code from Ibler et al, 2019 (c). Two-way ANOVA test was used with Tukey’s multiple comparison carried out
for b-f, i. Unpaired t-test was used for g-h. Asterisks indicate significance compared to untreated counterpart
unless otherwise indicated by brackets; if not indicated it is not significant. Error bars indicate SEM. Scale
bars of representative images are 50 µm.
(Fig.3.4e, 3.4g). Despite the loss of RINGs with low concentrations of toxinWT (0.05 ng/ml), SA-
β-gal was apparent in ∼75% of cells mirroring the proportion of cells with γH2AX foci (Fig.3.4f-h).
Thus, the data suggest that toxin-induced γH2AX foci and RINGs can both drive cellular senescence,
which may reflect damage in G1 (γH2AX foci) and S phase (RINGs).
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3.5 Toxin-induced γH2AX foci drive cellular senescence
The data in (Fig.3.4d) and (Fig.3.4e) show that RINGs cause cellular senescence but RINGs
were only apparent at ng concentrations (>5ng/ml), which suggests relatively high doses of toxin are
required for RING-driven senescence. Differences in toxin dose may also explain why RINGs were
observed with S. Typhi but not S. Javiana (Fig.3.2e, 3.2f). Thus, we extended our analysis of
γH2AX RINGs and foci to examine their relative contribution to toxin-induced senescence responses
between 24h and 96h (Fig.3.5a) . Surprisingly, the number of RING-positive cells decreased between
24h and 96h (Fig. 3.5a, 3.5b: ∼10% to ∼2%). Consistent with this, the reduction in RINGs
was concomitant with a reduction in RPApT21-positive cells (Fig.3.5a; 3.5c: ∼40% to ∼15%) In
contrast, there was no significant difference in the proportion of cells with γH2AX foci between 24h
and 96h (Fig.3.5d: ∼80% at 24h vs 70% at 96h). Deeper inspection of the toxinWT- induced γH2AX
foci in Fig.3.5a revealed further evolution of DDRs whereby the number of γH2AX foci per nucleus
decreased by the 96h point (Fig.3.5e), which was coincident with an increase in the size of γH2AX
foci (Fig.3.5f). Treatment of cells for 24h with the inducer of DNA replication stress aphidicolin
(APH) also triggered RINGs and RPApT21 that decreased between 24h and 96h (Fig.3.5b: ∼9%
to 0%, 3.5c: ∼35% to 1%). In contrast to the toxinWT, APH-induced γH2AX foci also decreased
between 24h and 96h (Fig.3.5d: ∼80% to 30%), which likely reflects significant DNA repair due
to removal of APH at 24h while intracellular toxinWT persists until presumably degraded by host
proteases. No DDRs were observed in negative control cells that were either untreated or treated with
toxinHQ (Fig.3.5b-d). Interestingly, examination of SA-β-gal positive cells by toxinWT and APH
(i.e. senescence inducers) were associated with significantly fewer γH2AX foci per nucleus (Fig.3.5g),
regardless of their size (Fig.3.5h). Despite the loss of RINGs (Fig.3.5a, 3.5b), nuclei of toxinWT-
treated were increasingly distended (Fig.3.5i), which is an indicator of cellular senescence243. These
data suggest that senescence is predominantly associated with persistent γH2AX foci.
3.6 Toxin induced DDR in caspase-deficient Retinal Epithelial
Cells (RPE-1)
RING cells were not observed after 48 h (Fig.3.5a, 3.5b) in HT1080 cells and their fate is
unclear. γH2AX at the nuclear periphery has been observed at early stages of apoptosis in a caspase-
dependent manner154,244. To investigate whether RING cells become apoptotic despite showing signs
of senescence (Fig.3.4d), RPE-1 cells, which resist apoptosis by expressing low levels of caspase-8245,
were intoxicated and assayed for γH2AX, RPApT21, and SA-β-gal. Unconventionally, at the standard
intoxication concentration (i.e. 20 ng/ml), RING cells were absent (Fig.3.6a, 3.6b), which indicates
that RING formation is potentially caspase-8 dependent. However, increasing the toxin concentration
10-fold in RPE-1 cells (20 ng/ml to 200 ng/ml) induced RINGs and RPApT21 positive nuclei in
a dose-dependent manner (Fig.3.6a, magenta arrows; 3.6b, ∼0% to ∼8%; 3.6c, ∼10% to 20%).
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Figure 3.6| DNA damage response in caspase-8 deficient cell line, RPE-1 cells. a, Representative
images of DNA damage responses in RPE-1 cells at early (24h) and late (96h) time-points experiment marked
by γH2AX (magenta), replication stress marker RPApT21 (white), and SA-β-gal (green) stained at 24h and
96h at different concentrations. Arrows indicate nuclei with γH2AX RINGs (magenta arrow), and γH2AX foci
(white arrow) phenotypes, and red box highlights cytosolic RPApT21. b-d, Percentage of b, γH2AX RING-,
c, RPApT21-, d, γH2AX foci-positive nuclei. e, Number of γH2AX foci per nucleus including foci in RING
cells. f, Percentage of RPE-1 cells expressing fluorescent CellEvent Green Probe for SA-β-gal. b-f, Each
circle represents technical replicates (1 biological replicate, ∼300-1700 nuclei/condition). g, Representative
image of intoxicated RPE-1 cells histologically stained for senescence-associated β galactosidase activity at 96h
post-intoxication. h, Quantification of g with toxinHQ concentration at 200 ng/ml. (1 biological replicate; 600-
3000 cells/condition). i, Number of viable cells as assayed using Trypan blue and hemocytometer. Average
percentage viability is denoted on each bar. Each circle represents a technical replicate from 1 biological
replicate. Two-way (b-f) and one-way (h) ANOVA test were used with Tukey’s multiple comparison to test
for statistical significance. Asterisks indicate significance compared to untreated counterpart unless otherwise




Figure 3.7| DNA damage response in primary fibroblast cell line, IMR90 cells. a and b, Rep-
resentative images of DNA damage responses in IMR90 cells at a, early (24h) and b, late (96h) time-points
experiment marked by γH2AX (magenta), repair protein 53BP1 (red), EdU (cyan) and SA-β-gal (green)
stained at 24h and 96h at 100 ng/ml of toxinWT and 200 ng/ml toxinHQ. c-e, Percentage of c, γH2AX
RING- d, γH2AX foci-positive nuclei and e, number of foci per nucleus at 24 and 96h post treatment at
different toxin concentrations. Each circle represents biological replicates (∼350-750 nuclei per variable). f-h,
Percentage of, f, EdU g, SA-β-gal and h, 53BP1-positive cells from 3 biological replicates (∼350-750 nuclei per
variable). Each circle represents a field of view. SA-β-gal of toxin-treated cells was thresholded using images
of untreated cells. Two-way (c-e) and one-way (f-h) ANOVA test with Dunnett’s and Sidak multiple com-
parison tests were carried out to test for significance. Asterisks indicate significance compared to untreated
counterpart unless otherwise indicated by brackets. Error bars indicate SEM. Scale bars of representative
images are 50 µm.
Consistent with HT1080s, RING and RPApT21 positive nuclei were induced at 24h but disappeared
by 96h post-intoxication. Notably, RPE-1 displayed cytosolic RPApT21 at high concentration at 96h
(Fig.3.6a; red boxes), which might indicate leakage of DNA fragments into the cytosol, a marker of
senescence155,246. RPE-1 cells showed an increase in γH2AX foci positive nuclei at 24h (Fig.3.6d,
∼80-100%) that were persistent at 96h for RPE-1 (Fig.3.6d). As with HT1080 cells (Fig.3.5a,
3.5e), the number of γH2AX foci per nucleus was significantly reduced between 24 and 96h for both
cell lines particularly at low concentrations in RPE-1 (Fig.3.6e).
ToxinWT induced up-regulation of SA-β-gal at all concentrations in RPE-1 cells at 96h (Fig.3.6f-
h; ∼30% fluorescence and ∼100% histology). However, at RING-permissive concentrations at 24h
in RPE-1 cells (Fig.3.6b), the number of viable cells (Fig.3.6i) and the extrapolated percentage
viability of RPE-1 cells were slightly reduced (Fig.3.6i; ∼100% to 75% n.s.) at 96h, which suggests
potential apoptosis that was delayed due to senescence responses.
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3.7 Toxin induced DDR in primary lung fibroblast cells, IMR90
Previously, RING formation had been observed in seven cell lines tested, including U2OS, HAP1,
HT1080, THP1, Caco-2, RAW, MEF cells (Fig.3.2)106. Thus, the lack of RINGs in RPE-1 cells
was surprising (Fig.3.7). Similarly, a lack of RINGs was observed in primary IMR90 fibroblast
cells (Fig.3.7a-c), which is an established senescence model and has been used to study senescence
induced by cytolethal distending toxins240,247,248. The observation with RINGs warranted further
investigation. Like RPE-1 cells (Fig.3.6), IMR90 cells showed an increase in γH2AX foci positive
nuclei at 24h (Fig.3.7d, ∼50-70%) but the effect was modest relative to HT1080 and RPE-1 cells
(Fig.3.5, Fig.3.6). Moreover, while γH2AX foci positive cells were persistent at 96h for HT1080
(Fig.3.5d) and RPE-1 (Fig.3.6d), γH2AX foci positive cells were reduced in IMR90s (Fig.3.7d,
∼10-20%). The number of γH2AX foci per nucleus was significantly reduced between 24 and 96h in
all cell lines (Fig.3.5e, Fig.3.6e, Fig.3.7e). Though the toxin caused cell-cycle arrest in IMR90 cells
as determined by EdU labelling (Fig. 3.7b, Fig.3.7f), the modest effect of the toxin in IMR90 cells
was reflected by no significant difference in 53BP1-positive cells and SA-β-gal (Fig.3.7g, Fig.3.7h),
which are hallmarks of senescence. In summary, both RPE-1 and IMR90 cells do not display RINGs,
and while RPE-1 cells show hallmarks of senescence in toxin-treated cells, this was not the case for
IMR90 cells.
3.8 Characteristics of toxin-induced senescence.
While characteristics of oncogene-induced senescence and replicative senescence are well estab-
lished, bacterial-induced senescence remains a relatively uncharacterised phenomenon with very few
examples cited in the literature213,222,240. Thus, senescence responses to the typhoid toxin were further
investigated.
A hallmark of senescence is the p53 effector p21, which is a CDK inhibitor249. Relative to negative
control cells, p21 expression was upregulated in toxinWT- or APH-treated cells, which was coincident
with induction of γH2AX (Fig.3.8a). Persistent DDRs in senescent cells can lead to enlarged senes-
cence DNA damage foci (SDF) identified by co-localisation of γH2AX and 53BP1179,250,251,252. At
96h, γH2AX foci were found enlarged in 80% of toxinWT-treated cells (Fig.3.5e, 3.5f). Similarly,
53BP1 was found co-localised in enlarged foci with γH2AX in 80% of cells at 96h (Fig.3.8b, 3.8c),
which were also SA-β-Gal positive indicating senescence (Fig.3.8b). Indeed, relative to untreated
cells, toxinWT significantly increased the proportion of 53BP1-positive cells at 24h, which was not
the case with toxinHQ, APH and the topoisomerase inhibitor, etoposide (ETP) (Fig.3.8c). By 96h,
toxinWT, toxinHQ, APH and ETP had increased the proportion of 53BP1-positive cells (Fig.3.8c),
albeit to a lesser extent with toxinHQ, which has been observed before106. The modest effect of
toxinHQ was reflected by the number of 53BP1 foci per nucleus, which mirrored untreated cells and
contrasted with the significant effects mediated by toxinWT, APH and ETP (Fig.3.8d) The increase
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Figure 3.8| Senescence hallmarks induced by toxinWT. a, Western blot of whole-cell lysates collected
at 48 h post-removal of the senescence-inducer from one biological replicate. b, Representative images of
intoxicated cells at 96h stained for γH2AX (magenta), 53BP1 (cyan), and SA-β-gal (green). White arrows
indicate 53BP1 positive cells. c, Quantification of 53BP1-positive nuclei from b using cell profiler and un-
treated as minimum threshold. d, Number of 53BP1 foci per nucleus using CellProfiler. c and d, Each circle
is a field of view (1 biological replicate, ∼30-180 nuclei/condition). e, Number of 53BP1 foci in cells that are
either positive or negative for SA-β-gal from all conditions. f, Pearson’s correlation of the number of 53BP1
foci and area of SA-β-gal occupying the corresponding cell. Each circle represent cells of senescence inducers
positive for SA-β-gal after outliers were removed using GraphPad ROUT (Q=1%). g, Representative images
of intoxicated cells at 24h stained for lamin A/C and lamin B1, and their contribution to SA-β-gal. Red ar-
rows indicate nuclei positive for lamin A/C. Cyan arrows indicate nuclei positive for lamin B1. White arrows
indicate nuclei with absent lamin B1. Green arrow indicates nucleus positive for SA-β-gal. h,i, Relative edge
intensity of the h, lamin B1 i, lamin A/C calculated by creating a ratio of intensity on the nuclear membrane
and intensity inside the nucleus. Each circle represents a nucleus (10 fields of view, 1 biological replicate,
∼40-140 nuclei/condition). All toxin concentrations are at 20 ng/ml. Asterisks indicate significance compared
to untreated at the same time-point unless otherwise indicated by brackets. Two-way ANOVA with Sidak and
Dunnet’s multiple comparisons test (c and d respectively), and unpaired t-test (e, h and i) were used to test
for statistical significance. Asterisks indicate significance compared to untreated counterpart unless otherwise
indicated by brackets. Error bars indicate SEM. Scale bars of representative images are 50 µm.
in the number of 53BP1 was associated with SA-β-gal-positive cells (Fig.3.8e) and the increase in
the area occupied by SA-β-gal activity in the cell (Fig.3.8f), indicating that 53BP1 is coincident
with toxin-induced senescence.
Lamin B1 downregulation has been proposed to drive the establishment of a full senescence phe-
notype, thereby triggering chromatin remodelling to induce SASP249. When the nuclear envelope was
examined, lamin B1 was down-regulated by toxinWT relative to toxinHQ (Fig.3.8g, 3.8h: lamin B1),
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while other nuclear lamina components remained unchanged (Fig.3.8g, 3.8i: lamin A/C). These
results show that the toxin induces a p21-driven senescence phenotype characterised by SDFs and
downregulation of lamin B1.
3.9 Typhoid toxin induces a host senescence-associated secre-
tory phenotype (SASP)
The typhoid toxin has demonstrated various senescence-associated phenotypes. Senescent cells are
typically metabolically active with a senescence-associated secretory phenotype that modulates the
surrounding environment253,155. Conditioned media (CM) harvested from intoxicated HT1080 cells at
96h post intoxication, transmitted senescence as exemplified by cellular distension and up-regulation of
SA-β-gal in naive HT1080 cells (Fig.3.9a, 3.9b; ∼50%), suggesting toxin-induced SASP (toxSASP).
Analysis of toxSASP at 24h intervals indicated a gradual increase in transmissible senescence that
reached maximum potency between 24-48 h (Fig.3.9c, ∼80%). Transmissible senescence was not
limited to cells of the same type. IMR90 SASP induced transmissible senescence in naive IMR90
(Fig.3.9d-f ; ∼95%) and naive HT1080 (Fig.3.9g, 3.9h; ∼70%).
Previous literature described that SASP of various senescent cell types retained the ability to induce
DNA damage254. Indeed, toxSASP showed 30% increase in γH2AX-positive HT1080 cells (Fig.3.9i,
3.9j; ∼40%) with negative control CM and ∼70% with toxSASP). Transmissible senescence was also
observed during infection by CM harvested from cells treated for 2h or 24h with toxinWT secreted from
cells infected by wild-type S. Javiana but not S. Javiana∆tox (Fig.3.9k-m; ∼80% SA-β-gal positive
cells). Importantly, this shows that Salmonella -infected cells transmit SASP in a toxin-dependent
manner.
To examine whether the paracrine effect in cells treated with recombinant toxin is due to con-
taminating toxin in the conditioned media, intoxication was carried out using the third wash fraction
(washtoxWT) after intoxication as illustrated in (Fig.3.10a). If any toxin remains, it would be able
to induce γH2AX in untreated cells. However, cells treated with washtoxWT showed significantly re-
duced DNA damage compared to intoxicated cells and mirrored negative controls (Fig.3.10b, 3.10c).
Additionally, CM harvested from toxinWT- and toxinHQ-treated cells was analysed by mass spectrom-
etry. Whilst all subunits were detected in the purified toxinWT, only the PltB subunit was detected
in the CM (Fig.3.10d, 3.10e). Interestingly, PltB is known to bind cell surface receptors so its
presence may indicate that intoxication can induce shedding of PltB-loaded receptors that have been
recycled to the cell surface. Nevertheless, it is well-established that only the holotoxin comprising
PltB-PltA-CdtB is toxigenic and drives toxin-induced phenotypes78,81,96.
∗Fig.3.9l and m were published as part of Ibler et al 2019 (Nat Comms). Access via this link.
∗Fig.3.10c was published as part of Ibler et al 2019 (Nat Comms). Access via this link.
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Figure 3.9| Transmissible senescence by the typhoid toxin. a, Representative images of naive HT1080s
treated for 5 days with either toxinWT-SASP or the toxHQ-CM harvested from intoxicated HT1080s at day 4,
before histologically stained for SA-β-gal. b, Quantification of a. Each circle is a field of a view (2 technical
replicates, 1 biological replicate; ∼1000-3000 cells/condition). c, Percentage of SA-β-gal-positive cells treated
with 24h fractions of conditioned media collected from intoxicated cells across 4 day. Each circle represents a
field of view (1 biological replicate; ∼50-1800 cells/variable). d-g, Representative images of naive e, IMR90
cells or g, HT1080 cells, treated for 5 days with either toxinWT-SASP or the toxHQ-CM from intoxicated
IMR90s at day 4, before histologically stained for SA-β-gal. f and h, Quantification of e and g respectively.
Each circle represents a biological replicate. (∼400 cells/condition for f; ∼400-3800 cells/condition for h). i,
Representative images of DNA damage (γH2AX; magenta) induced in HT1080 cells after 24h of treatment
with toxinWT-SASP or the toxHQ-CM harvested from intoxicated HT1080s at day 7. Each circle is a field of
view (1 biological replicate, ∼250-350 nuclei/condition). k-m, k, Workflow of conditioned media harvest from
Salmonella infected HT1080, l, Representative images of naive HT1080s stained for SA-β-gal after conditioned
media treatment, and m, Quantification of l of cells subjected to conditioned media after 2h or 24h treatment
with toxin harvested from Salmonella . Each circle is a technical replicate (1 biological replicate, 160-7000
cells/condition). Unpaired t-test (b), two-way ANOVA with Tukey’s multiple comparison tests (c and m),
one-way ANOVA with Tukey’s multiple comparison tests (f, h, j) were carried out to test for significance.
Error bars indicate SEM. Scale bars of representative images are 50 µm (i) and 100 µm (a, e, g, and l).∗
3.10 Discussion
The typhoid toxin-induced DNA damage has been implicated in typhoid fever and chronic Salmonella
carriage, which is mediated by manipulation of host cell functions through unknown mechanisms78,81,96.
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Figure 3.10| Transmissible senescence is due to host proteins. a, Experimental schematic to test
whether toxin is contaminating the conditioned media collected. b and c, representative image and quantifi-
cation of γH2AX (magenta) positive nuclei of HT1080 cells treated directly with the toxin, or treated with
the third wash post-intoxication at 24h. d and e, LC-MS/MS analysis of conditioned media harvested from
toxin-treated cells (4 biological replicates) with the recombinant purified typhoid toxin as a positive control.
Intensities of each toxin subunit detected is depicted in d and summarised in e. + denotes presence and -
denotes absence. Scale bars of representative images are 50 µm.∗
Little was explored into the DNA damage responses to the toxin in host cells and how this facilitates
invasive Salmonella systemic infections leading to typhoid and chronic bacterial carriage78,81,99,231.
This chapter presents evidence of a novel toxin-induced DNA damage phenotype localised at the
periphery of the nucleus we called RINGs that is replication-dependent. The RING phenotype was
observed with the recombinant toxin, and during infection in multiple cell lines, concurrent with
RPApT21 foci (Fig.3.11). Healthy human cells have a finite amount of RPA in the nucleus that
protects ssDNA during replication. Ibler et al (2019) showed that toxin nuclease activity caused ex-
cessive SSBs that exhausted the cellular pool of RPA resulting in massive DNA damage manifesting
as RINGs106. The data in Fig.3.3 were presented in Ibler et al (2019) and support the view that the
toxin causes RPA exhaustion directing the cell to a senescence-like phenotype. Similar to the typhoid
toxin, E. coli CDT has been shown to result in ssDNA and RPA activation236.
Senescence is a normal physiological process that increases in aging organisms. Emerging research
implicates senescence in both host-protection and pathogen hijacking mechanisms213. However, it
is unclear whether the senescence phenotypes induced by toxin are mechanisms of host defence or
pathogen attack.
This chapter presented evidence that toxin results in senescence phenotypes including persistent
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Figure 3.11| Proposed cell model. The typhoid toxin binds to the cells via the PltB subunit. The toxin’s
CdtB subunit translocates to the nucleus where it causes two distinct DNA damage phenotypes: foci and
RINGs. γH2AX foci localise with 53BP1, and RINGs lead to the exhaustion of RPA in the nucleus in early
senescence. In late senescence, γH2AX foci increase in number and decrease in size signifying potential repair.
RINGs disappear over time and potentially undergoes apoptosis or repair into γH2AX foci positive cells.
γH2AX foci localised with 53BP1 foci, up-regulation of p21, down-regulation of lamin B1, and SASP
that transmits senescence to naive cells (Fig.3.11). The experiments using RPE-1 cells indicate that
caspase-8 plays a key role in RING formation. γH2AX has previously been observed at the nuclear
periphery at early stages of apoptosis further suggesting a role for caspases in peripheral γH2AX lo-
calisation154,244,255. However, neither cleavage of caspase-3 or apoptosis marker PARP1 was observed
in intoxicated cells, and the pan caspase inhibitor ZVAD-OMe-FMK had no effect on toxin-induced
γH2AX RINGs106. How can the role of caspase-8 be explained? Sublethal activation of caspases
has previously been shown to resist apoptosis in a mechanism called minority-MOMP256, which has
also been implicated in host cell infections by diverse pathogens257. Thus, sub-lethal activation of
caspase-8 may contribute to RING formation and senescence. In contrast, RING cells’ disappearance
could be a result of repaired DNA damage that developed into γH2AX foci. Nevertheless, the lack
of RINGs and the high proportion of senescent RPE-1 cells suggests that RINGs are not required for
toxin-mediated senescence, which can in fact be driven by γH2AX foci (Fig.3.11).
Aged animals are more susceptible to infections by CDT secreting bacteria, such as Salmonella
Typhimurium258 and Staphylococcus aureus 259. Similarly, the typhoid toxin might be exploiting the
senescence phenotype in favour of S. Typhi infections. Indeed, research in the Humphreys lab106
showed that conditioned media harvested from intoxicated cells enhance infection in naive cells, pro-
viding a novel role to toxin-induced senescence. Additionally, in the context of infection, Salmonella
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-induced secretion of host survival proteins as part of SASP, would sustain host cell survival, creating a
safe haven to evade the immune system and establish more chronic infections. Therefore, it is prudent
to characterise the constituents of toxinSASP and examine their role in invasion. The next chapter
presents the optimisation of conditioned media harvest and analysis by mass spectrometry in an effort






Cell culture secretomes are typically analysed using pre-determined antibody arrays, ELISA, or
western blotting of conditioned media analyses175,195,205,260. Whole-cell transcriptomic analysis is
attractive because it represents an unbiased approach but this would not resolve the host secre-
tome189,261. LC-MS/MS is an unbiased quantitative approach for analysing the conditioned media
and identifying the host secretome. The aim of this chapter is to optimise methodology for identifying
the host secretome in cells undergoing toxin-induced senescence through conditioned media analysis
using LC-MS/MS. This will build towards understanding transmission of senescence and how this
enhances Salmonella invasion.
The main challenge of analysing conditioned media using mass spectrometry is the abundance
of foetal bovine serum (FBS) in the culture medium, which will mask less abundant proteins. This
chapter summarises an approach, which uses a methionine analogue, known as bio-orthogonal non-
canonical amino acid tagging (BONCAT), that enables LC-MS/MS analysis of the toxin-induced
secretome in conditioned media.
4.1 Optimisation of cell survival with the methionine ana-
logue, AHA.
BONCAT exploits the methionine analogue L-Azidohomoalanine (AHA), which can be used to
label newly synthesised proteins and identify secreted proteins262. BONCAT is a popular quantitative
method due to its non-radioactivity, and sensitivity which makes it ideal for secretome analysis by
mass spectrometry. This method has been recently used to identify proteins involved in autophagy in
cell cultures263 and translationally active populations of cystic fibrosis microbiota264.
After incubating cells with AHA, conditioned media containing labelled (SASPAHA) and unla-
belled SASP (SASPuntagged) were harvested before AHA-tagged proteins were immobilised on an
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Figure 4.1| HT1080 cell morphological response to methionine analogue AHA. a, Schematic of
the BONCAT experimental concept. AHA in methionine-free media is incubated on cells. Cells would then
incorporate AHA in the newly synthesised proteins. Next, Click-iT reaction is performed where the alkyne
on the agarose beads binds with the azide to the AHA tag. Untagged proteins subsequently flow through and
SASPAHA proteins are digested on bead. Peptides of SASPAHA are then analysed using mass spectrometry.
b-d, Different concentrations of AHA were tested on HT1080 and images of the cell morphology was taken
at indicated time intervals. b, Timeline of the experiment with AHA. Cells were starved of methionine (blue
line) before incubating with AHA (red line) for 4h, 12h, 24h and 48h. c, Representative images of the cells at
indicated concentrations and timepoints. White and black arrows depict dysmorphic cells and healthy cells,
respectively. Scale bar is 100 µm. d, Percentage of healthy cells from total cells counted in each well. Circles
indicate conditions that required pre-starvation, dialysed FBS, and methionine-free media unless otherwise
stated. The square indicates the usual culture conditions without any of the aforementioned conditions. Two-
way ANOVA of all conditions compared to complete DMEM was carried out to test for significance. Data
was collected from 1 biological replicate (3 technical repeats; ∼20 to 500 cells/condition). Asterisks under the
time-points are colour coded similarly to the legend. Error bars are SEM.
alkyne-beads column. The azido moiety binds to the alkyne moiety via a chemoselective ligation
reaction called Click-iT. Untagged abundant proteins flow through the column, then bound proteins
are digested into peptides on beads and analysed by LC-MS/MS (Fig.4.1a).
Methionine is an essential amino acid for protein synthesis and almost all research that uses
BONCAT, labels cells with AHA for a short duration e.g. 4h262,263,264. Thus, the proliferation and
morphology of cells was examined in the presence or absence of AHA after starving cells of methio-
nine (Fig.4.1b). HT1080 cells grown in complete DMEM had an extended morphology, typical of
fibroblast-like cells, which was observed at all timepoints (Fig.4.1c, black arrows; Fig.4.1d). In
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Figure 4.2| Influence of AHA:Methionine combinations on HT1080 cell viability. a and b, Trypan
blue survival assay was used to assess a, cell viability and b, number of viable cells in various ratios of 0.1
mM AHA to methionine at 96h. c, Representative images of cell morphology incubated with various ratios of
1 mM AHA to methionine, at different time-points. Scale bar is 100 µm. d and e, Trypan blue survival assay
was used to assess d, cell viability and e, number of viable cells in various ratios of 1 mM AHA and methionine
mixtures at 96h. a-e, Data was collected from three biological repeats, except methionine incubation on its
own was from two biological repeats and methionine-free DMEM negative control was from one biological
repeat. Each circle represents a technical replicate. One-way ANOVA with Dunnett’s multiple comparisons
test compared with complete DMEM was used to test for statistical significance. Error bars indicate SEM.
contrast, atypical cell morphology was observed in the presence of AHA from 12h incubation, which
was exemplified by cell rounding (Fig.4.1c; white arrows). Interestingly, increasing the concentra-
tion of AHA from 50 µM to 100 µM prolonged the typical fibroblast morphology from 12h to 24h
(Fig.4.1c). However, increasing AHA concentration to 200 µM seemed to increase cell rounding
(Figs.4.1c, 4.1d). Thus, it was clear that cells were susceptible to cell rounding in the absence of
L-methionine and prolonged exposure to AHA regardless of its concentration (Fig.4.1b, 0% fibrob-
last morphology at 72h in all concentrations). This correlated with a reduction in HT1080 cells with
typical morphology in methionine-free conditions with or without AHA (Fig.4.1d). In contrast, sup-
plementing methionine-free media with L-methionine, in place of AHA, sustained typical morphology
as observed with complete DMEM. In summary, while methionine-starvation appeared toxic to cells,
experiments suggest that AHA sustained a typical morphology of HT1080 cells at 100 µM up to 24
hours. This suggests utilisation of AHA in place of L-methionine for less than 24 hours. Thus, further
AHA optimisation experiments were initiated to improve cell homeostasis over a longer period of time.
Cell rounding in Fig.4.1 indicated cell death in response to AHA. To enable long incubations
with AHA while maintaining cell survival at the cost of sensitivity, Bagert and colleagues (2014)
recommended a mix of 1 mM AHA and L-methionine in a 30:1 ratio265. Therefore, trypan blue
staining of cells was used to assay cell viability directly following incubation with indicated AHA:MET
ratios in methionine-free media at 96h Fig.4.2.
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As 100 µM seemed to be the optimal concentration in terms of morphology (Fig.4.1), the effect of
different L-methionine ratios was examined on cell morphology and survival at a later time-point (96h).
As expected, cells did not survive in AHA alone (Fig.4.2a, 0%). However, increasing concentration
of L-methionine, i.e. from ratios of 50:1 up to 20:1 seemed to be positively promoting cell survival
and division to levels observed for complete DMEM and methionine-free media supplemented with
L-methionine alone (Fig.4.2a). However, the number of viable cells were quite low for all AHA-
containing media (Fig.4.2b). To maintain both cell viability and growth, the concentration of AHA
was increased to 1 mM, as recommended by Bagert and colleagues (2014)265. A 10-fold increase to 1
mM AHA was able to maintain both cell survival and growth (Fig.4.2c-e). However, by maintaining
the same AHA:MET ratios, the relative concentration of methionine was also increased in comparison
to (Fig.4.2a, 4.2b). The higher concentrations of methionine used in combination with 1 mM AHA,
were sufficient for cell growth even in the absence of AHA (Fig.4.2c-e), indicating that the cells
preferably use L-methionine rather than AHA for protein synthesis. As a result, concentration of
AHA-containing SASP proteins in the secretome might be reduced, which might impact the analysis
by mass spectrometry.
4.2 The typhoid toxin induces senescence and transmissible
senescence in AHA-containing media.
Though cells did not survive for long periods of time, e.g. 96h in Fig.4.2, without L-methionine,
even with AHA, cells appeared closer to control during short incubation periods, e.g. 12h with 100
µM AHA in Fig.4.1. Thus, cells were incubated with AHA then complete DMEM growth media
in cycles of 8h (day time) and 16h (overnight) for 96h as depicted in Fig.4.3a. As observed in
Fig.4.3c, at 96h, there was cell survival and no cell rounding. Next, the ability of the typhoid toxin
to induce senescence in AHA-containing media was examined. Indeed, the typhoid toxin and APH
induced significant senescence (Fig.4.3b-d; >80% SA-β-gal positive cells). They also induced cell
enlargement compared to untreated and toxinHQ (Fig.4.3c). Untreated and toxinHQ cells also induced
a relatively high number of SA-β-gal cells in AHA-treated cells (Figs.4.3a, red arrows; 4.3c, 4.3d).
However, it seems that SA-β-gal was reduced during the recovery period (Figs.4.3a, black arrows;
4.3c; 4.3d). These results indicate that even though AHA induces a stress response exemplified by
up-regulation of SA-β-gal, this effect is reversible, and does not induce permanent senescence-like
phenotype.
Next, transmissible senescence by conditioned media (CMAHA) collected from the experiment in
Fig.4.3c was examined (Fig.4.3e-g). Since APH is present in the first 24h of positive control experi-
ments, transmissible senescence was tested for all conditions using CMAHA fractions harvested between
24h-96h (Fig.4.3f ; fractions) for comparison. For controls, transmissible senescence was assayed using
complete DMEM harvested from untreated cells or cells treated with toxinWT or APH (Fig.4.3e-g).
Cells proliferated and exhibited no SA-β-gal activity when treated with untCM (Fig.4.3g). This
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Figure 4.3| Senescence and transmissible senescence induced by typhoid toxin in AHA-
containing media. a, Experimental design to label proteins with AHA over 96h, while maintaining a
healthy state of cells. cells in column 1 of a 6 well plate were treated with AHA post intoxication. Meanwhile,
cells in column 2 and column 3 were incubated in fresh DMEM. After 8h, CMAHA was collected, washed and
replaced with fresh DMEM. Simultaneously, labelling of cells in column 2 began for the overnight duration
(i.e. 16h), and third column remained in fresh DMEM that was not replaced with AHA until the 24 hour
time-point. The process was repeated until the end of the 96hour period and fractions collected were pooled
in together. This experimental design allowed cells to incubate in AHA for a maximum of 16h and at least
a 24-hour period of cell recovery in normal DMEM before re-incubating in AHA. The red arrow indicate the
end of the AHA experiment and the black arrow indicate recovery cells in c. b-d, Primary senescence of cells
marked by SA-β-gal at the end of the 96hour time-point from wells subjected to the last AHA incubation
in the series (col. 2) and cells undergoing the last recovery in complete DMEM incubation (col. 3). d,
Quantification of c from 2 biological repeats for AHA (∼300-800 cells/condition), and 1 biological repeat for
recovery (∼80-400 cells/condition). e-g, Transmissible senescence on naive HT1080, using conditioned media
in complete DMEM or conditioned media labelled with AHA (CMAHA) that were harvested and combined at
indicated time-points. CMAHA was diluted 1:1 with complete DMEM before cell treatments. f, Representa-
tive images of transmissible senescence assayed by SA-β-gal after 5 day treatment with conditioned media. g,
Quantification of f from 1 biological replicate (∼20-500 cells/condition). d and g, Each circle represents a
field of view. Unpaired student’s t-test were carried out between each condition and its untreated counterpart
unless otherwise indicated. Error bars indicate SEM. c and f, Scale bars are c, 100 and f, 200 µm
contrasted with toxWT-SASP induced transmissible senescence (Fig.4.3g; ∼95%). Interestingly, CM
from APH-treated cells, only induced modest SA-β-gal (Fig.4.3g; ∼25%). Consistent with this, re-
sults from Ibler et al (2019) showed that APH induced γH2AX RINGs and primary senescence, yet
transmissible senescence was reported to be ∼40% relative to ∼80% for the toxin106. The transmis-
sible senescence phenotypes observed in control experiments with complete DMEM were mirrored in
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Figure 4.4| Pilot mass spectrometry analysis. a, HT1080 cells were intoxicated and labelled with either
the methionine analogue, AHA, or cold L-methionine. Protein enrichment was carried out to select for AHA-
tagged proteins and samples were analysed by mass spectrometry. b, A plot of L-methionine intensity against
AHA intensity to visualize the specificity of AHA labelling. Each dot represents a protein. Proteins under
the dotted line depict proteins AHA-specific, and proteins above the line depict methionine-specific proteins.
c, Venn diagram of the mutual and exclusive proteins identified in this pilot experiment compared to the
compendium of secreted proteins262.
conditions with AHA media (Fig.4.3e-g). Thus, the toxin induces both primary and transmissible
senescence in -methionine/+AHA conditions.
4.3 Pilot experiment shows toxin-induced secretome was suc-
cessfully labelled by AHA.
In order to confirm that proteins collected incorporated AHA, a pilot mass spectrometry exper-
iment was carried out. Intoxicated cells were incubated with either AHA or L-methionine for 96h.
Click-iT reaction was then carried out on conditioned media to immobilise AHA-containing proteins
before on-bead digestion and mass spectrometry (Fig.4.4a).
If cells incorporated AHA, proteins in AHA samples should show higher intensity relative to L-
methionine samples. Indeed, 295 out of 944 proteins detected were solely found in the AHA samples
(AHA-specific) compared to 80 proteins solely in L-methionine samples (Met-specific). Additionally,
738 proteins were found more abundantly in the AHA samples (Fig.4.4b), 662 of which were human
proteins. Eichelbaum et al. (2012) published a study where they mapped out a compendium of
secreted proteins from various different cell lines using BONCAT262. They used PC3, WPMY-1,
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Figure 4.5| Raw data analysis exported from MaxQuant and processed using Perseus bioinfor-
matics analysis of AHA conditioned media. a, Heat map summarising the column Pearson’s correlation
analysis comparing LFQ intensities of samples with each other. b-d, Frequency distribution histograms of
the different samples analysed by mass spectrometry of b, unnormalised, c, normalised and d, imputed LFQ
values. c and d, untreated repeat 1 was excluded due to the low LFQ intensity shown in b.
RAW, PHC, Hepa1c1 and Hepa1-6 cell lines. Comparative analysis between human proteins identified
from the AHA experiment, and proteins identified in Eichelbaum et al (2012)262, showed 154 proteins
in common (Fig.4.4c). This data provides further evidence on the feasibility of AHA-labelling SASP
proteins for identification and elucidating the host cell secretome in response to toxinWT.
4.4 Newly translated proteins that are secreted in response
to toxinWT
Collection of CMAHA was harvested from 4 biological repeats of untreated, toxWT, toxHQ and
APH-treated cells over 96h using the protocol described in Fig.4.3a, and validated for transmissible
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Figure 4.6| Newly synthesised proteins in toxinWT-induced secretome. a, Conditioned media from
untreated, intoxicated cells (toxinWT and toxinHQ), and APH were harvested and validated for transmissible
senescence prior to mass spectrometry analysis. b, Representative images and c, quantification of transmissible
senescence induced in naive HT1080 cells by UntCM, toxinWT-SASP, toxHQ-CM and APHCM (0-96hr) for 6 days
then assayed for SA-β-gal. Each circle is a biological replicate of the samples analysed by mass spectrometry
(at least 10 fields of view per replicate, ∼300-2800 cells/condition per replicate). Scale bar is 200 µm. One-way
Anova with Tukey’s multiple comparison test was carried out to test for significance. Error bars denote SEM.
d-f, Volcano plots of secretomes induced between 0h and 96h post removal of toxin and analysed using Perseus
two-sample t-test (s0=0.01 and FDR=0.05) from at least 3 biological repeats/condition. Number of significant
proteins between d, toxinHQ and unt, e, toxinWT and unt, and f, toxinWT and toxinHQ, are indicated. Brown
dots indicate down-regulated proteins and blue dots indicate up-regulated proteins relative to each other. g,
Principal component analysis on the different CMAHA harvested at 96h post-intoxication. h, Toxin-specific
proteins compared to negative controls were analysed for their cellular localisation using Panther analysis of
the 178 gene names i, Heat map of the highest 20 secreted proteins in response to intoxication compared to
toxinHQ and Unt. j, Toxin-specific proteins that were shortlisted using the flowchart on the top. Heat map
lists gene names of significant different proteins in toxinWT-SASP compared to UntCM, toxHQ-CM. k, Potential
candidates for enhancing Salmonella invasion as filtered using the flowchart on the left.
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Gene name were cross referenced with proteins involved in growth factor signalling as dictated by
a search of the Human Protein Atlas. h and i, Blue text indicates proteins up-regulated in the
SASP Atlas as well. Gene names displayed were matched with the Human Secretome Atlas and the
compendium of secreted proteins262,266.
senescence (Fig.4.6a, 4.6b). As expected, CMAHA from toxinWT-treated cells showed ∼100% SA-
β-gal, whilst APHSASP did not show a significant increase in percentage of SA-β-gal positive cells
compared to the negative controls (Fig.4.6c). Given these observations, it was decided that the
best samples to carry forward for further analysis were untreated, toxHQ, and toxWT. MaxQuant
analysis and Perseus-generated multi-scatter plots and Pearson’s correlation analysis of the samples
demonstrated that even though untreated replicate 1 showed good correlation with replicate 2 (0.934),
the correlation to replicate 3 and 4 were not as high (0.878 and 0.864 respectively) (Fig.4.5a).
Furthermore, the analysis showed relatively good protein count of label-free quantification (LFQ)
intensities for all conditions analysed (Fig.4.5b). However, untreated replicate 1 showed lowest
counts of proteins (Fig.4.5a). As a result, untreated replicate 1 was excluded from further analysis.
LFQ intensities were then normalised and missing values from the MaxQuant analysis were imputed
from the normal distribution to provide complete normalised proteomics data (Fig.4.5c, Fig.4.5d).
There was no difference in secretomes of untreated and toxinHQ treated control cells (Fig.4.6d),
but a divergent secretome was induced by toxinWT-treated cells compared to untreated (Fig.4.6e,
n=403) and toxinHQ (Fig.4.6f, n=202). This was further consolidated by principal component anal-
ysis (PCA) that showed clustering of the negative control replicates together, which were divergent
from toxinWT (Fig.4.6g). Strikingly, the majority of proteins detected were up-regulated in toxWT
compared to the negative controls.
There were a sum of 920 proteins cumulatively in all samples∗. Peptides identified from the
samples contained both human and bovine sequences. Proteins that had bovine sequences are likely
to be due to the presence of dialysed FBS in the methionine-free media (Materials and Methods;
Section 10.1.1). Therefore, bovine peptide sequences were eliminated, which revealed 692 human
proteins (i.e. ∼75% of all proteins identified). To identify enhancers of infection, the toxinWT-induced
secretome was filtered against both negative controls (Fig.4.6h), which implicated 178 proteins.
However, PANTHER cellular component analysis indicated the majority of the proteins identified
in toxSASP are intracellular (∼120 proteins). Closer examination of the top 20 factors increased in
toxWT compared to toxHQ included: SNRPA, UBQLN1, and BTF3 all of which execute intracellular
functions267,268,269,270 (Fig.4.6i).
To identify toxinSASP proteins previously reported as secreted, two databases were used: i) Eichel-
baum et al 2012 Compendium of Secreted Proteins, which was identified using BONCAT on diverse
cell lines262, and ii) The Human Secretome Atlas266. The Human Secretome Atlas is a database
of 2641 proteins (i.e. ∼13% of all human coding genes) created by a) annotating transcriptomics
analysis for the presence of a secretion signal peptide, b) including proteins annotated as secreted
∗Click here to access the whole dataset extracted and used for BONCAT analysis
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on Uniprot, c) validating secretion using antibody- and mass spectrometry based-analyses on blood
plasma samples266.
Only 4.5% (i.e. 8 proteins) of the toxin-specific proteins were previously reported as secreted
in one or both of secretome databases used262,266, 6 of which have been reported in the SASP At-
las174(Fig.4.6j). Curiously, top factors in toxSASP included nuclear protein factors from the High-
mobility group (HMG) superfamily e.g. HMGA1, HMGB1, and HMGB2, which were recently im-
plicated in extracellular functions as well271. Notably, HMGB1 is a damage-associated molecular
pattern (DAMP), also known as an alarmin, which has been reported to be a core SASP component
of fibroblast senescence174. Similarly, extracellular HMGA1 was reported to mediate tumorigensis
and metastasis272, and work in conjunction with NOTCH to regulate chromatin organisation and
SASP170. Curiously, HMGB2, was not reported as an alarmin, but is involved in chromatin remod-
eling and SASP regulation211. Interestingly, extracellular DAMPs have been implicated in ageing
and inflammation and are used as a biomarker for infectious diseases, malignant tumours, and other
diseases273.
Growth factors have been previously reported to increase membrane ruffling274. Therefore, to
examine putative candidates that might be synthesised to enhance Salmonella invasion, proteins were
searched for any link with growth factor using “growth factor signalling” as a key word on the Human
Protein Atlas275. Out of 178 proteins, ∼13.5% of toxin-specific proteins were involved in growth factor
signalling (Fig.4.6k). Although, none of these proteins have been reported in the Human Secretome
or Eichelbaum et al 2012 (Fig.4.6k)262,266,276, 15 of the growth factor signalling proteins have been
reported in the SASP Atlas174, perhaps providing an insight into contextually-secreted proteins. For
instance, HDGF, which was up-regulated significantly in toxinWT-treated cells, is a growth factor that
is recently discovered to be secreted in cancer cell lines and has anti-apoptotic properties277, but was
not found in either atlases (Fig.4.6k). There were also conventionally abundant intracellular proteins
such as ACTB which might have been detected due to apoptotic cells.
4.5 Discussion
This chapter explored late senescence secretome using a novel approach, BONCAT, and revealed
newly synthesised proteins in response to the typhoid toxin. BONCAT is a very powerful technique as
it is safe, reliable, easy and non-radioactive compared to other proteomic techniques263. It has been
previously used in many temporal and spatial experiments providing great sensitivity262,263,265.
This approach revealed a unique secretome induced by the nuclease activity of toxinWT in com-
parison with the negative controls. It also identified previously reported SASPs, which validates the
senescence phenotypes induced by the toxin and provide potential factors involved in toxin-induced
phenotypes174. Nevertheless, there was a large amount of intracellular proteins that are reasoned to
be an apoptotic release due to the stress of the BONCAT protocol on the cells, which is exemplified
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by Panther Cellular Component analysis, the high presence of DAMPs such as HMG proteins, and
the few matches to the Human Secretome Atlas (Fig.4.6h-j). This suggests that secretomes analysed
might have included SASP as well as the secretome of cells undergoing cell death. It is worth-noting
that some intracellular factors identified, such as EIF2A and HMG proteins, can be secreted in ex-
osomes or in unconventional protein secretion pathway278,279,280, without bearing a secretion signal
peptide. Therefore, the secretome databases used may not be entirely inclusive. The abundance of
intracellular proteins and the scarcity of proteins reported as secreted in the examined SASP, reduced
the reliability of these results.
Moreover, the lack of senescence positive control (e.g. aphidicolin) (Fig.4.6c) hindered the ability
to narrow down the hits to the best toxin-specific SASP proteins for further examination.
Furthermore, even though toxinWT-induced senescence in the presence of AHA, there was a larger
percentage of senescence in untreated cells and toxinHQ treated cells than normal DMEM as depicted
by SA-β-gal. Additionally, the recovery period in complete DMEM added to the protocol might
include latent AHA-tagged protein secretions that were not analysed, which could have reduced sen-
sitivity and inclusiveness. All together, these results suggest that alternative approaches to identify




The typhoid toxin-induced host
secretome
In Chapter 4, BONCAT was used to identify newly synthesized proteins in response to the typhoid
toxin, which presented some challenges and disadvantages. In contrast, many research groups that
aimed to identify secretomes have cultured cells in serum-free media to restrict FBS contaminants
from masking low abundance proteins174,281,282,283,284,285. The aim of this chapter is to characterise
toxSASP via two complementary approaches using LC-MS/MS: (i) conditioned Essential 8 (E8) stem
cell minimal media, and (ii) serum-free DMEM.
5.1 HT1080 cell growth in diverse serum-free media
HT1080s cells were cultured with serum-free, xeno-free cancer cell line medium (XF; PromoCell),
Essential 8 (E8) and DMEM serum-free (SF) and compared with complete growth DMEM media with
10% FBS (Fig.5.1a). XF is a commercially available xeno-free, serum-free, cancer cell line media
that was advocated as a better alternative to DMEM. Essential 8 media (E8) is a stem cell media
comprising of only 8 essential components: DMEM:F12, L-ascorbic acid-2-phosphate magnesium (64
mg/L), sodium selenium (14 µg/L), FGF2 (100 µg/L), insulin (19.4 mg/L), NaHCO3 (543 mg/L),
transferrin (10.7 mg/L), and TGFβ1 (2µg/L), or NODAL (100 µg/L). SF has been previously used
by Basisty et al, 2019 to identify SASP in fibroblasts and epithelial cells174.
Cells were seeded at a low density (i.e. 1x103) and their morphology, growth and number were
examined across 4 days in indicated media (Fig.5.1). In all conditions, cells looked healthy and
similar to complete DMEM media at 24h. However, serum-free DMEM showed a distensive, string-
like morphology at 96h, indicating cell stress, whilst cells in XF and E8 had a similar morphology
to control (Fig.5.1a). When growth was quantified, cells doubled within each 24h interval in the
presence of DMEM. XF media showed an initial statistically significant lag in growth but followed a
similar trend to complete DMEM media starting from 48h. E8 also only supported growth from 48h
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Figure 5.1| Cells survival and protein concentration of different cell culture media. Cells were
seeded at 2500 per well and growth monitored for 96h. a, Representative images of HT1080s grown in each
culture medium at 24h and 96h. Scale bar is 100 µm. b, Number of viable cells over time showing growth
or cell cycle arrest assayed using trypan blue. c, Protein concentration of unconditioned media as assessed
by Bradford assay. d, Protein concentration of conditioned SF DMEM and E8 media of cells treated with
toxWT and toxHQ as assessed by Bradford assay at 48h post intoxication. c and d concentrations should
not be compared due to technical differences with the BSA standard curve, which is a limitation of this
method. b, Two-way ANOVA with Dunnett’s multiple comparison’s, c, an unpaired t-test were carried out
for each time point in comparison with DMEM of the same time-point. d, One-way ANOVA with Dunnett’s
multiple comparison’s was carried out in comparison to untreated of each medium. Where it is unindicated it
is non-significant difference. Each circle represents a technical replicate. b-c, are one biological replicate each
with 3-4 technical replicates. d each circle represents a biological replicate, which was later analysed by mass
spectrometry.
but at a much slower rate than DMEM (Fig.5.1b). Cells incubated in serum-free DMEM remained
at a low cell number and viability decreased after 48h as determined by a reduction in cell number
exemplified at the 72h timepoint.
To further examine which growth media supported production of a host secretome, protein concen-
tration of conditioned and unconditioned media were quantified. Although XF media is serum-free, it
contained a higher concentration of proteins than complete DMEM and therefore was excluded from
further experiments (Fig.5.1c). In contrast, E8 media showed significantly lower protein concentra-
tion than both DMEM and XF media. No proteins were detected in unconditioned serum-free DMEM
(data not shown).
Next, protein concentrations of toxWT-CM and toxHQ-CM were compared to untCM in both SF and
E8 conditions. In comparison to the negative controls, toxWT-CM showed a significant increase in
secretions in SF media, but no change in E8 media (Fig.5.1d). This suggests that E8 supplements
might confer high background protein level relative to SF, which might mask differences in secretions
between conditions. Since Basisty and colleagues used serum-free conditions to identify the secre-
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Figure 5.2| Senescence induced by typhoid toxin in serum-free and Essential 8 (E8) media. a,
Experimental schematic demonstrating the timeline of serum-free media application and collection timepoints
across 4 days. Each batch of cells were seeded differently to account for cellular replication every 24h in
complete media and cell cycle stalling in serum-free media. (2x104 cells for 0-24h, 1x104 for 24-48h, 5x103,
2.5x103 cells in a 24-well format. b-d, Primary senescence induced in HT1080s at the end of each incubation
with serum-free media (blue arrow in a). c, Quantification of SA-β-gal positive cells at the end of each
incubation with serum-free media. d, Representative images of c. e, Experimental schematic demonstrating
the timeline of E8 media application and collection timepoints across 4 days. Each batch of cells were seeded
differently to account for cellular replication every 24h as per the growth curve in Fig.5.1. Cells were seeded
in 6-well format at 1x105 (0-24h, 0-48h), 8x104 (0-72h), and 4x104 (0-96h). f-h, Primary senescence induced
in HT1080s at the end of each incubation with E8 media (green arrow in e). g, Quantification of SA-β-gal
positive cells at the end of each incubation with E8 media. h, Representative images of g. c and g, One-way
ANOVA with Tukey’s multiple comparisons test was carried out against the corresponding time-point for
untreated and toxinHQ treated cells. Each circle represents a field of view (1 biological repeat, ∼300-2500 cells
per variable). Error bars indicate SEM. d and h, Scale bar is 100 µm.
tome of fibroblast and epithelial cells174 and E8 showed potential in terms of viability and cellular
replication, both media were further tested for toxin-induced senescence phenotypes.
5.2 Primary senescence in cells cultured in SF and E8.
The ability of a 2h toxin treatment to induce primary and transmissible senescence in serum-
free DMEM (henceforth SF) and E8 was examined at different timepoints across 96h (Fig.5.2). Cells
incubated in SF media, hereafter SF cells were viable in the first 24h (Fig.5.1). Thus, intoxicated cells
were cultured in complete DMEM for up to 72h and the conditioned media was harvested following
a 24h incubation in SF at the relevant timepoints, as depicted in (Fig.5.2a). Upon harvesting
the conditioned media, cells undergoing toxin-induced primary senescence (toxSEN) were assayed for
92
Chapter 5
Figure 5.3| Transmissible senescence induced by typhoid toxin in serum-free and Essential 8
(E8) media. a, Experimental schematic demonstrating the timeline of serum-free media application and
collection timepoints across 4 days. Cells were seeded at 1000/well. b-d, Transmissible senescence induced in
naive HT1080s using each fraction of serum-free media collected (blue dotted lines). c, Quantification of SA-β-
gal positive cells induced by each serum-free conditioned media fraction in naive HT1080s. d, Representative
images of c. e, Experimental schematic demonstrating the timeline of E8 media application and collection
timepoints across 4 days. f-h, Transmissible senescence induced in naive HT1080s using each fraction of
E8 media collected (green dotted lines). g, Quantification of SA-β-gal positive cells induced by each E8
conditioned media fraction in naive HT1080s. h, Representative images of g. c and g, Two-way ANOVA
with Dunnett’s multiple comparisons test was carried out against the corresponding time-point for untreated
and toxinHQ treated cells. Each circle represents a biological replicate (∼200-7500 cells/condition) for c, and
technical replicates (∼600-2500 cells/condition) for g. Error bars indicate SEM. d and h, Scale bar is 100
µm.
senescence by SA-β-gal (Fig.5.2a; blue arrows). Senescence was observed in 50% of cells at 24h,
which increased to ∼100% thereafter (Fig.5.2b-d). This contrasted with cells treated with toxinHQ
, which was equivalent to untreated cells. Parallel experiments using E8 media, which unlike SF was
incubated with toxin-treated cells throughout (e.g. 0-24h, 0-48h)(Fig.5.2e; green arrows), mirrored
the trend observed in SF cells with maximal primary senescence observed at 96h (Fig.5.2e-h: ∼20%
at 24h to ∼80% at 96h).
5.3 Transmissible senescence in cells cultured with SF and E8
media.
Each fraction of conditioned SF or E8 media harvested at 24h intervals was assayed for its ability
to transmit senescence into naive cells (Fig.5.3a, blue lines; Fig.5.3e, green lines). Relative to un-
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Figure 5.4| Pilot mass spectrometry experiment comparing proteins from serum-free and E8
conditioned media of intoxicated cells. a, Comparison of label-free quantification intensity of proteins
detected in serum-free conditioned media from 0 to 48h post intoxication, and E8 conditioned media from 0 to
48h and 0 to 96h post intoxication. b, Number of proteins detected in each conditioned media from different
methodologies in comparison with BONCAT method that uses the methionine analogue, AHA to label newly
synthesised proteins. c, Venn diagram showing the number of proteins that are common and unique to each
conditioned media collection method using BioVenn. d, Number of gene names of each method that matched
with The Human Secretome, or the compendium of secreted proteins in human cell lines.262,266
treated and toxinHQ, only toxinWT (toxinSASP) retained the ability to induce transmissible senescence
(Fig.5.3b-d). SF fraction 0-24h showed the highest percentage of SA-β-gal positive cells in SF condi-
tions. The subsequent toxinSASP fractions (24-48h, 48-72h, 72-96h) weakened progressively to ∼40%
SA-β-gal positive cells (Fig.5.3c-d). However, when all SF fractions were combined, the transmission
of senescence mirrored the first 24h. This suggests that toxinSASP elicits an acute senescence response
due to a factor present in the 0-24h SF fraction. When SF was compared to E8, all 0-24h, 0-48h,
0-72h and 0-96h E8 fractions consistently showed ∼40-50% transmissible senescence compared to the
negative controls (Fig.5.3g-h). In summary, cells cultured in both SF and E8 media induced toxSEN
and toxSASP. As toxSEN and toxinSASP in SF were maximal in the first 48h, subsequent experiments
were carried out using 0-24 and 24-48h fractions. Since E8 fractions showed similar phenotypes in all
timepoints, 0-48h and 0-96h were analysed in a pilot mass spectrometry experiment.
94
Chapter 5
5.4 Pilot mass spectrometry analysis of host cell secretomes.
To examine the difference between SF and E8, three samples were analysed by mass spectrometry:
toxSASP in E8 (0-48h), E8 (0-96h) and SF (0-48h comprising 0-24h and 24-48h in combination)
(Fig.5.4).
Label-free quantification (LFQ) intensity is an indicator of the relative amount of proteins in the
samples. SF unconditioned media showed almost no LFQ intensities compared to E8 media which
shows a higher intensity (Fig.5.4a). Even though the LFQ intensity was higher in E8 toxSASP than
SF toxSASP at 0-48h (Fig.5.4a), SF analysis revealed the highest number of proteins (Fig.5.4b:
SF, n=1089 / E8, n=1026). ToxSASP from E8 conditioned media between 0-96h showed the highest
LFQ intensity and identified the most proteins (Fig.5.4a-b). Interestingly, there were 654 proteins
that were common between all three samples (Fig.5.4c) whilst also revealing significant differences
at 0-48h (Fig.5.4c: SF, 301 unique proteins / E8, 165 unique proteins). This suggests that growth
media composition regulates the secretome, as well as incubation time since the most significant
difference was observed between E8 0-48h and E8 0-96h (Fig.5.4c). Mass spectrometry on SF and
E8 conditioned media led to the detection of more than ∼50% additional proteins relative to AHA-
labelled proteins using BONCAT methodology (Fig.5.4b), which highlights BONCAT’s limitations.
Comparative analysis with the Human Secretome266 and the compendium of secreted proteins262
showed that even though E8 incubation for 96h has the highest LFQ intensity (Fig.5.4a) and the
most number of proteins detected (Fig.5.4b), conditioned media in SF for 48h has the highest number
and percentage of secreted proteins matches (n=280, ∼26%) compared to to E8 48h (n=244, 24%)
and 96hr (n=260, ∼11%) (Fig.5.4d). Given the higher sensitivity of both approaches compared to
BONCAT, and to examine toxSASP in different growth media, quantitative LC-MS/MS on both E8
and SF conditioned media were used to identify the proteins secreted by intoxicated cells.
5.5 Mass spectrometry of toxin-induced host secretome in E8
media.
ToxSASP and APHSASP both transmitted senescence to naive cells indicating a common mechanism,
but only toxSASP enhanced Salmonella invasion by macropinocytosis into bystander cells106. This
suggests the toxin induces a secretome customised for infectious disease. To investigate the molecular
basis of these divergent SASPs, toxSASP was compared to SASP generated by chemical inducers of
DNA double-strand breaks and senescence, APH and ETP286 and negative controls. A minimum of
3 biological replicates of conditioned media from untreated, toxinWT-, toxinHQ-, APH-, and ETP-
treated cells cultured in E8 media (0-48h) were harvested and assayed for transmissible senescence.
ToxinWT-SASP induced senescence in ∼70% of cells relative to ∼20% in negative controls (Fig.5.6a-
c). Similarly, APH induced significant senescence (∼40%), but ETP only induced ∼25% senescence,
which was not statistically significant.
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Figure 5.5| Raw data analysis exported from MaxQuant and processed using Perseus bioin-
formatics analysis. a, Heat map summarising the column Pearson’s correlation analysis comparing LFQ
intensities of E8 samples with each other. b-d, Frequency distribution histograms of the different E8 samples
analysed by mass spectrometry of b, unnormalised, c, normalised and d, imputed LFQ values.
Pearson’s column correlation analysis showed high correlation between the different biological
replicates of each condition (Fig.5.5a, r>0.84), which indicates high reproducibility. Surprisingly,
toxinHQ replicates had low correlation with untreated samples (Fig.5.5a, r<0.8), but a high correla-
tion with toxinWT samples (Fig.5.5a, r>0.9). This indicates a technical error following assaying of
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Figure 5.6| Analysis of typhoid toxin-induced secretome in E8 media. a, Conditioned media from
untreated, intoxicated cells (toxinWT and toxinHQ), and other senescence inducers (APH and ETP) were
harvested and validated for transmissible senescence prior to mass spectrometry analysis. b, Representative
images and c, quantification (right) of transmissible senescence induced in naive HT1080 cells by untCM,
toxinWT-SASP, toxHQ-CM, APHCM and ETPCM (0-48hr) for 4 days then assayed for SA-β-gal. Each circle is
a biological replicate of the samples analysed by mass spectrometry (at least 10 fields of view per replicate,
∼300-2800 cells/condition per replicate). Scale bar is 200 µm. One-way Anova with Tukey’s multiple com-
parison test was carried out to test for significance. Error bars denote SEM. d-h, Volcano plots of secretomes
induced between 0h and 48h post removal of toxin and analysed using Perseus two-sample t-test (s0=0.01 and
FDR=0.05) from at least 3 biological repeats/condition. Number of significant proteins between d, toxinHQ
and unt, e, toxinWT and unt, f, toxinWT and toxinHQ, g, toxinWT and APH, and h, toxinWT and ETP are
indicated. Brown dots indicate down-regulated proteins and blue dots indicate up-regulated proteins relative
to each other. i, Principal component analysis on the different E8 SASP and conditioned media collected after
48h post removal of inducer after excluding toxinHQ. j, Heat map listing gene names of significant different
proteins in toxinWT-SASP compared to both untCM, APHCM and ETPCM. Flowchart of the filtering steps
(left). The list was compared to GeneChip microarray data (p<0.05), and matches are displayed. Blue text
indicates up-regulated genes, brown text indicates down-regulated genes, and black text indicates opposing
fold changes in both mass spectrometry and microarray analyses.
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k, Proteins identified to be significantly increased or decreased in a senescence-specific manner com-
pared to the untCM. Flow chart of the filtering steps used (left) to reach the list of candidates (right)
potentially responsible for transmitting senescence. j and k, Gene names displayed were matched
with the Human Secretome Atlas and the compendium of secreted proteins266,262.
transmissible senescence in Fig.5.6b, 5.6c and mass spectrometry of toxinHQ samples, e.g. toxinWT
contamination of toxinHQ. LFQ intensities of the samples were normalised (Fig.5.5b-c) and miss-
ing values imputed (Fig.5.5d) from the normal distribution before carrying out Student’s t-test for
comparative analysis of the secretomes. Consistent with the Pearson’s correlation analysis, volcano
plot analysis revealed significant differences between toxHQ-CM and untCM (Fig.5.6d, n=1378), but
almost no difference with toxinWT (Fig.5.6f, n=10)∗. Given the marked difference in transmissi-
ble senescence (Fig.5.6b-c), volcano plot analysis further indicates a technical error during sample
preparation for Orbitrap analysis. Therefore, toxinHQ samples were excluded from further E8 analysis.
Similar to the data extracted using BONCAT, toxinWT showed a significantly divergent secretome
compared to untCM and the positive controls in E8 media (Fig.5.6e, 5.6g-h), which was exemplified
with the PCA clustering analysis (Fig.5.6i). To compensate for the lack of toxinHQ data in E8
media analysis, toxin-specific proteins were compared to the GeneChip microarray of toxinWT vs
toxinHQ (Fig.5.6j). E8 and microarray analysis revealed co-regulation in both the secretome and
transcriptome. Half of the significant proteins identified in toxinWT compared to negative and positive
controls were also significant in the microarray analysis (Fig.5.6j, 57 out of 110).
Interestingly, the top significant candidates included COPA and SEC22B which were up-regulated
and essential in vesicle trafficking, indicating potential exosomal release of proteins287,288. Of interest,
the ubiquitin-like protein ISG15, a regulator of the Type I interferon pathway was up-regulated in
toxinWT-treated cells (Fig.5.6j). ISG15 has previously been shown to constitute anti-viral proper-
ties289. Additionally, in Listeria monocytogenes infections, free ISG15 was up-regulated and resulted
in restricted infection290. Interestingly, the typhoid toxin also induced inflammatory constituents,
previously associated with senescence phenotypes (Fig.5.6j). The toxin positively regulated the in-
flammatory protein CXCL8, which reinforces senescence through ROS and p53 activation195,205, but
negatively regulated anti-inflammatory metalloproteases such as MMP14. Downregulation of MMP14
was shown to induce senescence in mice291. Additionally, the toxin upregulated S100A13, which is
a DAMP that drives inflammation292(Fig.5.6j). In fact, cell stimulation using S100A13 showed in-
duction of NF-κB which drives senescence phenotypes293,294. To identify mediators of transmissible
senescence, the secretomes of all senescence inducers (toxinWT, APHSASP and ETPSASP) were filtered
against untCM (Fig.5.6k; n=319), then cross examined with secretome atlases262,266 and the SASP
Atlas174 (Fig.5.6k, n=26). Interestingly, GDF15, also known as macrophage inhibitory cytokine-1,
and a TGFβ family member was up-regulated (Fig.5.6k). TGFβ signaling pathways have been pre-
viously reported as pivotal in transmissible senescence187, which hints at TGFβ signaling activation
by the typhoid toxin.
∗Click here to access the whole dataset extracted and used for E8 analysis
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Although E8 conditioned media provided a more inclusive secretome compared to BONCAT, the
lack of toxinHQ control was not ideal. In addition, SF showed a higher percentage of secreted proteins
in the pilot experiment. Therefore, conditioned media collected from SF was analysed by LC-MS/MS
and controlled for DNA damage phenotypes, as well.
5.6 Toxin-induced host secretome underlying toxSASP in SF
media.
Prior to analysing the SF conditioned media by mass spectrometry, the DNA damage responses
to the typhoid toxin were investigated at 24h and 48h when SF conditioned media was harvested
(Fig.5.7a, red arrows). As expected, in serum-free conditions no RINGs were detected, and the
majority of cells displayed a γH2AX foci phenotype (Fig.5.7b-f, ∼90%). Cells showed a decrease in
RPApT21 positive nuclei, (Fig.5.7g, 16% to 8%) but a sustained 53BP1 response across timepoints
(Fig.5.7h, 70-80%). Other senescence inducers, i.e. aphidicolin and etoposide, displayed a similar
γH2AX foci phenotype but less significant RPA and 53BP1 responses in serum-free conditions.
Conditioned SF media fractions 0-24h and 24-48h from the experiment in Fig. 5.7 were combined
and 4 biological replicates were validated for their ability to transmit senescence (Fig.5.9a, 5.9b).
Next, LC-MS/MS was used to identify the protein constituents of each secretome. Perseus column cor-
relation analysis showed high correlation between the different biological replicates of each condition
(Fig.5.8a, r>0.90), which indicates the samples’ high quality. Label-free quantification of the samples
were normalised (Fig.5.8b, 5.8c) and missing values imputed (Fig.5.8d) from the normal distri-
bution before carrying out Student’s t-test for comparative analysis of the secretomes (Fig.5.9c-e).
Similar to BONCAT, there was very little difference in the secretomes of untreated and toxinHQ-treated
negative control cells (Fig.5.9c, n=65 significant proteins), which contrasted with the secretome of
toxinWT-treated cells that was significantly divergent from untreated (Fig.5.9d,n=1153) and toxinHQ
(Fig.5.9e, n=1186)∗. Interestingly, previous literature provided evidence that SASP proteins were
predominantly upregulated in response to irradiation- and oncogene-induced senescence174. Similarly,
the majority of significant secreted proteins were upregulated in response to the toxin (Fig.5.9e, 954
out of 1186). Fig.5.9f reveals the toxinWT-induced secretome defined by proteins in the Human
Secretome and Eichelbaum et al 2012 compendium of human secreted proteins that were differentially
regulated relative to untreated and toxinHQ-treated negative controls262,266(P<0.05, n=133 significant
proteins).
To further investigate the toxinWT secretome, global changes in transcription were determined
by GeneChip microarray analysis of cells at 48h following 2h treatment with toxinWT or toxinHQ
(Fig.5.9g). Of the 133 proteins comprising the toxinWT-induced secretome (Fig.5.9f), 65 proteins
were identified as significant by both mass spectrometry and microarray analyses (Fig.5.9g).
∗Click here to access the whole dataset extracted and used for SF analysis
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Figure 5.7| DNA damage responses of intoxicated cells in serum-free conditions during condi-
tioned media extraction. a, The experimental protocol of serum-free conditioned media extraction for
mass spectrometry analysis. Arrows indicate cells fixed at the end of 0-24h (red) and 24-48h (black) incu-
bation with serum-free media time point for DNA damage assays. b, Experiments shown are toxin-induced
senescence. c, Representative images of toxin-induced γH2AX (magenta) and RPApT21 (cyan) response at
the end of the 0-24h and 24-48h serum-free incubation. d, Representative images of toxin-induced γH2AX
(magenta) and 53BP1 foci (red) at the end of the 0-24h and 24-48h serum-free incubation. c and d, Scale
bars on representative images denote 50 µm. e, Percentage of RING positive nuclei detected using the RING
tracker. f, Percentage of γH2AX foci positive nuclei quantified using CellProfiler. g, Percentage of RPApT21
positive nuclei quantified using CellProfiler. h, Percentage of 53BP1 positive nuclei quantified using Cell-
Profiler. e-h, RPApT21 positive nuclei were determined using CellProfiler by thresholding the amount of
RPA occupying each nucleus. γH2AX and 53BP1 foci were counted using CellProfiler, and positive cells were
determined using the cut-off value derived from number of foci in untreated cells between 0-24h. Each circle
on the graphs represents a biological replicate (30 fields of view, ∼500 nuclei/condition). Two-way ANOVA
with Sidak multiple comparisons test was carried out to test for significance. Error bars denote SEM.
Panther analysis of the matches between SF mass spectrometry and microarray analyses showed
that the proteins identified are involved in various pathways most notably the gonadotropin-releasing
hormone receptor pathway (GnRHR), TGFβ signalling pathway, angiogenesis and notch signaling
pathway (Fig.5.9g, Supplementary Fig.S1). TGFβ signalling pathway was the only pathway to
have all the three proteins involved upregulated, hinting at an activation of the pathway in paracrine
senescence signaling. INHBA (i.e. activin βΑ), GDF15 and BMP1, which activate the TGFβ sig-
nalling pathway, a major axis in transmissible senescence187,295, was also found upregulated in both
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Figure 5.8| Raw data analysis exported from MaxQuant and processed using Perseus bioin-
formatics analysis. a, Heat map summarising the column Pearson’s correlation analysis comparing LFQ
intensities of samples with each other. b-d, Frequency distribution histograms of the different samples anal-
ysed by mass spectrometry of b, unnormalised, c, normalised and d, imputed LFQ values.
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Figure 5.9| The typhoid toxin-induced secretome. a, Conditioned media from untreated and intoxi-




b, Representative images (left) and quantification (right) of transmissible senescence induced in naive
HT1080 cells by untCM, toxinWT-SASP and toxHQ-CM (0-48hr) for 4 days then assayed for SA-β-gal.
Each circle is a biological replicate of the samples analysed by mass spectrometry (40 fields of view,
∼500 and 2500 cells per condition). One-way Anova with Tukey’s multiple comparison test was carried
out to test for significance. Error bars denote SEM. b, Scale bar is 100 µm. c-e, Volcano plots of
secretomes induced between 0h and 48h post removal of toxin and analysed using Perseus two-sample
t-test (s0=0.01 and FDR=0.05) from 4 biological repeats per condition. Number of significant proteins
between c, toxinHQ and unt, d, toxinWT and unt, and e, toxinWT and toxinHQ are indicated. Brown
dots indicate down-regulated proteins and blue dots indicate up-regulated proteins relative to each
other. f, Heat map listing gene names of significant different proteins that increase or decrease in
toxinWT-SASP compared to both untCM and toxHQ-CM. Gene names displayed were matched with the
Human Secretome Atlas and the compendium of secreted proteins262. Proteins that showed opposing
secretion profile in toxinWT-SASP vs untCM and toxinWT-SASP vs toxHQ-CM are not displayed. Genes
were sorted from highest to lowest t-test difference in toxinWT-SASP vs toxHQ-CM g, Heat map of a
comparative analysis between the toxin-induced secretome displayed in f, and GeneChip microarray
data (p<0.05). Blue text indicates up-regulated genes, brown text indicates down-regulated genes,
and black text indicates opposing fold changes in both analyses. h, Panther pathway analysis of genes
listed in g. Blue text indicates up-regulated genes, brown text indicates down-regulated genes, and
black text indicates opposing fold changes in both mass spectrometry and microarray analyses. i,
Venn diagram displaying the gene names of proteins that were found (i) in the Human Secretome266,
(ii) up-regulated in the mass spectrometry, (iii) up-regulated in the microarray and (iv) up-regulated
in the SASP Atlas174.
analyses (Fig.5.9h,; blue labelling). Interestingly, inhibitors of Activin βΑ-driven TGFβ signalling,
TGFBR3 and FST, which are constituents of the GnRHR (Fig.5.9g, 5.9h), were found upregulated
in mass spectrometry but downregulated in the microarray (black labelling). This perhaps suggests
that the receptor TGFBR3, for example, is shed from senescent cells rather than overexpressed.
Other factors identified were notably regulators of blood coagulation and blood vessel formation
(Fig.5.9h, Supplementary Fig.S1). PDGFs, which were upregulated in the secreted proteins are
pro-angiogenic296, whilst JAG1, which is also pro-angiogenic, was downregulated in both E8 secre-
tome, SF secretome and microarray analyses297 (Fig.5.6j; 5.9g, 5.9h). Additionally, SERPINA1
which is a positive regulator of blood coagulation298 was upregulated in both analyses, whilst PLAUR,
which is an anticoagulant299 was downregulated, indicating potential toxin-induced blood coagulation
(Fig.5.9g,5.9h). Of the proteins that were downregulated in both mass spectrometry and microarray
analyses (brown labelling), the most striking were the interleukins, IL6 and CCL2, which are a hall-
mark of pro-inflammatory SASP (Fig.5.9g, 5.9h).174,189,300 The secretome included known SASP
proteins such as effectors of innate immunity (e.g. complement C3, C1S) that were upregulated in
both analyses (indicated by blue labelling), as were GDF15, SERPINA1, SERPINE-2, ECM1, and
TIMP1 amongst others that were identified in the SASP Atlas database174 (Fig.5.9i).
To examine the factors that contribute to the toxSASP-specific phenotypes, APHSASP and ETPSASP
constituents were also compared to toxSASP (Fig.5.10a-c). Conditioned media from each senes-
cence inducer was validated for their ability to transmit senescence before analysing the secretomes
by LC-MS/MS (Fig.5.10b). PCA analysis of the secretomes displayed 3 distinct clusters group-
ing senescence-inducers APHSASP and ETPSASP(red), the negative controls secretomes (blue), and
toxSASP, which generated an independent cluster establishing that the toxin has the most divergent
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Figure 5.10| The unique toxin-induced secretome relative to other senescence inducers. a, Rep-
resentative images of DNA damage (γH2AX - magenta) and primary senescence (SA-β-gal - green) responses
induced by toxinWT, aphidicolin (APH) and etoposide (ETP) at 96h. White arrows indicate γH2AX-positive
nuclei for ETP-treated cells. Scale bar is 50 µm. b, Quantification (right) of transmissible senescence induced
in naive HT1080 cells by untCM, APHSASP and ETPSASP (0-48hr post removal) for 4 days then stained for
SA-β-gal. Each circle is a biological replicate of the samples analysed by mass spectrometry (40 fields of
view; ∼500 and 2500 cells/condition). One-way Anova with Tukey’s multiple comparison test was carried
out to test for significance. Error bars denote SEM. c, Principal component analysis on the different SASP
and conditioned media collected after 48h post removal of inducer. d-f, Volcano plots of secretomes induced
between 0h and 48h post removal of toxin analysed using Perseus two-sample t-test (s0=0.01 and FDR=0.05)
from 4 biological repeats per condition. Number of significant proteins between d, toxinWT and APH, e,
toxinWT and ETP, and f, APH and ETP indicated. Brown dots indicate down-regulated proteins and blue
dots indicate up-regulated proteins relative to each other. g, Proteins identified to be significantly increased
in a toxinWT-specific manner compared to all negative and positive controls.
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Flowchart of the filtering steps (left) to reach toxin-specific list including proteins that are poten-
tially involved in enhancing Salmonella invasion (right). h, Proteins identified to be significantly
increased or decreased in a senescence-specific manner compared to the negative controls. Flow chart
of the filtering steps used (left) to reach the list of candidates (right) potentially responsible for trans-
mitting senescence. i, Venn diagram of proteins that were consistently significantly up-regulated in
toxinWT-SASP compared to untCM from all three mass spectrometry techniques (SF, E8 and AHA).
Genes listed are the proteins detected as secreted by the Human Secretome Atlas and the compendium
of secreted proteins262,266
secretome of the senescence-inducers (Fig.5.10c). Upon closer inspection, toxSASP was significantly
divergent from APHSASP (Fig.5.10d, 1479 significant proteins) and ETPSASP (Fig.5.10e, 1387 sig-
nificant proteins). Interestingly, most proteins were upregulated in toxinSASP compared to APHSASP
(646 out of 1479) and downregulated compared to ETP (848 out of 1387). Consistent with PCA, ETP
and APH were less divergent to each other only showing 688 significant proteins (Fig.5.10f).
To identify enhancers of infection, the toxinWT-induced secretome was filtered against all significant
secretome proteins in unt, toxinHQ, APHSASP and ETPSASP (Fig.5.10g, left flowchart). All toxin-
specific proteins identified were upregulated. Putative enhancers of infection included regulators of
TGFβ signalling TGFBR3, FST, the transmembrane protein vasorin (VASN) and metalloprotease
ADAM17. ADAM17 liberates the extracellular domain of vasorin, which negatively regulates TGFβ
pathways301. ADAM17 is the prototype sheddase liberating membrane-bound growth factors (e.g.
TGFβ and EGF ligands) that makes ADAM17 an important regulator of growth factor signalling
and membrane ruffling302. Interestingly, n-EGF-like 2 (NELL2) was identified, as was the ADAM17
activator PDGF303(Fig.5.10g, Supplementary Fig.S1). Thus, the data implicates growth factor
signalling in toxSASP-driven infection into bystander cells.
Another putative candidate of infection was Wnt5a (Table 5.1). Strikingly, Wnt5a was amongst
33 proteins identified only in toxinWT-treated cells prior to any Perseus analysis (Table 5.1) indicating
toxin-specificity. Wnt5a was previously shown to increase macrophage uptake of bacteria and increased
bacterial survival304. Additionally, Wnt5a reportedly activated TGFβ to mediate intestinal repair
post-injury, demonstrating a crosslink between Wnt5a signaling and TGFβ pathway305. This suggests
a potential collaborative action of TGFβ and Wnt ligands in toxin-induced senescence.
Proteins detected only in toxinWT samples prior to Perseus analysis
Gene names
C1RL LTBP4 RAB35 NUP85 WNT5A SULF2 NELL2 CD99L2 SEC24B SIRT5 ACVR1
ATP2B4 RHOG TOR4A RPL23A TAF15 TPST1 MYADM OSTF1 CFH ADGRL2 THTPA
BABAM1 POMGNT1 ARRB1 ARFGAP2 PHLDB1 TRIM21 UBE2C RAB13 ACTB NOG STRN
Table 5.1|List of 33 gene names of proteins that were detected by LC-MS/MS exclusively in toxinWT-SASP,
in at least 3 out of 4 replicates, after MaxQuant analysis and before importing into Perseus for statistical
analysis.
To identify mediators of transmissible senescence, the secretomes of all senescence inducers (toxinWT,
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APHSASP and ETPSASP) were filtered against negative controls (unt, toxinHQ) (Fig.5.10h, n=661)
then cross-examined with the SASP Atlas and the secreted protein databases. Out of the 14 upreg-
ulated protein, the TGFβ family member GDF15 was immediately striking, as it was also identified
in E8 and SF toxinWT-induced secretome (Fig.5.6k, 5.9f-i). GDF15 was previously reported to be
differentially expressed during ageing, negatively regulates IL6 expression (observed in Fig.5.9f-h),
and has been identified as a SASP component306,307,308.
Similarly to the toxSASP, APHSASP and ETPSASP showed a reduction in MMP1, and growth factors
such as Myeloid-derived growth factor (MYDGF), insulin growth factor 2 (IGF2), and connective
tissue growth factor (CTGF) (Fig.5.10h). Interestingly, CTGF remodels tissues during fibrosis
by modulating pathways, for instance through inhibiting BMP and Wnt pathways, and activating
TGFβ309. The most downregulated secretions include Dermcidin (DCD), S100A9, and S100A8. DCD
is a peptide that displays antimicrobial activity. Furthermore, S100 proteins are considered Damage-
Associated Molecular Pattern (DAMP) proteins which are released from unhealthy cells to elicit
immune cell driven inflammation292. The fact that DCD, S100A9 and S100A8 are downregulated the
most in toxinWT-induced SASP suggests a host pro-survival and a Salmonella protective environment
by suppressing antibacterial activity or immune activation by DAMPs.
Given that there were diverse secretomes induced by the typhoid toxin in SF, E8 and BONCAT,
the common proteins that were up-regulated were examined using BioVenn (Fig.5.10i). Interestingly,
199 proteins were found consistently significant in toxinWT-SASP compared to untCM from the three
secretomes, but only 12 proteins were reported as secreted (Fig.5.10i). The most intriguing was
GDF15, which implicated the TGFβ pathway using three diverse mass spectrometry methods at
acute and chronic SASP.
5.7 Discussion
This chapter, together with Chapter 4 reveals an unbiased analysis of the human cell secretory
responses to a bacterial toxin for the first time using three different approaches. It also establishes
a road map for understanding the molecular mechanisms by which diverse genotoxic agents remodel
bystander cells to induce transmissible senescence, which represents a powerful innate defence against
the proliferation of cells with pathological potential (e.g. cancer, virus-infected). Counter to its role in
innate defence, toxSASP was shown to enhance Salmonella invasion, induce transmissible senescence
and DDRs in bystander cells through unidentified factors106. In disease, SASP is known to evolve from
a good servant into a bad master when deregulated, and is implicated in age-related pathologies such
as cancer, cardiovascular disease, and neurodegenerative disorders249. The contribution of senescence
and SASP to bacterial infection is not understood.
Whilst some toxin-induced significant proteins in SF matched E8 (e.g. COPA, SEC22B, JAG1,
PLAUR, CTGF, GDF15), there was very little overlap in secretomes, which indicates an important
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Figure 5.11| Role of TGFβ network identified in the toxin-induced secretome. Schematic represen-
tation of the different toxin-specific proteins involved in the TGFβ pathway. The different players identified are
either involved in activating the pathway or inhibiting it. Ligands that activate the pathway include Activin
A, TGFβ, GDF15 or BMP1 binding to their respective receptors and activating a cascade of phosphorylated
smad transcription factors that leads to the production of various proteins involved in establishing a senes-
cence phenotype. These ligands are inhibited via follistatin that sequesters Activin A, TGFBRIII that delivers
inhibinA and negatively regulates the activin pathway, and ADAM17 that cleaves membrane-bound vasorin
into a soluble secreted protein that sequesters TGFβ. The inhibitory pathway thus prevents the cascade of
smad phosphorylation and the senescence-associated gene transcription.
role of growth media in influencing the secretome. E8 showed intriguing candidates such as ISG-15,
which could be activated in response to the typhoid toxin as an innate host defence mechanism289,290.
Interestingly, ISG15 is an interferon-stimulated gene, which modifies host proteins in a manner similar
to ubiquitination, i.e. ISGylation310. It would be interesting to examine whether ISG15 in the
secretome was free, or in fact ISGylated a host factor in a senescence-dependent manner. Interestingly
in E8, the toxin had a more inflammatory phenotype, which could be due to the prior priming of
cells using E8 components. The differential regulation of toxSASP constituents in different growth
media is fitting with the reported dynamic properties of SASP, which is context-dependent174,187,189.
However, SF mass spectrometry was the most-controlled experiment out of the three growth media
used. Therefore, for the purposes of this thesis, information was mainly inferred from SF analysis.
The secretome analysis from acute senescence responses identified toxSASP candidates that po-
tentially drive infection and senescence. The most prominent upregulated proteins included TGFβ
family members (Fig.5.9f-i), which are major players in transmissible senescence driving cancer
(Fig.5.11)187,311. Fig.5.11 demonstrates the potential mode of action of the identified TGFβ lig-
ands.
While other potential candidates in this study also present themselves as possible players in infec-
tion and senescence, the TGFβ network represents an interesting starting point. The TGFβ pathway
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is further implicated by toxinWT-induced increases in TGFβ1 (relative to untreated, APHSASP and
ETPSASP) and TGFβ2 (relative to APHSASP and ETPSASP) (data not shown). However, it is unclear
whether the toxin would activate or inhibit the TGFβ pathway (Fig.5.11), which will be an impor-
tant step in understanding its significance in the mechanisms underlying toxin-driven transmissible
senescence and infection (henceforth toxinSASP phenotypes). Interestingly, the downregulation of IL6
and CCL2 and the implication of NOTCH signaling (Fig.5.9g,5.9h) suggest that pro-inflammatory
SASP is downregulated in the toxin in favour of a TGF-rich secretome295. Other proteins of interest
that were shown to be implicated directly in increased phagocytosis of bacteria and their survival in
macrophage is Wnt5a312, which also retains the ability to activate TGFβ signaling305.
Moreover, this study demonstrated the modulation of pro-angiogenic host proteins in response to
intoxication (namely PDGF and JAG1) (Fig.5.9h). Interestingly, other pathogens have also been
observed to modulate these pathways for survival313. For instance, Mycobacterium tuberculosis in-
duces host proangiogenic factors that ease its spread to systemic sites, whilst Aspergillus fumigatus
attenuates angiogenesis to allow for its persistence. Therefore, it is unsurprising that the typhoid
toxin might modulate angiogenic host factors to regulate systemic infections and Salmonella persis-
tence. Furthermore, the increase of blood coagulants potentially implicates the typhoid toxin in the
appearance of blood clots in Salmonella Typhi patients314.
A comparative analysis with other senescence inducers provided insight into the similarities to
toxSASP. These included down-regulation of inflammatory proteins such as MMPs, S100A8, and
S100A9, which could be hypothesized to be pro-infection and allows for Salmonella immune evasion.
Together with data from BONCAT and E8 conditioned media, SF confirmed the divergent and unique
secretome induced by the typhoid toxin. BONCAT and E8 also confirmed that the common denom-
inator regardless of the growth medium or the time-point is the up-regulation of GDF15, a TGFβ
pathway activator. All in all, the three mass spectrometry techniques provided inclusive and diverse
methods to explore the toxin-induced secretome, and confirmed that Salmonella is likely hijacking the
TGFβ pathway.
The use of HT1080s, a fibrosarcoma cell line, is a limitation of this analysis. However, as the
toxinSASP phenotypes were demonstrated using conditioned media from intoxicated HT1080s, it was
prudent to use this cell line to identify putative, responsible host proteins106. Other suitable cell lines
include IMR90s, the cell line of choice in most senescence studies187 or primary colonic cell lines such
as HIEC-6, and CCD-112CoN.
Interestingly, whilst the serum-free approach is commonly used to characterise secretory pheno-
types174,281,282,283,284,285, a recent publication suggested that cells cultured in serum using BONCAT
in combination with pulsed-SILAC, i.e. stable non-radioactive isotopes, provides a higher secretion
profile compared to serum-free media315. Indeed, TGFBI, TGFB2, and MMPs amongst others were
much more highly secreted in serum-containing media than serum-free media315. This approach al-
lows to examine secretomes in serum-containing media, and avoids affecting replication and secretion
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rates of SF cells315.
In summary, Salmonella hijacking of the TGFβ and Wnt signalling pathway would represent a
novel host-pathogen interaction that may be of significance to invasive infections underlying typhoid
fever and chronic carriage.
5.8 Supplementary figure
Figure S1| Panther pathway analysis for the rest of the genes. Gene names and their relevant
pathways from Fig.5.9g that are not displayed in Fig.5.9h.
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TGFβ pathway and Wnt5a
contribution to toxin phenotypes
6.1 Introduction
The TGFβ superfamily constitutes a plethora of multifunctional cytokines that are master regula-
tors of diverse cellular processes, including proliferation316,317, survival318, differentiation319, wound
healing320, angiogenesis316,321 and senescence187,322. There are over 30 members of the TGFβ family
in humans, e.g. BMPs, Activins and GDFs323. Structural differences confer the diversity and dif-
ferential actions of the TGFβ members324. For instance, Activin A is a homodimer of activin βA
(INHBA) subunits, whilst its antagonist, inhibin A is a heterodimer of activin βA (INHBA), and
Inhibin Aa (INHA) subunits (Chapter 5, Fig.5.11)325.
As illustrated in Fig.5.11 (Chapter 5), canonical TGFβ signalling is initiated upon binding of
ligands to membrane-bound serine/threonine kinase receptors, forming a complex326. Type II kinase
activity phosphorylates and activates type I kinase receptors. Subsequently the signal is transduced
intracellularly via phosphorylation of Smad transcription factors that translocate to the nucleus and
regulate TGFβ target genes in collaboration with DNA-binding co-factors (activators and repressors).
The human genome encodes seven type I receptors (Activin-like kinases, ALK1-7), five type II
receptors (TβRII, ActRIIA, ActRIIB, BMPRII, and AMHRII) and eight Smad proteins (smad1-
8)327,328,329. The different combinations of type I and type II receptors confer ligand specificity and
as a result, also confers differential R-smad signal transduction, and target gene transcription330.
Furthermore, there are three classes of Smad proteins: regulatory smads (R-smad1,2,3,5,8), co-smad
(C-smad4) and inhibitory smads (I-smad6,7). Upon positive activation of the TGFβ pathway, phos-
phorylated R-smads (psmad) form a transcriptional complex with co-smad4 which is necessary for
gene transcription. Conversely, I-Smads are post-translationally modified to be either degraded or
stabilised by multiple accessory proteins (e.g. ubiquitin ligases). I-smads can inhibit the pathway by
competing with smad 4 to bind with R-smads, or prevent trafficking of receptors to the membrane to
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receive less activatory signals331.
Increasing evidence has implicated activated TGFβ signaling in senescence responses. It was
reported the TGFβ can induce reactive oxygen species (ROS) from mitochondria332,333, up-regulates
SA-β-gal and CDK inhibitors such as p21, leads to cell-cycle arrest in G1 phase334, and down-regulates
telomerase reverse transcriptase (TERT) in fibroblasts, colon and breast cancer cells335,336,337. It
was also shown to be a pivotal component of SASP that acts in an autocrine manner to reinforce
senescence elicited via the inflammasome187. TGFβ can trigger these responses canonically (via
phosphorylation of R-smads) or in a non-canonical manner via smad-independent pathways311,338,
such as p38MAPK339, JNK340, and ERK pathways341. It can also influence Ras, RhoA, Rac and
Cdc4342, which are all regulators of membrane ruffling343.
The cellular responses to TGFβ stimulation are context-dependent and require fine tuning of
three main determinants: i) the intensity of the signal (ligand concentration, receptor abundance, and
extracellular regulators); ii) downstream activation of smad classes; iii) epigenetic modifications of the
receiving cell that would open or hide genes from transcription factors324.
Several papers propose that the TGFβ ligands are excellent therapeutic targets, as well as diagnos-
tic and prognostic markers of disease344. Given that the toxinSASP leads to transmissible senescence
and increases Salmonella invasion, potentially due to increased membrane ruffling, and TGFβ regu-
lators were amongst the most up-regulated SASP components, the aim of this chapter is to examine
their contribution to the senescence phenotype and Salmonella infection.
6.2 The typhoid toxin activates downstream effectors of the
TGFβ signalling pathway
It was next examined whether toxin-induced senescence is transmitted through factors upregulated
or down-regulated in the secretome. ToxinWT-SASP conditioned media was combined with untCM or
toxHQ-CM to replenish down-regulated factors before assaying transmissible senescence by remaining
upregulated factors in the secretome (Fig.6.1a, 6.1b). ToxinWT-SASP alone or in combination with
untCM and toxHQ-CM increased SA-β-gal indicating that factors upregulated in the secretome mediate
transmissible senescence (Fig.6.1a, 6.1b, ∼40% SA-β-gal positive cells), and were thus prioritised
for investigation. Up-regulated proteins in toxinWT-SASP included both inhibitors (e.g. FST) and
activators (e.g. GDF15, BMP1, and Activin A) of the TGFβ signalling pathway (Fig.5.9, 5.10,
in Chapter 5). To investigate if the toxin activates the TGFβ pathway, phosphorylated smad2
(psmad2) and smad1/5 (psmad1/5) were examined using mean psmad intensity of untreated cells as
a threshold. Indeed, toxinWT induced nuclear localisation of psmad2 (Fig.6.1c, 6.1d) and psmad1/5
(Fig.6.1e, 6.1f) in ∼90% of the cells, which was similar to APH and ETP, but more statistically
significant than 10 ng/ml TGFβ3 on its own (Fig.6.1d). Phospho-smad positive nuclei displayed
either near pan-staining phenotype, or foci of varying intensities (Fig.6.1e). There was also high
111
Chapter 6
Figure 6.1| ToxinWT induction of TGFβ signalling. a, Transmissible senescence in naive HT1080 cells
treated with serum-free conditioned media harvested 48 h post intoxication and supplemented with 10% FBS
before assaying for SA-β-gal after 5 days. ToxinWT-SASP was combined with negative control conditioned media
to examine whether factors of interest are up- or down-regulated. b, Quantification of a from 3 biological
replicates (∼1000-6500 cells/condition per replicate). c and e, Representative images of intoxicated cells in
primary senescence at 48 h post intoxication assayed for γH2AX (magenta) and c, psmad2 (red), e, psmad1/5
signaling (cyan). d and f, Quantification of c and e respectively from three biological replicates (c, ∼100
to 400 cells/condition per replicate; e, ∼50-200 cells/condition per replicate). g and h, Pearson’s correlation
of γH2AX and g, psmad2 and h, psmad1/5 intensity in each cell. Each circle represent a field of view.
Quantification of immunofluorescence images was carried out using CellProfiler. Mean intensity of untreated
cells were used to sort psmad-positive nuclei. One-way ANOVA with b, Tukey’s or, d and f, Dunnett’s
multiple comparisons test were carried out to test for statistical significance. Error bars denote SEM. Scale
bars are a, 100 µm and c and e, 25 µm.
correlation between DNA damage induction in cells and elevated levels of psmad2 (Fig.6.1g, r=0.85)
and psmad1/5 (Fig.6.1h, r=0.82), indicating an increased level of psmad2 with increased γH2AX
intensity.
6.3 ToxinSASP transmits senescence via TGFβ ligands
Previous research has demonstrated that TGFβ ligands induce senescence phenotypes322. To en-
sure that the same phenotype occurs in HT1080, purified recombinant TGFβ3 control, and toxinSASP
components Activin A and GDF15 were examined for induction of senescence phenotypes (Fig.6.2).
At a relatively low concentration (10 ng/ml), TGFβ3 showed an increased level of SA-β-gal positive
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Figure 6.2| Contribution of TGFβ family ligands to senescence. a, Representative images of HT1080
cells assayed for SA-β-gal after 5 days treatment with TGFβ3 (10 ng/ml) compared to toxinSASP. b, Quan-
tification of a from 3 biological replicates (∼1500-6500 cells/condition per replicate). c, Immunofluorescence
images of cells treated with high concentrations of Activin A and GDF15 (500 ng/ml) for 5 days before assay-
ing for EdU (magenta) and SA-β-gal (cyan). d and e, Quantification of EdU- (magenta line) and SA-β-gal
(cyan line) positive nuclei after 5 days incubation with d, Activin A and e, GDF15 at various concentrations
(5, 10, 20 ,50 ,100, 200, 300, 400, 500 ng/ml) and compared to untreated cells using CellProfiler from 3 bio-
logical replicates (300-1300 nuclei/condition per replicate). f, Representative images and g, quantification of
cells treated +/- TGFBRI kinase inhibitor (1 µM) and serum-free conditioned media harvested at 48 hrs post-
intoxication and supplemented with 10% FBS before assaying for SA-β-gal (3 biological replicates; ∼600-3500
cells/condition per replicate). One-way ANOVA b, with Tukey’s or d and e, Dunnett’s multiple comparisons
compared to untreated cells, and g, Two-way ANOVA with Sidak multiple comparisons test were carried out
to test for statistical significance. Error bars denote SEM. Scale bars are a and f, 100 µm and c, 50 µm.
cells (Fig.6.2a, 6.2b, ∼25%) compared to untreated cells, which was concurrent with elevated ps-
mad2 positive nuclei (Fig.6.1d). However, only high concentrations (500 ng/ml) of Activin A led to
the up-regulation of SA-β-gal (Fig.6.2c, 6.2d, cyan) and cell cycle arrest marked by decreased EdU
positive nuclei (Fig.6.2c, 6.2e, magenta). Although there were mild observable differences between
GDF15-treated and untreated cells, all concentrations used for GDF15 were not sufficient to mirror
TGFβ3 (Fig.6.2c, 6.2e).
To examine the significance of TGFβ ligands in transmissible senescence induced by toxinSASP, in-
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hibitor of TGFβ type I Kinase was used at 1µM according to previous studies examining TGFβ-driven
senescence187. Astonishingly, blocking receptor kinase activity reduced transmissible senescence by all
SASPs, and was observed significantly in toxinWT-SASP (Fig.6.2f, 6.2g). These findings were exem-
plified by the reduced SA-β-gal positive cells, and increased cell number per field of view (Fig.6.2f).
Together with the activation of psmad2, and psmad1/5 signaling, evidence suggests that toxinWT
hijacks the TGFβ signalling pathway to transmit senescence in naive cells.
6.4 The typhoid toxin-induced Activin A causes DNA dam-
age.
TGFβ induces ROS, which contributes to its senescence induction332,333. Although the typhoid
toxin’s CdtB subunit has high DNase homology, research has shown that it acts as a weak nuclease
in vitro 106. Therefore, the effect of TGFβ signalling on toxin-induced DNA damage phenotype was
examined by knocking down smad2 and INHBA.
To determine the optimal cell density and lipid reagent (Lipofectamine RNAiMax) for efficient
knockdown, siRNA against Polo-Like Kinase-1 (PLK1) was used. PLK1 is a protein that regulates
cell cycle transition and its decreased expression leads to apoptosis345. Lipofectamine was titrated
from 1.5 µl, which is the advised volume in a 24-well plate format, to 2.5 µl and applied on cells of
various seeding densities with or without siPLK1. All concentrations of lipofectamine with siPLK1
at all cell densities showed high levels of apoptosis compared to the same volume of lipofectamine
without siPLK1 (Fig.6.3a). Therefore, subsequent experiments used 0.25-0.5 µl of Lipofectamine on
0.5x104 cells density to allow for cells to reach 60-70% confluency before toxin treatments.
Next, the role of Activin A during toxin-induced senescence was examined. Immunofluorescence
of toxinWT-treated cells validated the up-regulation of Activin A intracellularly compared to the
negative control toxinHQ (Fig.6.3b-d). Following a 48h INHBA knockdown, toxinWT-treated cells
(48h) showed similar levels of Activin A to that observed in the negative control toxinHQ (Fig.6.3c,
6.3d), 50% knockdown). Astonishingly, siINHBA significantly reduced γH2AX foci induction by
toxinWT (∼70%) relative to non-targeted siRNA (Fig.6.3e). However, a much larger proportion
of siINHBA cells were positive for SA-β-gal (Fig.6.3f), which was more intense than non-targeted
intoxicated cells (Fig.6.3c), with no change to nuclear size (Fig.6.3g). This could be attributed to the
fact that INHBA acts as a subunit in the Inhibin A/Inhibin B heterodimer which antagonises Activin
A activity, i.e. homodimer of Inhibin A325, leading to a more intense SA-β-gal activity (Fig.6.3c).
Like Activin A (Fig.6.3c, 6.3d), intoxication also increased production of pSmad2 (Fig.6.1c). Thus,
γH2AX foci were examined in cells transfected with siSmad2 (Fig.6.3h). The increase in pSmad2
following intoxication (Fig.6.1c, 6.1d) was reduced by siSmad2 (Fig.6.3h, 6.3i, 40% knockdown) to
the levels observed for negative controls (Fig.6.1c, 6.1d). Remarkably, relative to the siNT negative
control, siSmad2 led to significant halving of γH2AX foci by the toxinWT (Fig.6.3j) but this had no
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Figure 6.3| Influence of TGFβ signalling on DNA damage and senescence. a, Optimisation ex-
periment to develop a functioning protocol for Lipofectamine RNAiMAX as a lipid reagent to deliver siRNA.
Viability of HT1080 cells was examined using light microscopy after 48 h PLK1 knockdown to assay for
knockdown efficiency at different cell densities and Lipofectamine RNAiMAX volumes in a 24-well format.
b-i, Representative images and quantification of intoxicated HT1080 cells that were assayed for DNA damage
(magenta) and SA-β-gal (green) after knocking down c-g, Activin A (red) and h-l, psmad2 (red). Quantifi-
cation was carried out using CellProfiler and included d, Activin A intensity, e, number of γH2AX foci per
nucleus, f, percentage of SA-β-gal positive cells and g, nuclear sizes after knockdown of INHBA (3 biological
replicates, ∼30-500 nuclei/condition per replicate). Quantification also included i, psmad2 intensity per cell
(circles represent fields of view), e, number of γH2AX foci per nucleus, f, percentage of SA-β-gal positive
cells and g, nuclear sizes after knockdown of psmad2 (3 biological replicates, ∼50-500 nuclei/condition per
replicate). NT=non-targeting. e-l, One-way ANOVA with Tukey’s multiple comparison test and i, unpaired
t-test, were carried out to test for statistical significance. Error bars denote SEM. Scale bars are a, 100 µm
and c and h, 50 µm.
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effect on the proportion of SA-β-gal positive cells (Fig.6.3k) or nuclear size (Fig.6.3l).
This data potentially uncouples toxin-induced DNA damage responses from toxin-induced senes-
cence.
6.5 Wnt5a contributes to toxin-induced transmissible senes-
cence
Mass spectrometry analysis showed that Wnt5a was specifically up-regulated in toxinSASP, but
not in the secretomes of positive and negative controls (Chapter 5). Several studies have shown that
TGFβ signalling led to up-regulation of Wnt5a346,347. Wnt5a is a pro-survival secreted protein348 that
belongs to the Wingless protein family (Wnt) and mainly activates the non-canonical Wnt signalling
pathway349. It is increasingly apparent that TGFβ and Wnt proteins work collaboratively to establish
multiple disease states such as cancer progression and fibrosis324,347,350,351,352.
To confirm that Wnt5a is induced in other non-cancer cell lines in a toxin-specific manner, intoxica-
tion experiments were performed in IMR90 cells, which have also demonstrated a strong transmissible
senescence phenotype (Chapter 3, Fig.3.9). Western blot of whole IMR90 lysates confirmed that
Wnt5a was up-regulated in toxinWT-treated, but not by other senescence inducers or the negative
controls (Fig.6.4a, 6.4b), which confirmed that it is not cell-line specific. This was further con-
solidated by immunofluorescence of Wnt5a/b in HT1080s, which showed an increased expression in
toxinWT but not toxinHQ treated cells (Fig.6.4c).
Wnt ligands were previously shown to induce senescence stress responses187,353,354,355. Indeed,
augmenting concentrations of the Wnt signalling agonist CID11210285 from 0.1 nM to 100 nM, in-
creased SA-β-gal positive cells in a dose-dependent manner at 48h (Fig.6.4d-e). To examine the
relevance of Wnt5a specifically, recombinant Wnt5a was applied on cells at increasing concentrations,
as well. Similarly to CID11210285, Wnt5a induced up-regulation of SA-β-gal at varied concentrations
(Fig.6.4f, 6.4g), albeit to a lesser extent than the agonist, and showed maximal effect at 500 ng/ml
(Fig.6.4g, ∼30-40%). To test whether Wnt is involved in toxin-induced transmissible senescence me-
diated by the toxin, inhibitor of Wnt production (IWP-2) was incubated with toxinWT-SASP. IWP-2
acts on Porcupine, a membrane-bound acyltransferase that palmitoylates Wnt allowing for its secre-
tion356. However, IWP-2 did not cause any observable change to EdU incorporation (Fig.6.4h, 6.4i;
magenta) or SA-β-gal (Fig.6.4h, 6.4j, cyan) in intoxicated cells at 48h.
As IWP-2 is a generic Wnt inhibitor and does not isolate the effects of Wnt5a, siRNA of Wnt5a
was examined for toxin-induced DNA damage, senescence and SASP (Fig.6.5a). In intoxicated
cells, Wnt5a expression was observed following siNT but this was markedly reduced in siWnt5a cells
(Fig.6.5b, 6.5c, 84% knockdown). Similar to Activin A, siWnt5a reduced toxin-induced γH2AX
foci by 70% relative to siNT cells, which was still statistically more significant than the untreated
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Figure 6.4| Contribution of Wnt signalling to senescence. a, Western blot of IMR90s whole-cell
lysates 96h post-treatment. b, Quantification of Wnt5a/b intensity relative to tubulin from two biological
replicates using ImageStudio Lite. c, Immunofluorescence image of Wnt5a/b in intoxicated HT1080 cells at
48h. d, Representative images of HT1080 cells assayed for SA-β-gal after 5 days treatment with Wnt agonist,
CID11210 at different concentrations (0.1, 1, 10, 50, 100 nM), and e, its quantification from 3 biological
replicates (∼5-3000 cells/condition per replicate). f, Representative images of HT1080 cells assayed for SA-β-
gal after 5 days treatment with Wnt5a at different concentrations (25, 50, 100, 200, 300, 400, 500 ng/ml) and
g, its quantification from one biological replicate (∼300-500 cells/condition). h, EdU (magenta) and SA-β-gal
(cyan) in naive HT1080 cells treated for 5 days with conditioned complete media harvested from intoxicated
HT1080 cells at incubated with 2 µM of inhibitor of Wnt production (IWP2) at 48h. i and j, Percentage
of i, EdU- and j, SA-β-gal positive cells +/-IWP2 from 3 biological replicates (∼60-350 nuclei/condition per
replicate). e and g, One way ANOVA with Dunnett’s multiple comparisons test compared to untreated and i
and j, Two-way ANOVA Sidak multiple comparison tests were used to test for statistical significance. Error
bars denote SEM. Scale bars are c and h, 50 µm and d and f, 100 µm.
and toxinHQ negative controls (Fig.6.5d). Although this was consistent with previous reports of
Wnt5a inducing ROS357, other research groups demonstrated that Wnt5a inhibits ROS in a context-
dependent manner358. Equally, no major difference to percentage of SA-β-gal positive cells (Fig.6.5e)
or intoxicated nuclear size (Fig.6.5f) were observed. The reduction in DNA damage by the toxin
was also confirmed using western blot of HT1080 lysates at 48h (Fig.6.5g). Interestingly, Wnt5a
knockdown halved the transmissible senescence induced by toxSASP (Fig.6.5h-j), which provided
evidence of Wnt5a contribution to toxin-induced senescence phenotypes.
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Figure 6.5| Influence of Wnt5a on DNA damage and senescence. a-f, Representative images and
quantification of intoxicated HT1080 cells that were assayed for DNA damage (magenta) and SA-β-gal (green)
after knocking down Wnt5a (red). c-f, Quantification was carried out using CellProfiler and included c, Wnt5a
intensity (each circle represents a field of view), d, number of γH2AX foci per nucleus, e, percentage of SA-β-gal
positive cells and f, nuclear sizes after knockdown of Wnt5a (2 biological replicates, ∼90-140 nuclei/condition
per replicate). g, Western blot with anti-γH2AX of whole-cell lysates knocked down of Wnt5a 48 hours
post intoxication. h-j, Transmissible senescence induced in naive HT1080s by complete conditioned media
harvested Wnt5a knocked down at 48 h. NT=non-targeting. j, Quantification of i from 5 biological replicates
(∼800-2000 cells/condition per replicate). c, Unpaired t-test, and d-f, and j, One-way ANOVA with Tukey’s
multiple comparison test were carried out to test for statistical significance. Asterisks denote significance
compared to untreated unless otherwise indicated by brackets. Error bars denote SEM. Scale bars are b, 50
µm and i, 100 µm.
In summary, Smad2, Activin A and Wnt5a facilitate toxin-induced DDRs but despite this they
did not influence primary senescence in toxin-treated cells (toxSEN). Nevertheless, Wnt5a promotes
toxin-induced transmissible senescence in naive cells, which validates its role in toxSASP.
6.6 Activin A and Wnt5a in combination phenocopy toxSASP
Several studies show that TGFβ and Wnt signalling pathways work synergistically to cause dis-
ease319,324,347,350,351,352. To test their synergy in transmissible senescence, toxHQ-CM was supple-
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Figure 6.6| Potential cross-talk between Wnt5a and TGFβ signalling pathways. a, Transmissible
senescence induced by toxHQ-CM supplemented with Activin A, or GDF15 with or without the equivalent
concentration of Wnt5a in HT1080 cells. b and c, Quantification of b, Wnt5a and Activin (500 ng/ml)
and c, Wnt5a and GDF15 (200 ng/ml). Each circle represents a field of view (b, 250-1400 cells c, 750-2200
cells /condition per replicates). d, Immunofluorescence of psmad2 signaling (red) in Wnt5a knocked-down
intoxicated cells. NT=non-targeting. e, Quantification of d from 1 biological replicate. Each circle represents
a field of view (2 technical replicates, ∼50-220 cells/condition). b and c, One-way ANOVA with Tukey’s
multiple comparisons test and e, two-way ANOVA with Sidak multiple comparsions test were used to test for
significance. Error bars denote SEM. Scale bars are a, 100 µm and d, 50 µm.
mented with either Activin A, Wnt5a, or in combination. Consistent with previous data (Fig.6.2c-d,
6.4f-g), each of Activin A and Wnt5a enabled transmissible senescence by toxHQ-CM (Fig.6.6a, 6.6b,
∼20%). Interestingly, toxHQ-CM supplemented with both Activin A and Wnt5a had an additive effect
and pheno-copied toxSASP with significant transmissible senescence (Fig.6.6a, 6.6b). Nevertheless,
SA-β-gal positive cells were more abundant when treated with toxSASP and there were observable
cell cycle arrest and distension (Fig.6.6a). This suggests additional factors in toxSASP play a role.
Thus, synergy between GDF15 and Wnt5a was also examined. However, toxHQ-CM supplemented with
GDF15, was not enough to cause senescence on its own (Fig.6.6a, 6.6c). Although in combination
with Wnt5a, there was more induction of senescence, the number of senescent cells did not increase
beyond that observed for Wnt5a alone (Fig.6.6c).
TGFβ ligands can mediate their effects through smad-driven signalling187,322. To test whether
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the synergy between Activin A and Wnt5a centres on smad signalling, Wnt5a was knocked down and
psmad2 examined (Fig.6.6d). Wnt5a knockdown led to the reduction of nuclear psmad2, (Fig.6.6e,
34% reduction), which was consistent with Borcherding et al 2015352. This suggests that Activin A
and Wnt5a cooperate to augment smad-driven signalling induced by toxinWT.
6.7 Effect of Wnt5a, Activin A, and GDF15 on Salmonella
invasion and replication.
Ibler et al (2019) described that toxSASP enhanced Salmonella infection of mouse embryonic fi-
broblast (MEF) cells relative to APH in complete media106. However, drivers of the enhanced invasion
remain unexplored.
As HT1080 cells have mutated Ras activation359, they continuously undergo high basal levels
of membrane ruffling. Therefore, an experimental protocol was established to examine the rate of
Salmonella invasion in NIH/3T3 cells, which are mouse embryonic fibroblasts (Fig.6.7a). To assay
Salmonella invasion, serum-starved cells are infected in the absence of antibiotics for 30min before
aspiration of extracellular bacteria then cell incubation with gentamicin, which kills any extracellular
Salmonella. After 2h, whole-cell lysates are cultured on agar plates and Salmonella colony forming
units are quantified.
To begin with, serum-starved cells were primed for 1h with conditioned media before infecting with
Salmonella. ToxinWT-SASP showed a subtle but significant increase in invasion compared to untCM,
whilst toxHQ-CM and APHSASP showed no significant change (Fig.6.7b, 6.7c). Interestingly, unlike
APHSASP, ETPSASP showed an increase in Salmonella colony forming units (CFUs) (Fig.6.7b).
Next, to further remodel the target cells prior to infection, cell incubation with conditioned media
was extended from 1h to 24h. Whilst toxinWT-SASP, toxHQ-CM, and ETPSASP showed an increased
invasion compared to short incubation (1h) with conditioned media, APHSASP showed decreased
invasion rates (Fig.6.7d), showing diverse cell remodelling abilities of the different SASPs within an
infection niche.
To examine the effects of SASP components on Salmonella invasion, toxHQ-CM was supplemented
with recombinant Activin A, GDF15 or Wnt5a for 1h prior to infection. Although previous experi-
ments showed that Activin A, but not GDF15, and Wnt5a work collaboratively to induce transmissible
senescence, invasion rates were increased when toxHQ-CM was supplemented with Wnt5a or GDF15
but not Activin A (Fig.6.7e). Supplementing toxHQ-CM with both Wnt5a and Activin A, increased
invasion to levels similar to Wnt5a alone. To validate the role of Wnt5a, neutralising antibodies were
added to toxSASP before assaying invasion. If toxSASP enhances invasion via these factors, then the
antibodies would decrease invasion rates. Curiously, anti-Wnt5a and anti-Activin A led to increased
invasion (Fig.6.7f). Similar findings were made when Wnt5a and Activin A were knocked down
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Figure 6.7| Effect of Wnt5a and TGFβ ligands on Salmonella invasion. a, Experimental protocol
for assaying Salmonella invasion. All experiments were carried out with 1h incubation with conditioned media
prior to infection unless otherwise stated. b, Representative pictures of Salmonella colony forming units
(CFUs) on agar plates after a 2 hr infection from 5 µl of a 10-2 dilution. c, Quantification of b depicting
Salmonella CFUs relative to cells treated with untCM (3 biological replicates). d, Salmonella CFUs that
invaded naive 3T3 cells with 1h or 24h pretreatment with conditioned media prior to infections (1 biological
replicate). e, Salmonella CFUs in 3T3 cells pretreated with toxHQ-CM supplemented with Wnt5a (500 ng/ml),
Activin A (500 ng/ml), both, or GDF15 (200 ng/ml) for 1h prior to infection (1 biological replicate). f,
Salmonella CFUs after treating conditioned media with neutralising antibodies 1:500 for 1 hour prior to
applying them on 3T3 cells and carrying out the invasion protocol (1 biological replicate). g, Morphology of
intoxicated cells at 48 h in serum-free media after 48 hour knockdown of Wnt5a, INHBA, and ADAM17 in
complete media. Scale bar is 100 µM. h, Invasion assay with 3T3 cells pretreated with conditioned media
for 1h from Wnt5a, INHBA, and ADAM17 knocked down cells before infection (1 biological replicate). i
and j, Fold change of Salmonella replication at 24h relative to 2h Salmonella infection post treatment with
indicated conditioned media. (1 biological replicate). c-f and h-j, Each circle represents technical replicates.
c, Unpaired t-test compared to untCM cells and e and g one-way ANOVA with Tukey’s multiple comparisons
test were used to test for statistical significance. All other graphs showed no statistical significance. Error
bars denote SEM.
(Fig.6.7h). Interestingly, the conflicting observations for Wnt5a was previously reviewed360, where
both Wnt5a knockout mice and treatment with recombinant Wnt5a show heightened responses to
β-catenin361. While purified Wnt5a retains the ability to activate or repress canonical Wnt signalling
by competing with Wnt3a, knocking down Wnt5a also leads to heightened sensitivity to Wnt3a362.
As stated in Chapter 5, the toxSASP constituent ADAM17 is a sheddase that liberates growth
factors from the cell surface and represents an important regulator of TGFβ301 and other growth
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factors involved in membrane ruffling302. To examine whether a disruption in TGFβ modulation
would impact on infection, ADAM17 was knocked-down (Fig.6.7g-h). Consistent with Activin A
knockdown, conditioned media from siADAM17 intoxicated cells also increased invasion (Fig.6.7g-h).
Next, Salmonella intracellular replication was examined after 1h incubation with conditioned me-
dia supplemented with the different ligands by examining intracellular Salmonella following a 24h
infection relative to a 2h infection. The most striking observation was that cells subjected to toxSASP
limited Salmonella replication (Fig.6.7i). Interestingly, toxHQ-CM supplemented with Wnt5a also
limited Salmonella intracellular replication, but not GDF15 or Activin A, indicating that Wnt5a
might restrict Salmonella replication (Fig.6.7j). It is also worth noting that the cell morphology of
siWnt5a intoxicated cells showed a more round-up appearance, which is indicative of either defected
adhesion, or cellular death (Fig.6.7g).
6.8 Discussion
Salmonella subversion of the human secretome presents a novel, unexplored area of research. This
chapter examined a few up-regulated proteins implicated in TGFβ in the toxin-induced secretome
identified by mass spectrometry in Chapter 5. Consistent with previous findings187, inhibiting
TGFβ receptor ameliorated transmission of senescence. Data suggest that Activin A and Wnt5a work
separately and in combination to enhance senescence-phenotypes. Evidently, both ligands induce DNA
damage, potentially via ROS, in directly intoxicated cells. This matches previous reports332,333,357
that SASP proteins induce DNA damage in bystander cells. These observations present a novel method
of toxin-induced DNA damage, by which it subverts the host secretome to indirectly consolidate
the DNA damage. Not only do TGFβ ligands release ROS from mitochondria, they also suppress
antioxidants allowing for ROS accumulation363. Although the majority of research implicated Wnt5a
in inhibiting ROS production, knocking down Wnt5a in intoxicated cells showed decreased DNA
damage foci. This could be due to the fact that TGFβ genes are also targets of the Wnt5a pathway,
which was observed in colonic crypts305. The notion of indirect DNA damage mandates examining
ROS generation in intoxicated cells via fluorescent probes such as dihydroethidium (cellular) and
mitoSOX (mitochondrial)364.
Data presented in this chapter, showed that even though Activin A induced senescence, it did not
necessarily enhance invasion. In contrast, GDF15 was shown to drive Salmonella invasion regardless
of its ability to induce senescence. As previously mentioned, reports provide evidence that TGFβ
ligands regulate membrane ruffling by activating Ras, RhoA, Rac and Cdc4343,342 in smad-independent
pathways such as MAPK, JNK, ERK and p38 pathways as well338,339,341,340. Additionally, Wnt5a
was also observed to modulate the actin cytoskeleton in stem cells365. Interestingly, my results showed
that too much Wnt5a (applying purified protein), or too little Wnt5a (knockdown) enhanced invasion.
As Salmonella uptake is an actin-dependent process366, it seems that the typhoid toxin might exploit
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Wnt5a secretion levels to influence actin-mediated membrane ruffling and hence modulate bacterial
burden to promote host survival, and bacterial persistence. Therefore, it would be interesting to
visualise how my proteins of interest affect membrane ruffling and actin cytoskeleton assembly via
immunofluorescence.
Preliminary experiments explored the effect of ALK2,4,5,7 receptors knockdown individually or
knockdown of all receptors on Salmonella invasion (data not shown). When toxWT-SASP was applied
on ALK-receptor deficient cells, invasion was ameliorated in ALK2 and ALK7 knockdown cells, and
invasion was halved when all receptors were partially knocked down (data not shown). There was no
change to invasion rate with toxHQ-CM-treated cells. This gave preliminary insight into a potential
mechanism by which Salmonella manipulates the host. However, it is worth noting that a knock-
down control confirming RNAi targeting was not carried out, but is still required to corroborate the
observations.
As it currently stands, there is no direct link between transmitting senescence to naive cells and
enhancement of invasion. It appears that Wnt5a (a toxin-specific protein) and GDF15 (senescence-
specific protein) would bring about both toxinWT phenotypes independently. Many of the invasion
experiments are preliminary and require more biological replicates. Investigating toxinWT senescence
phenotypes are yet to be explored in GDF15 knockdown cells.
TGFβ ligands are important immuno-modulators367. For instance, Activin A is produced by im-
mune cells such as macrophages and regulates both inflammatory and anti-inflammatory responses
depending on context368. Follistatin (a toxin-specific protein, and unexplored in this thesis) has been
previously reported as an important regulator of Activin A and can ameliorate inflammatory responses
by Activin A369. Additionally, GDF15 has been described as macrophage inhibitory cytokine-1370. It
is involved in suppression of some immune cells via immunosenescence306, enhances phagocytosis by
dendritic cells and involved in tumour immune evasion371. It is also a good diagnostic and prognostic
in patients with colorectal cancer372,373. Similarly, Wnt5a has an emerging role in immunosuppres-
sion374. It has also been implicated in increased bacterial phagocytosis, and ameliorated bacterial
killing by macrophages312.
The examined SASP components GDF15, Activin A and Wnt5a showed only a modest influence
on Salmonella invasion, which is consistent with the effect seen with toxWT-SASP and findings reported
in Ibler et al 2019106. Given that Salmonella invades host cells in the absence of SASP components,
it is possible that SASP plays a more significant role in other aspects of Salmonella host-pathogen
interactions. Indeed, it is interesting to speculate that Salmonella could hijack long-lived, death-









Senescence could be considered a good servant, but a bad master. Whilst its benefits are evident
in development, wound healing and tumour-suppression182,186, chronic senescence can render the
organisms more susceptible to age-related pathologies such as Alzheimer’s and cardiovascular diseases,
and counterintuitively even cancer176. Ageing organisms are more susceptible to infections224,225,
as observed in the recently emerged Coronavirus pandemic (COVID-19)375. Similarly, mortality of
people >50 years old infected with Salmonella Typhi is significantly higher relative to their younger
counterparts376.
In the past decade, the interlink between senescence and infections has attracted the attention of
cell biologists, giving rise to the emerging research avenue of senescence and bacterial host-pathogen
interactions213. Whether pathogens accelerate senescence in local infection niches to establish infection
is unclear. My thesis explored the effect of the typhoid toxin of Salmonella Typhi on host cell
responses implicated in typhoid fever. My thesis highlights three main findings relevant to senescence
and the host-pathogen interaction field: i) the typhoid toxin causes premature cellular senescence-like
responses via replication stress and persistent γH2AX foci; ii) toxWT-SASP is divergent from SASP of
other acute DNA damage inducers; iii) the typhoid toxin subverts the host’s TGFβ signalling pathway
to transmit senescence and potentially enhance invasion into naive cells.
7.1 Does the typhoid toxin induce true senescence?
Senescence is a dynamic, multi-step phenomenon that evolves over a long period of time and con-
fers continuous molecular changes over weeks and months. It is generally recognised that cultured
cells reach full senescence weeks post-exposure to the inducer, and remain viable for months there-
after168,377. As observations reported in this thesis were extended to 96h, it could be argued that key
senescence hallmarks such as ‘permanent’ cell-cycle arrest are yet to be addressed. Durable cell-cycle
arrest up to 7-days was observed with typhoid toxin106 and this thesis revealed additional markers of
senescence, e.g. p21 expression, lamin B downregulation, persistent DDRs. Nevertheless, an undefined
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stress response that may, or may not later develop into senescence could also explain the phenotypes
and so timepoints could be extended in the future to align with senescence studies. This will likely
require cell culture experiments modelling chronic infection, which are under development. Even so,
the acute senescence responses addressed in this thesis were chosen specifically to investigate their
influence on initial decisive host-pathogen interactions, e.g. host cell invasion.
This thesis explored toxWT-SASP at two time-points (48h and 96h), with few matches to the SASP
Atlas174. As SASP is dynamic, it develops over time and not all factors are secreted simultane-
ously175,189. Therefore, it would be expected if the typhoid toxin induces ‘true’ SASP that it would
display plasticity as well, which should be examined at diverse timepoints. This would provide insight
into the host secretome in chronic toxin-secreting Salmonella infections.
7.2 Host secretomes as a target of bacterial pathogens
This thesis reveals that bacterial pathogens employ sophisticated toxins to manipulate the host
secretome and reprogram naive bystander cells. This opens up the possibility that pathogens are able
to remodel multiple cells within the infection niche from a single infected cell. This virulence strategy
may not be unique to SASP and pathogen-induced secretomes likely have broader significance in host-
pathogen interactions. For instance, single-cell RNA sequencing revealed that dendritic cells infected
with invasive S. Typhimurium (ST313) showed regulation of host secreted proteins that reprogram
transcription profiles of bystander cells and result in immune evasion378. Whilst the cell fate of these
infected cells was unaddressed, a notable gene reported was IL-1β which is a known SASP, but also
implicated in inflammasome activation during pyroptosis378,379,380. Highlighting the importance of
pathogen manipulation of the host secretome is the fact that the non-invasive S. Typhimurium (ST19)
counterpart showed a differential secretome which was proposed to account for the distinct disease
outcomes, e.g. bacteremia378.
My thesis provides a new platform of research that can be used to investigate host secretory
responses to diverse pathogen-induced cell fates and their influence on infection niches. In particular,
this thesis contributed to dissecting a secretome induced by a bacterial toxin, using three different
techniques, under a senescence-like stress response.
7.3 Is senescence an efficient hijack target for a bacterial vir-
ulence factor?
Taking into consideration that senescence can be host-protective, it is undoubtedly a risky hijack
target for bacteria188,189. Senescent cells typically secrete inflammatory SASP molecules to recruit
immune cells, eliminate pathological cells and protect the host. For instance, SASP-dependent recruit-
ment of cytotoxic T-cells and macrophages eliminates neoplastic tumour formation, prevents tumour
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progression and promotes host survival381,382. However, due to the heterogeneous nature of SASP
which is context-dependent, some factors would be protective, whilst others could promote pathol-
ogy. Previous literature implicate bacterial-induced pro-inflammatory senescence in tumour progres-
sion and establishment of pathology, such as with the case of E. coli ’s colibactin and H. ducryei ’s
CDT222,240,383. Additionally, SASP can transmit senescence to immune cells resulting in an immuno-
suppressive phenotype via a process known as immunosenescence384, which could permit pathogen
persistence and survival. We previously published that toxWT-SASP transmitted senescence, and pro-
moted Salmonella infection in naive THP1 macrophages in a CdtB-dependent manner. ToxWT-SASP,
and not APHSASP was able to enhance invasion in bystander cells, which suggested pathogen hijacking
of senescence106. Therefore, to further our understanding of pathogen subversion of senescence, the
DDR was examined and the SASP proteome elucidated by LC-MS/MS.
7.4 The typhoid toxin induces premature ageing in vitro and
in vivo.
In Chapter 3, I presented evidence of the typhoid toxin inducing senescence-like phenotypes in
vitro similar to known chemical inducers of senescence. The toxin induced: i) replication stress marked
by RPA exhaustion, ii) persistent DDR markers such as γH2AX and 53BP1 foci; iii) increased p21
expression in intoxicated cells; iv) lamin B1 down-regulation and v) SASP phenotype that transmits
senescence and enhances invasion in naive cells106. Whilst the concentration of typhoid toxin during
infection is unknown, I showed that picogram amounts of toxin were sufficient to induce γH2AX
foci, cell cycle arrest and SA-β-gal up-regulation. Additionally, Salmonella infections resulted in
transmissible senescence in a CdtB-dependent manner, implicating toxin-induced senescence during
infections. Despite the ability of LPS to induce DNA damage and senescence385,386, Salmonella lacking
CdtB did not induce SASP, which indicates that PAMPs are insufficient for Salmonella induction of
senescence and would require dedicated virulence factors, in this case - the typhoid toxin.
Intravenous injection of typhoid toxin indicated a role in acute typhoid fever symptoms and lethal-
ity81,97 while mouse infection experiments revealed a role for the toxin in promoting host survival to
facilitate chronic Salmonella carriage78. A common feature of both studies was toxin suppression
of immune responses. Thus, it is reasonable to hypothesise that senescence might contribute to the
in vivo role of the toxin. In concordance with my findings and at the time of writing this thesis, a
recently published article presented evidence of typhoid toxin-induced senescence during infection in
vivo 107 marked by NFκB activation, p16 activation and histological stain of lipofuschin. Despite this
senescence phenotype, the typhoid toxin reduced recruitment of inflammatory T-cells and sustained
levels of non-inflammatory macrophages, which is consistent with an anti-inflammatory SASP profile
reported in Chapter 5.
In contrast to findings in animal models, a human infection challenge study conducted in 2019 using
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wild-type Salmonella Typhi revealed that the typhoid toxin did not underlie acute typhoid fever in
humans100. In fact, disease manifestation was less severe than the toxin-null mutant, which supports
mouse infection studies by indicating a host-protective role played by the toxin. Furthermore, the
duration of wild-type bacteraemia was reduced and immune responses of B cells were ameliorated
compared to the toxin null mutant, suggesting an immune-repressive role of the toxin. It is important
to note that due to ethical considerations and the small number of volunteers, the results are not
representative of S. Typhi infections in endemic countries, and do not give insight into severe, chronic
typhoid fever. All in vivo studies, together with my proteomic analysis in vitro, show that the typhoid
toxin plays an immunosuppressive role which is consistent with the stealth strategy of typhoidal
Salmonella 78,100,107.
7.5 Immuno-modulatory functions of TGFβ and Wnt5a path-
ways
In accordance with the human infection challenge results, LC-MS/MS bioinformatic analysis of
intoxicated fibroblast HT1080 cells in serum-free media, presented in this thesis, showed the repression
of some inflammatory interleukins such as IL-6, and the up-regulation of GDF15, Activin A and Wnt5a
implicated in immunosuppression (Fig.7.1) . Interestingly, both TGFβ ligands and Wnt signaling
pathways have implications in immuno-modulation. For instance, disruption of TGFβ signaling in
immune cells such as T cells and dendritic cells resulted in spontaneous colitis in mouse models, and
was dysregulated in patients of inflammatory bowel disease387,388. Activin A was previously recognised
as an immunological cytokine that results in the differentiation of the inflammatory M1 macrophage
into the immunosuppressive M2 phenotype389. Additionally, GDF15 has also been implicated in
immunosenescence, whereby it inhibits macrophages and maturation of dendritic cells resulting in
immune evasion371. Therefore, the increased invasion in fibroblast cells treated with purified GDF15
could provide a novel insight into a pathogen-subversion mechanism whereby the bacteria are up-taken,
but not eliminated by immune cells.
Interestingly, upon inflammatory stimulation via LPS, Wnt5a is anti-inflammatory, blocks differ-
entiation of M1 macrophages, and does not affect M2 macrophages also leading to immunosuppres-
sion390. Given that Wnt5a, GDF15 and Activin A are all up-regulated in a toxin-dependent manner,
and confer immunomodulatory functions, proposes an intriguing question whether indeed these factors
are essential for the typhoid toxin phenotypes in vivo.
This thesis presented evidence that the typhoid toxin induces transmissible senescence partially
via Activin A and Wnt5a, which was ameliorated via their knockdown and chemical inhibition. The
fact that Activin A enhanced transmissible senescence and GDF15 enhanced invasion uncouples trans-
missible senescence from Salmonella invasion and implicates a complex cooperative network of TGFβ
ligands that mediate a pathogen-hijack mechanism via SASP. On the contrary, Wnt5a, which is a
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Figure 7.1|Proposed mechanism of disease that would aid in transmission of senescence, en-
hanced invasion and potential chronic carriage of Salmonella. The role of these secreted SASP have
been implicated in immuno-modulation and therefore are important to examine in Salmonella infections
toxin-specific secreted protein, might confer host protection as well. The debilitated cellular state
in intoxicated cells and enhanced invasion in naive cells in Wnt5a knockdown cells implicates it in a
potential pro-host survival mechanism. However, the opposing effect on invasion observed when cells
were treated with purified Wnt5a indicate that it might be controlled in a more complex mechanism
whether temporally, by concentration, or downstream signalling, which were unexplored in this thesis.
These results show that senescence as a pathogen hijack target is not black and white, and constitute
an interplay between host-protection and pathogen-hijack mechanisms in one context.
7.6 Future directions
This thesis has opened many research questions that would need to be addressed to enhance our
understanding of the typhoid toxin and the establishment of invasive Salmonella infections.
Examining SASPs in vivo. This thesis used HT1080s, a fibrosarcoma cell-line, to characterise
the SASP constituents and their role during invasion. It would be important to establish core SASPs
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induced by the typhoid toxin in other non-carcinogenic primary cell lines including bone marrow de-
rived macrophages, and the colonic epithelial HIEC-6 cells. More complex systems, such as organoids
of primary gut epithelial cells, could also be used to simulate a more physiologically relevant envi-
ronment for examining SASP and Salmonella invasion. More importantly, the identified putative
proteins of interest should be examined in vivo in animal models upon toxigenic Salmonella infection.
Previous work showed that SASP of mice in vivo was different from SASP of mouse cultured cells391.
Given that a human infection challenge model with S. Typhi was carried out100, LC-MS/MS could
be carried out on the volunteers plasma to examine biomarkers of senescence, and then comparatively
analysed to the proteomics data in this thesis.
Alternative role of toxinWT-SASP in persistence and chronic carriage. Salmonella was
previously shown to target aged cells in vivo and in vitro 227. Following these findings, Ibler et al
2019 showed that the typhoid toxin hijacks senescence to induce premature ageing in bystander cells
via SASP to promote infection106. However, although my data shows an increase in invasion due
to identified SASP factors via Wnt5a and GDF15, the change was modest. Therefore, it is possible
to assume a different function to toxin-induced senescence and SASP. Whilst toxWT-SASP could be
modulating the actin cytoskeleton, SASP is better studied for its anti-apoptotic properties.
Persistence and chronic carriage of S. Typhi were attributed to the CdtB subunit of the typhoid
toxin78. To allow for Salmonella persistence, host cells are required to survive. Hence, it could be
hypothesised that toxWT-SASP propagate anti-apoptotic signals to bystander cells, prolonging host
cell survival and as a result allows for Salmonella persistence. Thus, it would be interesting to exam-
ine whether Salmonella persistence is facilitated by intracellular survival within cell death-resistant
senescent host cells. .
Effect of toxinWT-SASP on Salmonella replication. The emergence of a prevalent antibiotic
resistant strain is what makes Salmonella an important issue to tackle42. Whilst antibiotics are usually
the go-to treatments, sometimes they are unable to eliminate all Salmonella leading to persistence
and chronic carriage observed in typhoid patients. Experiments in vivo showed that the rate of
Salmonella replication determines survival or mortality of the bacteria upon antibiotic treatments.
Antimicrobial therapy had the biggest impact on fast growing bacteria392. Slow growing bacteria with
low metabolic activity can evade antibiotics and survived best, with limited impact on disease, but
the moderate growing bacteria survived and dominated the antimicrobial resistance392. Whilst this
project examined Salmonella invasion into host cells, a preliminary experiment showed toxWT-SASP
might ameliorate the rate of Salmonella replication. Therefore it is essential to explore whether
increased invasion is also accompanied by slower growing bacteria, which might influence chronic
carriage and antimicrobial resistant typhoid.
Senolytics as a therapeutic approach. Senolytics, which are chemical compounds that selec-
tively kill senescent cells have become the focus of the senescence field393, however its impact in vivo
is still in its infancy. Many research groups established that senolytics alleviate and improve many
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age-related pathologies in mice including osteoarthiritis, diabetes, cardiovascular health amongst oth-
ers393,394,395,396. Given the increased susceptibility of senescent cells to Salmonella infections227, it
is intriguing to pose the question whether senolytics would reduce SASP and as a consequence re-
duce S. Typhi infection burden. Interestingly, a clinical trial in the late 1990s, using azithromycin, a
currently renowned senolytic, has shown high efficacy in curing typhoid fever patients397. Although
it is sensible to ablate senescent cells, senescence has important physiological roles and more clinical
work is underway to determine the cost-benefit balance of senolytics as a therapeutic intervention for
senescence-driven diseases.
Metabolomic SASP is a potentially vital niche to explore. Senescent cells are metabolically
active and characterised by increased secretion profile. Whilst there is an abundance of research articles
addressing SASP in a proteomic approach, very few papers explore metabolomic SASP. Multiple
non-protein molecules such as DNA, RNA, lipids, ROS, amongst others are secreted from senescent
cells via exosomes398,399,400. Metabolomic SASP is also highly dynamic and context-dependent, but
significantly understudied. Understanding how the typhoid toxin modulates metabolomic SASP could
prove insightful in Salmonella Typhi-specific biomarkers important for non-invasive diagnostics and
therapeutic interventions.
Exploring senescence using a new variant of the toxin. A recent paper discovered a new
variant of the typhoid toxin that uses an alternative “B” subunit, namely PltC in place of PltB231.
Although it was less potent than the holotoxin with PltB, experiments on mouse models showed higher
survival rate after infection with Salmonella encoding PltC, and lower recruitment of immune cells,
specifically white blood cells such as lymphocytes and monocytes. It is intriguing to hypothesise that
this new variant of the typhoid toxin might confer immunosenescence or facilitate chronic carriage of
Salmonella.
7.7 Concluding remarks
This thesis provided, for the first time, an unbiased compendium of SASP proteins induced by
a bacterial toxin using LC-MS/MS in combination with GeneChip microarray transcriptomics data
to pinpoint putative players involved in toxin-induced phenotype (i.e. primary and transmissible
senescence, and enhanced invasion). The project demonstrated that even though DDRs were similar
to other senescence inducers, toxWT-SASP constituents are divergent from other SASPs. I conclude that
Salmonella subverts the senescence phenotype in favour of infection via multiple, possibly redundant,
ligands that activate the TGFβ signalling pathway. As the typhoid toxin is related to a large family
of CDTs, this thesis acts as a stepping stone for further examination of senescence and host-pathogen
responses, not only in typhoid fever, but also other diseases caused by CDT-secreting bacteria. At the
centre of this thesis, is the idea that bacterial pathogens activate DDRs to reprogram multicellular










8.1.1 Creating Chemically Competent Cells
This process was carried out near a blue flame with no antibiotics. An overnight culture of 50 µl of
DH5α E. coli in 5 ml sterile LB broth (Millipore, 28713) was created in a shaking incubator at 37°C,
200 rpm. Next, a day culture was carried out by adding 5 ml culture to 500 ml of sterile LB broth
until it reached an OD of 0.4-0.6 in the same conditions. The culture was subsequently aliquoted in 10
× 50 ml falcon tubes and kept on ice for the subsequent steps. The cultures were centrifuged at 3000
rpm (i.e. ∼2000 × g) for 10 mins in Beckman Coulter centrifuge. The supernatant was discarded in
Virkon (SLS, L2897) and the pellets were resuspended in two 40 ml of sterile 0.1M CaCl2 (Sigma,
C5670). Centrifugation was repeated and both pellets were washed with 25 ml of sterile 0.1M CaCl2.
Subsequently, each pellet was resuspended in 2-3 ml of autoclaved CaCl2 with glycerol (Sigma-Aldich,
G5516) and stored in 50 µl aliquots in -80°C until ready to use. The importance of CaCl2 as a washing
and storage buffer is to attract DNA into the cells during transformation.
8.1.2 Transformation in chemically competent cells
DH5α aliquots were thawed on ice and 1 µl of plasmid DNA (equivalent of ∼200 ng) was added
to each aliquot (50 µl) and incubated on ice for 30 mins. Bacteria were heat shocked for 30 seconds
at 42°C then immediately incubated on ice for 5 mins. They were then incubated in 900 µl of SOC
media (BioBasic, SD7009) at 37°C for 1h. Next, cultures were pelleted at 13000 rpm for 1 min and
resuspended in ∼200 µl SOC media. Bacteria were then spread, using rotational movement of an
L-shaped spreader, onto LB-agar (Sigma-Aldich, L2897) plates with the relevant antibiotic(s) and
incubated overnight at 37°C and observed for colonies.
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8.1.3 Transformation in electrically-competent cells.
E. coli B21 Rosetta, resistant to chloramphenicol, in 50 µl aliquots were thawed on ice and 200 ng
of DNA was added to them. Bacteria with DNA were transferred to ice-cold electroporation cuvette
and electroporated at 1.25 V for ∼4 ms. Bacteria were allowed to cool down on ice for 5 mins then
cultured in 900 ul SOC media and incubated in a shaking incubator at 37°C for 1 h at 200 rpm. Next,
cultures were pelleted at 13000 rpm for 1 min and resuspended in ∼200 µl SOC media. Bacteria
were then spread, using an L-shaped spreader, onto LB-agar plates with the relevant antibiotic(s) and
incubated overnight at 37°C and observed for colonies.
8.2 Purifying recombinant typhoid toxin using Ni- NTA beads.
8.2.1 Expressing the typhoid toxin in E. coli
Plasmid encoding the typhoid toxin was transformed into chemically competent cells C41 strains
using the same method previously described81,106. Electrical or chemical transformation was car-
ried out using the T7 expression vector pETDuet1-pltB-HIS/pltA-MYC/cdtB-FLAG. Three bacterial
colonies were inoculated in 30 ml of LB broth (i.e. a colony per 10 ml broth) containing ampicillin
antibiotic (Melford Lab, A0104) at 100 µg/ml overnight at 37°C in a shaking incubator at 200 rpm.
The overnight culture was diluted 1:100 in an ampicillin-containing LB broth and incubated at 37°C in
a shaking incubator at 200 rpm until OD600 of 0.8-0.9 was reached. This is to ensure that the bacteria
are at the late-end of the exponential phase to synthesize masses of protein. A 1 ml sample was taken
and OD600 measured. Hereafter, every sample collected was measured for OD600, the bacteria were
centrifuged at 13000 rpm for 1 min and the pellet was resuspended in a calculated volume of SDS
urea (50 mM Tris pH 6.8, 8 M Urea, 2% SDS, 0.3% Bromo blue) using the following equation
Volume of SDS Urea for resuspension (µl) = OD600 × 200
Protein production was then induced using 0.1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG)
insert product code at 18°C overnight. The next day, a sample of the bacteria was collected. Cul-
tures were then pelleted at 6000 × g and supernatant discarded. The pellet was resuspended and
homogenised in 50 ml Tris Buffer Saline pH 7.4 (TBS) containing 20 mM Tris, 150 mM NaCl). Subse-
quently, glycerol (Sigma-Aldich, G5516) was added to the suspension at a final concentration of 10%,
and two tablets of cOmpleteTM, Mini, EDTA-free Protease Inhibitor Cocktail per 50 ml solution
(Roche, 11836170001) were added to stabilize proteins and generate a high yield of purified toxin.
The resuspended bacteria were then lysed using a french press machine at 25 KPSI and the lysate was
centrifuged at 60,000 × g for 60 mins at 4 C. Considering volumes of culture at the point of collection
the equivalent of 1 ml culture was collected. For example, if the starter culture is 3L (i.e. 3000 ml)
and the volume of the lysate after resuspension with glycerol is 75 ml then, (75/3000 = 25 µl) should
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be collected and made up to 200 µl using SDS-Urea.
A sample of the supernatant was collected as the “soluble proteins” sample. The insoluble pellet
was homogenised in 20 ml TBS and an “insoluble proteins” sample was collected.
8.2.2 Binding the toxin to Ni-NTA agarose by affinity chromatography.
The toxin contains a 6×-His tag on its PltB subunits therefore allowing Ni-NTA beads to specifi-
cally bind the typhoid toxin. 1 ml bed volume of Ni-NTA agarose beads (Jena Bioscience, AC-501-25)
was washed with MQ water and then incubated with lysate on a rotating wheel for 1 hour to allow
for affinity chromatography. The mix was subsequently immobilised in a column, and a sample of the
flow through was collected. The beads were then washed with 50 ml of washing buffer (20 mM Tris-
HCl pH 7.4, 500 mM NaCl) and a sample of the wash was collected. The toxin was then eluted off
in 1 ml batched using the elution buffer (20 mM Tris-HCl pH 7.4, 50 mM NaCl, 250 mM imidazole).
Imidazole is a competitive binder of the Ni-NTA that would elute the bound typhoid toxin. Each
elution collected was tested for the presence of protein using Bradford assay in a 96-well format as
previously described, and elution was halted when the blue colour no longer appeared. All elution
fractions were combined together. 5 µl of the elution was mixed with 15 µl SDS-Urea to run on a gel.
All samples collected were assessed on protein gels and stained with Colloidal Blue stain, Coomassie
stain or western blotting.
8.2.3 Dialysis of imidazole out of the toxin elutions
The combined fractions were poured into a sealed dialysis tubing (Fisher Scientific, 11465879),
placed in a dialysis buffer (TBS) and stirred at 4°C overnight. The solution was then centrifuged
at 13,000 rpm for 1 minute to pellet and remove any proteins that crashed out of solution. Finally,
20% glycerol was added to the solution for preservation and stored in -80°C freezer until intoxication
(described in Section 9.2).
8.3 Protein concentration measurement using Bradford assay
Bradford Reagent (Sigma-Aldrich, B6916) was diluted 1:1 with milliQ water before any quantifi-
cation. It was either used for qualitative (e.g. during toxin purification) or quantitative measure (e.g.
for mass spectrometry).
Qualitatively: 200-400 µl of the diluted solution was pipetted in a 96-well plate and 1 µl sample
was mixed in each well. The appearance of a blue precipitate indicates presence of proteins. The
higher the protein concentration, the darker the colour.
139
Chapter 8
Quantitatively: A BSA standard curve was created by mixing increasing masses of BSA 2
mg/ml standard solution (Thermo Scientific, #23210) with 1 ml of diluted Bradford reagent. OD600
was then measured using a spectrophotometer and a mass standard curve created using Graphpad
Prism. Known volumes of the sample with an unknown concentration was then mixed with the
Bradford solution and OD600 measured in the same way. Mass of protein was then interpolated from
the standard curve and divided by volume pipetted into Bradford to calculate the concentration.
8.4 Protein gels
8.4.1 Preparation of whole cell lysate samples.
Cells were either seeded in 10 cm dishes (Corning) or 6-well plates (CellStar, 657160) at a density
which would reach 70-80% confluency at the end of the experiment. Cells were washed three times with
sterile PBS (Sigma Aldrich, D8537), and left in PBS the third time. Using a cell scraper, cells were
gently scraped across the whole plate and transferred into Eppendorf tubes. Cells were centrifuged at
2000 rpm for 5 mins and resuspended in 1 ml of PBS. OD600 was measured using a spectrophotometer
and recorded. To calculate the volume of sample buffer to use i.e. SDS-Urea (50 mM Tris pH 6.8,
8 M Urea, 2% SDS, 0.3% Bromo blue) with 1% β-mercaptoethanol (Merck, 805740), the following
equation was used:
Volume of SDS Urea for resuspension (µl) = OD600 × 250 × volume of cells in suspension (i.e. 1)
Cells were pelleted at the same speed, PBS was removed, then the cells were resuspended in the
calculated volume of the sample buffer. Cells were then boiled for 5 minutes at 95°C and run on
SDS-PAGE gel or stored in -20°C.
8.4.2 Making in-house SDS-PAGE protein gels
Protein gels were cast in the lab using BioRad Mini PROTEAN Tetra Cell Casting Stand Clamps
(1658050) or Mini-PROTEAN 3 Multi-Casting Chamber (165-4110). Protein gels consisted of two
entities: A resolving gel (Table 8.1) that separates the different proteins and a stacking gel (Table
8.2) that contained the loaded wells .
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Resolving gel (9% Bis-tris acrylamide gel) for 100 ml
Solution
Volume for







2.5 M Bis-Tris pH 6.5 14.25 356 mM
20% SDS 0.5 0.1%
MQ water 62.75 62.75%
Table 8.1|Protocol for creating the resolving gel of a western blot gel
Stacking gel (5% Bis-Tris acrylamide gel) for 100 ml
Solution
Volume for







2.5 M Bis-Tris pH 6.5 14.25 356 mM
20% SDS 0.5 0.1%
MQ water 68.65 68.65%
Table 8.2|Protocol for creating the stacking gel of a western blot gel
To polymerisation the gels, a few crystals (final concentration ∼ 0.1%) of Ammonium Persulfate
(APS; Melford, A1512); used for cross- linking), and N,N,NN-Tetramethylethylenedi (TEMED; Sigma
Aldrich, T9281) used as a catalyst at 1:1000 dilution) were dissolved in pre-prepared resolving gel
solution and pipetted in a casting chamber (∼9 ml). A small amount of isopropanol was used to remove
bubbles, and the solution was left to polymerise. Once complete, the isopropanol was poured out and
APS and TEMED were dissolved in the same concentration for the stacking gel. Approximately 2 ml
of the stacking gel were pipetted on top of the resolving gel and either a 10-well or a 15-well comb
was placed before its polymerisation. When polymerised, the gels were stored in a humidified box in
the refrigerator until ready to be run. Gels were stored for a maximum of a week and discarded if not
used.
8.4.3 Running a protein a gel
Samples were loaded in wells using Fisherbrand™ Gel-Loading Tips (11927734) and gels were
run at 40 mA/gel in Mini-PROTEAN Tetra System (Bio-RAD) in either MES or MOPS buffers
(Life Technologies, NP0001, NP0002 respectively) depending on the size of the protein of interest.
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PageRuler Plus Prestained Protein Ladder (Thermo Scientific, #26619) was used as a protein size
standard. After running the gel, it was either used for Commassie staining, Colloidal staining or
western blotting.
8.5 Coomassie and Colloidal staining for global protein visu-
alisation
Once gels were run, they were incubated in a small petri dish containing Coomassie (50% methanol,
10% acetic acid, 2.5 g/L Blue R250) or Colloidal Blue (10% ammonium sulphate, 0.1% Coomassie
G250, 3% orthophosphoric acid, 20% ethanol) for 3-4 hours or until protein bands appear. The stain
was then discarded appropriately and the gels were washed regularly with water to remove non-specific
stain. Gels were then imaged using Gel Doc EZ Imaging System.
8.6 Western Blotting
Pre-run protein gels were rinsed in MQ water and transferred onto PVDF membranes (Thermo
Scientific, 88518) using wet electroblotting, or semi-dry electroblotting. Prior to transfer, the PVDF
membrane was cut into the appropriate size and activated via 100% methanol (Sigma-Aldrich, 900658)
for 30 seconds.
Wet transfer. Activated PVDF membranes were submerged into a fresh transfer buffer (20mM
Tris-base, 150 mM Glycine, and 20% methanol v/v). A transfer pad was prepared by assembling a
sandwich in the following order: black frame (negative electrode), sponge, 3 layers of filter papers
(BioRad, 1703931), pre-wet gel in the transfer buffer, 3 layers of filter papers, transfer sponge, and
finally close the clear frame (positive electrode). The transfer tank was filled with a fresh transfer
buffer and the sandwich inserted with the black frames of the holder and the sandwich aligned together.
The transfer was then initiated at 400 mA for 80 min or 20-22 mV for 800-999 min.
Semi-dry transfer. Either Trans-Blot Turbo Transfer System (Bio- rad, 1704150), or iBlot 2
(Thermofisher Scientific, IB21001) were used per manufacturer’s instructions. The transfer was carried
out using a preset program of incremental voltage steps (total of 7 mins): 20 V for 1 min, 23 V for 4
min, then 25 V for 2 min.
Membranes were then carefully separated from the transfer system and blocked with Odyssey
Blocking Buffer (927-40000, Li-Cor) for 1 hour or 5% non-fat dried milk (Tenak, A08300500) in tris-
buffered saline (TBS; Millipore, 524750-1EA). If OBB was used, all subsequent incubations were in
PBS (Biotech, PD8117) with 0.1% tween. If 5% milk was used, all subsequent washes were in 5% milk
in TBS. After blocking, membranes were washed 3 times in PBS with 0.1% tween (PBST) or TBS
for 5 mins each. The blots were then incubated with primary antibody diluted in the relevant buffer
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(Table 8.3) for 1 hour at room temperature or overnight at 4°C on a rotator and washed 3 times for 5
mins each. Next, a fluorescent secondary antibody, specific to the species of the primary antibody was
diluted in in the relevant buffer (1:10000) for 30 minutes - 1 hour before being washed with PBST or
TBS twice (Table 8.4). The blots were imaged using Li-Cor scanner (OdysseySa 100 µm resolution,
300 µm depth). All antibodies were stored in their respective buffer at 4°C for short-term or -80°C
for long-term storage and future reuse. Blots were then processed using Image Studio software and
Photoshop.
Primary antibodies used for Western blotting
Target protein Species Product code Dilution
FLAG M2 mouse monoclonal Sigma-Aldrich 5F3165 1:1000
c-myc rabbit monoclonal Abcam 32072 1:500











p21 Waf1/Cip1 rabbit monoclonal Cell Signalling technology 2947 1:1000
Wnt5a/b rabbit monoclonal Cell Signalling Technology 2530 1:1000
Table 8.3|Primary antibodies used for western blotting, their product codes and dilution factor.
Secondary antibodies used for Western blotting
Secondary antibody Source Product code Dilution
IRDye® 800CW anti-Mouse IgG Donkey Licor 926-32210 1:10000
IRDye® 680RD anti-Rabbit IgG Donkey Licor 926-68071 1:10000








Cells were kept frozen in 10% sterile DMSO (Sigma-Aldrich, D2438) and 90% complete media in
-80°C until they were revived. Cells were thawed for 1 min at 37°C then diluted 1:10 with complete
growth media to reduce DMSO concentration. The cells were then pelleted by centrifugation at 2000
rpm for 5 mins. Media was aspirated and cells were resuspended in 1 ml of complete growth media.
Cells were then transferred to T25 flasks, then T75 or T175 (Greiner, 690175, 658175, or 660175
respectively) depending on the amount of cells.
9.1.2 Cell maintenance
Cells were maintained in a humidified incubator (Panasonic, MCO-170AICUV-PE) at 37°C and
5% CO2. Cells were passaged every 2-3 days in their appropriate media according to instructions
depicted on ATCC website. Depending on the cell type, either Dulbecco’s Modified Eagle’s Medium -
high glucose (DMEM; Sigma Aldrich, D6546), Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture
F-12 Ham (DMEM F12 Ham; Sigma Aldrich, D6421), or Eagle’s Minimum Essential Media (EMEM;
Sigma Aldrich, M4655). Table 9.1 summarises information about each cell line and their culturing
method.
To prepare complete growth media, 10% fetal bovine serum (FBS) (Sigma Aldrich, F7524), 10
U/ml Penicillin/Streptomycin (Gibco, 11548876), 50 µg/ml Kanamycin sulphate (BioBasic, KB0286)
and 2 mM L-glutamine (Thermofisher Scientific, #25030024), were added if not already in the media.
Culture media was stored at 4°C for up to 3 months.
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human DMEM 1:6 - 1:10
NIH/3T3 fibroblast cells mouse DMEM
1:3-1:6
100% confluency avoided
Table 9.1|Cell lines used and their culturing method.
9.1.3 Passaging and cell seeding
Growth media was aspirated from the flask, and the cells were washed with an equivalent volume
of sterile PBS (Sigma Aldrich, D8537). Cells were then trypsinized with 1 ml (in T25), 3 ml (in T75),
or 5 ml (in T175) sterile trypsin (Sigma Aldrich, T4049) depending on the flask size for 3 to 5 minutes
in the cell culture incubator. Once the majority of cells detached, the flask was tapped gently to
dislodge any remaining attached cells. Trypsin was then neutralised using an equivalent amount of
complete growth media. Cells were separated by pipetting them out against the bottom of the flask
and placed in a falcon tube, then an appropriate volume was either taken back into a cell culture flask
for maintenance or used for seeding an experiment.
9.1.4 Counting cells for seeding experiments.
After cell detachment as described in Section 9.1.3, 10 µl of suspended cells were pipetted un-
der a coverglass in a glass haemocytometer (Hawksley, AC1000). Cells in the four corners of the
haemocytometer were counted under a light microscope and averaged.
The number of cells/ml = average number × 104
The volume of cell suspension to dilute in media was then calculated using the following equation:
Volume (ml) =
number of cells to be seeded
calculated number of cells/ml of suspension
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The volume calculated was diluted in complete growth media and divided across the required wells
in culture plates.
9.2 Intoxication and drug application
9.2.1 Identifying the concentration of the toxin elution.
The stock concentration of the purified toxin was estimated by interpolation from a standard curve
of a known concentration of purified recombinant GST-CdtB-FLAG, measured using a quantitative
Bradford assay. To create the standard curve, a sample of the typhoid toxin and different dilutions
of the purified CdtB were analysed using western blot. Antibodies against FLAG were used to blot
for the recombinant CdtB and the CdtB subunit in the purified toxin. The intensity of FLAG was
measured using ImageStudio Lite and plotted using Graphpad prism. The mass of the CdtB was
extrapolated from the standard curve and divided by the loaded volume to estimate the concentration
of the toxin stock.
Cultured cells were intoxicated using purified recombinant typhoid toxin (described in Section
8.2). Standard intoxication dose was 20 ng/ml unless otherwise indicated.
9.2.2 Standard intoxication procedure.
Culture media was aspirated off and replaced with media containing 20 ng/ml toxin for 2h on the
chosen cell line. Next, cells were washed three times with sterile PBS to remove any extracellular
toxin and chased with fresh complete growth media for the duration of the experiment until fixation
or conditioned media harvest.
9.2.3 Drug and recombinant protein application.
Cells were treated with drugs listed in Table 9.2 with the relevant incubation times. The cells
were then washed 3 times with sterile PBS and chased with fresh complete growth media for the
duration of the experiments. Alternatively, cells were treated with commercially available purified
proteins at the indicated concentrations unless otherwise indicated in figure legends (Table 9.3).
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Drug concentration in cell culture
Drug Mode of action
Working
concentration
Pulse time Product code
Aphidicolin inhibitor of DNA polymerase α 20 µM 24 h Sigma-Aldrich (A0781)
Etoposide Topoisomerase inhibitor 10 µM 24 h Cayman Chemicals (12092)







4, 5, and 7
1 µM 1 h pre-treatment
and in SASP
Sigma-Aldrich (616453)
CID11210 Wnt signaling agonist 0.1-100 nM 5 days Merck (Sml0698)
Table 9.2|Concentrations of drugs used in cell culture (unless otherwise stated in the thesis). All drugs were
resuspended in sterile DMSO.





TGFB3 10 ng/ml CST 8425LC 20 mM Citrate, pH 3.0
Activin A 500 ng/ml R&D Systems 338-AC-010 sterile 4 mM HCl
GDF15 200 ng/ml R&D Systems 957-GD-025 sterile 4 mM HCl with 0.1% BSA
Wnt5a 500 ng/ml R&D Systems 645-WN sterile PBS with 0.1% BSA
Table 9.3|Recombinant proteins and their concentration used in cell culture. All proteins are human.
9.3 Knockdown using siRNA transfections.
Cells were transfected using Lipofectamine RNAiMax (Invitrogen, 13778-150) with small adjust-
ments to their user manual. Briefly, per well of a 24-well plate format, 0.25 µl or 0.5 µl of Lipo-
fectamine RNAiMax in 25 µl of serum-free, antibiotic-free DMEM, was mixed with 0.5 µl of 20 µM
short-interfering RNA (siRNA) in 25 µl of serum-free, antibiotic-free DMEM for 5 minutes at room
temperature with gentle tube flicking. The final concentration of siRNA in culture was 20 nM. The
50 µl mix of siRNA and lipofectamine were added to 450 µl complete growth DMEM, and incubated





Target protein (siRNA) Source Catalogue number
Non-targeting Control ON-TARGETplus SMARTpool D-001810-01-20
PLK1 siGENOME Individual siRNA D-003290-05-0020
Wnt5a ON-TARGETplus SMARTpool L-003939-00-0005
ACVR1/ALK2 ON-TARGETplus SMARTpool L-004924-00-0005
ACVR1B/ALK 4 ON-TARGETplus SMARTpool L-004925-00-0005
TGFBR1/ALK5 ON-TARGETplus SMARTpool L-003929-00-0005
ACVR1C/ALK7 ON-TARGETplus SMARTpool L-004929-02-0005
INHBA ON-TARGETplus SMARTpool L-011701-00-0005
Smad2 ON-TARGETplus SMARTpool L-003561-00-0005
ADAM17 ON-TARGETplus SMARTpool L-003453-00-0005
Table 9.4|List and product codes of siRNA used throughout the thesis. All siRNAs are from Horizon Discovery
9.4 Infection assays
9.4.1 Preparation of cells and bacterial culture.
Cells were seeded in a 24-well plate at 4×104 onto glass coverslips to reach approximately 80%
confluency the next day. Salmonella strains used are for infections experiments are listed in Table
9.5 .
Salmonella strains
Serovar Strain Kind gift from
S. Javiana WT S5-0395 Prof. Martin Weidmann98,99
S. Javiana ∆cdtB M8-0540 Prof. Martin Weidmann98,99
S. Typhi Ty2 BRD948 vaccine strain Prof. Gordon Dougan401
S. Typhi Ty2 ∆cdtB BRD948 vaccine strain Prof. Gordon Dougan106
Table 9.5|Salmonella strains used for infection.
A bacterial colony was cultured in 5 ml LB broth with the relevant antibiotic overnight at 37°C
in a shaking incubator. Next day, 1:100 dilution of the overnight culture was performed in 10 ml LB
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broth with the relevant antibiotic and incubated at 37°C in a shaking incubator until OD600 is close
to 2.0 (i.e. 1.4 - 1.8). The following formula was used to normalise the culture to OD600 2.0:
Volume to spin down (ml) =
2.0
calculated OD600
9.4.2 Preparation of infection media and infection
The volume calculated was added to Eppendorf tubes and spun down at 13,000 rpm for 1 minute.
Supernatant was discarded as much as possible and the pellet was then resuspended in 1 ml of sterile
PBS. The relevant volume of bacteria was pipetted onto the cells seeded in 24-well plates. The plate
was then spun for 1 min at 1000 × g and incubated for 30 min at 37°C 5% CO2. Infection media
was then washed with PBS, and incubated with gentamicin-containing media (Chem Cruz, sc203334)
50 µg/ml for 1.5 h. Next, media containing a lower concentration of gentamicin (i.e. 10 µg/ml) was
replaced for the duration of the experiment.
9.4.3 Invasion assay
NIH/3T3 cells were seeded at 2×104 cells per well in a 24-well plate and serum-starved 24h to
deprive the cells of factors in FBS that might stimulate membrane ruffling. Serum-free conditioned
media was added for the relevant duration before infection as described in Section 9.4.2 using an
MOI of 160. After high concentration of gentamicin for 1.5h, cells were washed 3× with PBS, then
lysed using 1% triton X (VWR, 28817.295) in water for 5-10 mins, and pipetted vigorously. Next,
the supernatant was transferred to a 96-well plate, and using a multichannel pipette, consecutive
10-fold titrations were carried out, by serial dilution (20 µl of supernatant with 180 µl PBS, etc).
Salmonellawere then cultured on agar plates with relevant antibiotics by spotting 5 µl of each dilution
overnight in a dry incubator at 37°C. Colonies were then counted manually, and the highest, countable
Salmonellacolonies (i.e. the lowest dilution with visible colonies) were counted and normalised to
calculate Salmonellacolony forming units (CFUs).
9.4.4 MOI calculation
The number of bacteria at OD600 1.0 was estimated to be 8×108 bacteria/ml. Since OD600 was
normalised to 2, the number of bacteria was 16×108 bacteria/ml. Subsequently the following formula
was used:
volume of infection media (ml) × 16×108




Media was removed from cells seeded in a 24-well plate and washed three times with PBS and
150 µl trypsin was added. Trypsin was neutralised with a 150 µl media and placed in an Eppendorf
tube. 10 µl of cells was mixed with 10 µl trypan blue (Sigma-Aldrich, T8154) for 3 minutes at room
temperature, and 10 µl were applied in a haemocytometer. Blue cells were counted as dead cells
and transparent cells were counted as viable. Then, the following calculations were carried out and
represented in bar graphs:
No. of viable cell/ml = No. of live cells counted dilution (i.e. 2) × 10,000
No. of dead cell/ml= No. of dead cells counted dilution (i.e. 2) × 10,000
% viability =




Cells were seeded at 2000 cells in a 10 cm dish. Cells were treated as described previously and
incubated in fresh media for 7 days. Media was aspirated and cells were air-dried. Next, 80% ethanol
was applied to cells for 15 minutes, then removed and air-dried. Methylene blue (1%) was added for 1
hour, washed off with distilled water until the background colour disappears and then air-dried before
images were taken.
9.7 Conditioned media harvest
Conditioned media was harvested using stripettes and pipetted into falcon tubes. Conditioned
media were then centrifuged at 6000 × g for 5 mins to pellet the cells before filtering using a syringe
and 0.2 µm filters to prevent cell contamination and release of other factors due to bursting due to the
filtration pressure. The centrifugation step is to remove any cells that would otherwise burst releasing
non-SASP proteins into the conditioned media, and the filtration is an extra step to filter out cells
from the conditioned media. Conditioned media was then stored at -20°C for short term storage and
-80°C for long term storage. Before incubation on cells, conditioned media was either supplemented
1:1 with complete growth media, or 10% FBS if conditioned media was serum-free.
9.8 Histological stain of SA-β-gal
Senescence-associated βgal (SA-β-gal) was stained as per the protocol denoted in Senescence β-




9.9 SPiDER β-gal fluorescence
Cellular Senescence Detection Kit - SPiDER β-Gal (Dojindo Molecular Technologies, SG-04) was
used according to the manual. Briefly, Mcllvaine buffer was made by mixing 0.1 mol/L citric acid
solution and 0.2 mol/L sodium phosphate solution at 1:1.7 ratio respectively. The buffer was acidified
to pH6 by adding more citric acid, then the buffer was diluted 5× in milliQ water. Resuspended
SPiDER β-gal was diluted in Mcllvaine buffer 1:1000 and applied on fixed cells in a 37°C incubator
without CO2. Before staining for other proteins, cells were incubated with 0.1% triton X-100 in PBS
(Biotech, PD8117) for 30 mins at room temperature and then immunofluorescence described below.
9.10 CellEvent Senescence Green Detection
Staining was carried out according to the detection kit manual (Invitrogen, C10851). Briefly,
after the cells were fixed with 4% PFA (Sigma-Aldrich, P6148) in PBS , they were washed with 1%
BSA (Sigma-Aldrich, 1073508600) in PBS to remove fixative. Next, staining solution constituting
CellEventTM Senescence Green Probe diluted 1:1000 in the CellEventTM Senescence Buffer was
applied on cells and incubated for 2h in a 37°C incubator without CO2. The cells were then washed
in PBS before immunofluorescence staining of other proteins resumed as previously described. The
probe was imaged using a FITC filter set. Where immunofluorescent, and EdU were to be co-stained
with CellEvent Green, the order of assays were CellEvent Senescence Green, EdU staining Kit, and
then immunofluorescence.
9.11 EdU staining
Click-iT™ EdU Cell Proliferation Kit for Imaging, Alexa Fluor™ 647 dye (Thermofisher, C10340)
was used per the manufacturer’s instruction. Depending on the duplication time of each cell line, EdU
incubation in culture was adjusted. For example, HT1080 duplication time is 18h, therefore EdU was
added to the culture 18-24h before fixation. Post-fixation, the reagent’s volumes were economically
reduced at a ratio of 1:16 to allow for more experiments using the kit.
9.12 Immunofluorescence staining for cell culture
Cells were seeded at the appropriate density for each experiment on glass coverslips 13 mm. At the
end of the experiment, media was washed off three times with PBS, then fixed with 4% paraformalde-
hyde (PFA) in PBS for 10-15 mins at room temperature. The fixative solution was removed and
disposed of appropriately. Cells were washed two more times with PBS (Biotech, PD8117) and stored
in the fridge until the staining began.
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Cells were blocked and permeabilised using a blocking buffer containing 3% BSA (Sigma-Aldrich,
1073508600), 0.2% Triton X-100 (VWR, 28817.295) in PBS, at room temperature for 1h then coverslips
were dipped in a reservoir with. Next, primary antibodies were applied in the relevant PBS 0.2% Triton
X-100 for either an hour at room temperature or overnight at 4°C then dipped in a reservoir with
PBS (Table 9.6). Secondary antibody was next applied for 30 mins in 1:500 dilution in PBS 0.2%
Triton X-100 (Table 9.7). Finally, the cells were counter-stained with DAPI (6 µg/ml) in PBS Triton
X-100 for 3 mins at room temperature, washed with PBS then water and left to dry for 30 minutes.
Coverslips were then mounted on 6 µl of VectaShield mounting agent (Vector Lab, H1200), and sealed
before being imaged on the Nikon Widefield Microscope.
Primary antibodies used for immunofluorescence











53BP1 rabbit polyclonal Novus Biotechnology NB100-304 1:1000
Lamin A/C mouse monoclonal Santa Cruz sc7292 1:1000
Lamin B1 rabbit polyclonal Abcam ab16048 1:1000







rabbit monoclonal Cell Signalling Technology 3108 1:500-1:1000
phospho-smad1/5
(Ser463/465)
rabbit monoclonal Cell Signalling Technology 9516 1:500-1:1000
Activin A rabbit polyclonal Novus Biotechnology NBP1-30928 1:500
Wnt5a/b rabbit monoclonal Cell Signalling Technology 2530 1:500
Wnt5a rabbit monoclonal Abcam ab179824 1:500
Salmonella rabbit polyclonal Abcam ab35156 1:200
Table 9.6|Primary antibodies used for immunofluorescence, their product codes and dilution factor.
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Secondary antibodies used for immunofluorescence
Secondary antibody Source Product code Dilution
anti-rb 568 IgG, Alexa Fluor Donkey Invtirogen A11036 1:500
anti mouse 488 IgG, Alexa Fluor Donkey Invitrogen A21202 1:500
anti rabbit 488 IgG, Alexa Fluor Goat Invitrogen A11008 1:500
anti-ms 594 IgG, Alexa Fluor Donkey Invitrogen A21203 1:500
anti-ms 647 IgG, Alexa Fluor Goat Invitrogen A-21240 1:500
Table 9.7|Secondary antibodies used for immunofluorescence, their product codes and dilution factor.
9.13 Microscopy
9.13.1 Nikon Wide-field Live-cell system
Fixed cells were imaged using Nikon’s Inverted Ti eclipse equipped with an Andor Zyla sCMOS
camera (2560 x 2160; 6.5µm pixels). The objectives used were Plan Apo 10x (NA 0.45); Plan Apo 20x
(NA 0.75); Plan Fluor 40x oil (NA 1.3); Apo 60x oil (NA 1.4); Plan Apo 100x Ph oil (Na 1.45); Plan
Apo VC 100x oil (NA 1.4). Quad emission filters for used with SpectraX LED excitation (395nm,
470nm, 561nm, 640nm). The imaging software used was NIS elements software.
9.13.2 Olympus CK30
Histology staining of SΑ-β-gal was imaged using an Olympus Wide-field microscope CK30 10x
objective and captured with Dino-Lite adaptor and Dino-Lite software. Images were then processed
using Adobe Lightroom to neutralise colours with good white-balance.
9.13.3 Nikon Eclipse Ts2
For phase-contrast images of histologically stained SΑ-β-gal, the inverted microscope Nikon Eclipse
Ts2 equipped with sCMOS Ds-Fi-3 camera with built-in Diascopic, high-intensity LED illumination
system at 10x and 40x objective lenses.
9.14 Illustrations, Image Processing and Quantification
Adobe Illustrator was used to manually hand-draw illustrations, and assemble all results figures.
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9.14.1 Microscopy Image processing
Fiji 2.1.0/1.53c macro code was created to automate processed images. Briefly, brightness and con-
trast are normalised across all images of interest, a pre-set ROI is used to crop images to regions of in-
terest, and a pre-set scale bar is added. DAPI nuclei are then outlined, overlaid with the other channels
and saved as png files. Many variants of the code has been created to cater for 2-channel, 3-channel and
4-channel images, with either normal composite images or with DAPI outlines. The codes can be found
via this link: https://drive.google.com/drive/folders/1SwUO-bgyW0rjY9MetAfKGtdd77FsCahF?usp=
sharing
9.14.2 Manual quantification
For histological SΑ-β-gal, images were opened in FIJI and cell counter plugin was used. Raw
numbers were then recorded in Microsoft Excel.
9.14.3 Automatic quantification - RING tracking
Analysis of the RING phenotype was carried out using MATLAB image processing code, which
was published106 and publicly available via https://github.com/nbul/Nuclei. To differentiate between
γH2AX negative cells and pan staining cells, γH2AX upper-quartile of untreated cells were used as a
cutoff.
9.14.4 CellProfiler: Semi-automatic quantification
γH2AX foci: CellProfiler 4.0.7 was used to automate quantifying foci and their sizes. A pipeline
was created to identify nuclei with a manually determined threshold. RING positive cells were removed
manually from the analysis and foci intensity was enhanced. Foci in each nucleus was then identified
using a threshold obtained manually.
Lamins: To quantify the change in lamin intensity, each nucleus was first thresholded in FIJI
and then input into CellProfiler. Next, the maximum intensity of the lamin channel at the edge of
each nucleus was measured. To mitigate the intensity variations between images, the intensity of the
centre of the nucleus was measured and a ratio between the edge and middle intensity was calculated
and displayed in bar charts.
SA-β-gal: To quantify fluorescent SA-β-gal positive nuclei, the SA-β-gal channel was initially
thresholded in FIJI and then input into CellProfiler. Each cell was identified by expanding an area
around the nucleus (around 50 px). A positive nucleus was identified depending on the fraction of
SA-β-gal overlapping with each cell, which was set manually depending on experiment.
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Other nuclear components: Other nuclear components were quantified by either i) using a
manual signal threshold and automatic classification within CellProfiler, or ii) by measuring intensity
and setting a threshold using the negative control’s upper quartile.
Other cytplasmic components: Global image intensity for the protein was quantified, and
divided by the number of nuclei counted.
9.15 Statistical analysis
Graphs and statistical analysis were carried out using GraphPad Prism 9. Statistical analysis
method is indicated in each legend as appropriate. Significance is denoted by asterisks (*) where




10.1 Bioorthogonal Noncanonical Amino Acid Tagging (BON-
CAT)
10.1.1 Click-iTTM AHA metabolic tagging of cells in culture
L-azidohomoalanine (Thermofisher Scientific #C10102) is a methionine analogue used to tag newly
synthesized proteins produced by cells in culture for mass spectrometry purposes. The tag is useful
when proteins need to be purified from FBS containing media for better mass spectrometry sensitivity.
It is light-sensitive, therefore wherever used, it was hidden from light.
HT1080 were seeded in 6 well-plates in complete media and treated as previously described. Cells
were washed with PBS three times, then starved with methionine-free DMEM (Thermofisher Scientific,
#21013-024) for 30 minutes to 1h. Methionine-free media was created by adding 50 ml dialysed heat
inactivated FBS (Hyclone, 12349822), 10 ml L-glutamine (Thermofisher Scientific #25030032), 10 ml
L-cystine HCl (Sigma- Aldrich, 57579), 5 ml sodium pyruvate (Sigma-Aldrich, S8636), 1% Kanamycin,
and 1% Pen/Strep (Gibco, #11548876) to 450 ml of DMEM methionine-free media. Next, 100 µM
AHA in methionine-free media was applied in 1.5 ml in each 6-well plate for the duration indicated in
the results section then harvested as previously described in Section 9.7. The samples were stored
away from light at -80°C until enrichment for mass spectrometry.
10.1.2 Enrichment of newly synthesized proteins tagged with AHA
Samples were hidden from light throughout the experiment to prevent degradation of the tag.
Water used for washes and preparing reagents was HPLC-grade (Fisher Chemical, W6-1).
Samples were thawed in a 37°C water bath. One tablet of Roche protease inhibitor cocktail (Merck,
11836170001) was crushed per 40 ml of conditioned media tagged with AHA (CMAHA) to preserve
harvested proteins. CMAHA was centrifuged through amicon filters with 3 KDa cutoff to concentrate
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the proteins down to 500 µl at 4000 ×g swing bucket centrifuge at 4°C. The concentrated proteins
were collected for enrichment and the flow-through was stored at -20°C for future use. Click-iT™
Protein Enrichment Kit (Thermofisher Scientific, C10416) was used to select for AHA labelled proteins
in concentrated media as per their instructions with slight modifications. Per 500 µl concentrated
CMAHA, 500 µl of urea lysis buffer containing 8 M urea (Melford, U1363), 200 mM Tris pH 8 (Sigma-
Aldrich, T1503), 4% CHAPS, 1 M NaCl was added. The mixture was then centrifuged at 10,000
×g for 5 mins and placed on ice. The sample was then incubated with 100 µl bed volume of alkyne
beads and half the catalyst solution described in the kit’s manual was used overnight in a roller away
from light. This allows alkyne beads to bind the azide motif of the AHA in labelled proteins via click
chemistry reaction.
10.1.3 Reduction and alkylation of the Resin-Bound proteins
The reaction mix was centrifuged at 1000 ×g for 1 minute, and the supernatant was collected and
stored in -20°C in case of repetition needed. Resin was washed with water and centrifuged at 1000
×g for 1 minute. The supernatant was discarded. Subsequently, 0.5 ml of SDS wash buffer and 10 µl
of 0.5 M TCEP were added to the resin. TCEP was used instead of DTT, which was suggested by
the protocol, as it would interact with iodoacetamide, an alkylating agent used in later stages. The
mixture was heated at 70°C in a Thermomixer at 600 rpm for 15 mins then cooled down at room
temperature for a further 15 mins. The mixture was centrifuged at 1000 ×g for 5 minutes and the
supernatant was discarded. Next 500 µl of 20 mM iodoacetamide in the SDS wash buffer was added
to each reaction and incubated for 30 mins in a Thermomixer at 6000 rpm in the dark.
10.1.4 Stringent washing of the resin to remove non-specifically bound
proteins
The resin was transferred to a spin column (Wizard, Promega) and centrifuged quickly in an
Eppendorf using a picofuge for a few seconds. Resin tube was washed with 500 µl HPLC-grade water
and centrifuged again. Subsequently, using vacuum flow, the columns were washed with 20 ml of SDS
wash buffer, 8M Urea/100 mM Tris-HCl pH 8, 20% isopropanol and 20% acetonitrile in that order.
All flow-through solutions were discarded.
10.1.5 Digestion of resin-bound beads to peptides.
The column was rinsed with 500 µl of 50 mM ammonium bicarbonate and centrifuged briefly in an
Eppendorf in a picofuge for a few seconds to remove excess liquid. Next, 150 µl of 50 mM ammonium
bicarbonate was added to the spin column, resuspended using a cut pipette tip and transferred to
a clean tube. Then, 1 mg of Pierce MS grade trypsin (Fisher Scientific, 13464189) i.e. 10 µl of 0.1
mg/ml and resuspended in 0.1% TFA (Merck, 108262), was added to the resin slurry, and incubated
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at 37°C overnight in a Thermomixer at 800 rpm.
10.1.6 Desalting the digested peptides
Peptides must be desalted to remove salts and urea from the digestion buffer that would affect
the Orbitrap. Stagetips C18, 200 µl tip (Thermofisher Scientific) were washed with 100 µl of 0.1%
TFA/50% ACN (Sigma-Aldrich, 900667) to acidify the pH as peptides bind better in acidic conditions.
The stage tip was washed again with 100 µl of 0.1% TFA.
Samples were acidified by adding TFA to a final concentration of 0.4%. TFA was added as needed
until pH 2 was reached. The peptide samples were added to the stage tip. The samples were slowly
passed through the stage tip 3 times then washed with 100 µl of 0.1% TFA. Slowly, the peptides were
eluted with 100 µl of 0.1% TFA/50% ACN.
10.2 Sample preparation of serum-free (SF) and Essential 8
(E8) conditioned media
10.2.1 Harvesting SASP proteins
Post-intoxication in complete media as described in Section 9.2, cells were incubated with either
serum-free DMEM or stem cell media Essential 8 (Thermofisher, A1517001). Serum-free media was
created as described in Section 9.1.2 without the addition of FBS. As cells were mostly viable with
only 24h incubation, cells were split into 2 sets, and each day a single set was incubated for 24h (ie.
plate 1 for 0-24h, plate 2 for 24-48h) and fractions were then combined.
However, as cells were viable in E8 media for 48h, cells were cultured in E8 for 48h without any
media change (0-48h plate). For both serum-free and E8 conditioned media, a home-made protease
mixture of leupeptin, pepstatin, and chymostatin (Sigma Aldrich, 62070, 77170, C7268, respectively)
each at a final concentration of 10 µg/ml), as soon as they were harvested. Samples were then stored
in -80°C until S-trap digestion.
Samples were concentrated by centrifuging through amicon filters with 3 KDa cutoff (Merck,
ufc900324) down to 250 µl at 4000×g using swing bucket centrifuge at 4°C. The concentrated proteins
were used for enrichment and the flow through was stored at -20°C for future use.
10.2.2 S-Trap digestion of proteins
Next, the samples were normalised by volume where 50 µl of the concentrated media was used for
S-trap digestion.
Equal volume of 2x S-trap lysis buffer containing 10% SDS (Sigma-Adrich, 05030), 100mM TEAB,
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pH 7.55 (Thermofisher, 90114) was added to the samples (i.e. 50 µl). Next, the samples were reduced
by adding TCEP (Merck, 646547) at a final concentration of 10 mM. The samples were then heated
at 70°C for 15 mins at 750 rpm in a shaking incubator. SDS from the lysis buffer with a reducing
agent leads to denaturation and reduction of disulphide bonds important in secretory proteins. The
samples were then cooled down for 5 mins at room temperature.
Next, the samples were alkylated by adding twice the concentration of TCEP for iodoacetamide
(Merck, I6125), i.e. 20 mM, and pipetted really well, to prevent the reformation of the disulphide
bonds. The solution was kept in the dark for 30 mins at room temperature.
The samples were then acidified by adding aqueous phosphoric acid to a final concentration of
1.2%. The acidification step is essential for the S-trap to bind proteins.
S-trap binding buffer (90% aqueous methanol, 0.1M TEAB, pH 7.1) was added to the solution
in a ratio of 1:7. Samples were then loaded into the S-trap columns (Protifi, C02), 150 µl at a time
gently without poking the bottom and centrifuged at 4000 x g for 10 seconds to pass through the
S-trap. The S-trap was then washed 3X with 150 µl binding buffer before transferring it to a clean
2 ml Eppendorf tube. MS grade trypsin (Fisher Scientific, 13464189) resuspended in 0.1% TFA was
then added to a ratio of 1:10 trypsin:protein w/w in 50 mM TEAB buffer. At least 30 µl of trypsin
in TEAB buffer was added to the samples and air bubbles were avoided. The S-trap was sealed with
parafilm, and incubated at 47°C for 1 hr without shaking. The peptides were then eluted by adding
40 µl of 50 mM TEAB, 40 µl of 0.2% aqueous formic acid (Fisher Chemical, A117-50)and 40 µl of 50%
ACN containing 0.2% aqueous formic acid in that order and passing the buffers through the trap at
4000 ×g for 10 seconds before adding the next. Store till ready for drying and LC-MS/MS analysis.
10.3 Drying and preparing samples for Orbitrap injections.
Samples were centrifuged in a SpeedVac (Eppendorf) at 45°C for 60-90 minutes with Eppendorf
tube lids open to allow for evaporation, with vacuum setting V-AQ. Once samples were dried, peptides
were resuspended in 0.5% formic acid and mixed by vortex at the lowest speed for 10 minutes. Samples
were then transferred to labelled polypropylene vials (Thermo Scientific #160134) and injected in the
orbitrap.
10.4 Mass Spectrometry Data Analysis
10.4.1 LC-MS/MS analysis
18 µl of each sample was analysed by nanoflow LC-MS/MS using an Orbitrap Elite (Thermo Fisher)
hybrid mass spectrometer equipped with an easyspray source, coupled to an Ultimate RSLCnano LC
System (Dionex). The system was controlled by Xcalibur 3.0.63 (Thermo Fisher) and DCMSLink
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(Dionex). Peptides were desalted on-line using an Acclaim PepMap 100 C18 nano/capillary BioLC,
100A nanoViper 20 mm x 75 µm I.D. particle size 3 µm (Fisher Scientific) and then separated using
a 125-min gradient from 5 to 35% buffer B (0.5% formic acid in 80% acetonitrile) on an EASY-Spray
column, 50 cm × 50 µm ID, PepMap C18, 2 µm particles, 100 Å pore size (Fisher Scientific). The
Orbitrap Elite was operated with a cycle of one MS (in the Orbitrap) acquired at a resolution of
60,000 at m/z 400, with the top 20 most abundant multiply charged (2+ and higher) ions in a given
chromatographic window subjected to MS/MS fragmentation in the linear ion trap. An FTMS target
value of 1e6 and an ion trap MSn target value of 1e4 were used with the lock mass (445.120025)
enabled. Maximum FTMS scan accumulation time of 500 ms and maximum ion trap MSn scan
accumulation time of 100 ms were used. Dynamic exclusion was enabled with a repeat duration of 45
s with an exclusion list of 500 and an exclusion duration of 30 s.
10.4.2 MaxQuant Analysis
All raw mass spectrometry data were analysed with MaxQuant version 1.6.10.43. Data were
cross-referenced against a human UniProt sequence database (June 2015) using the following search
parameters: digestion set to Trypsin/P with a maximum of 2 missed cleavages, methionine oxidation
and N-terminal protein acetylation as variable modifications, cysteine carbamidomethylation as a
fixed modification, match between runs enabled with a match time window of 0.7 min and a 20-min
alignment time window, label-free quantification enabled with a minimum ratio count of 2, minimum
number of neighbours of 3 and an average number of neighbours of 6. A first search precursor
tolerance of 20ppm and a main search precursor tolerance of 4.5 ppm was used for FTMS scans and
a 0.5 Da tolerance for ITMS scans. A protein FDR of 0.01 and a peptide FDR of 0.01 were used for
identification level cut-offs.
10.4.3 Perseus Bioinformatic Analysis
MaxQuant output was loaded into Perseus version 1.5.6.0 and all LFQ intensities were set as
main columns. The matrix was filtered to remove all proteins that were potential contaminants, only
identified by site and reverse sequences. LFQ intensities were then transformed using log2(x) default
function. To group experimental conditions, rows were categorically annotated with their condition
names. Rows with no LFQ intensities in all categorized groups were eliminated by filtering rows
based on valid value in at least one group with a minimum number of 3 out of 4 repeats for statistical
analysis.
Subsequently, data were visualized using multi-scatter plots and Pearson’s correlation analysis and
outliers removed. Data were then normalised by subtracting column medians and missing values were
randomly imputed with a width of 0.3 and downshift of 1.8 from the standard deviation.
In order to identify quantitatively enriched proteins between groups, two-sided Student’s t-tests
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were performed with a permutation-based FDR calculation (FDR = 0.05) with an (S0) =0.1. Data
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Ann W Hsing, Juan C Roa, Marcela F Pasetti, Juan F Miquel, Myron M Levine, Catterina
Ferreccio, the Gallbladder Cancer Chile Working Gallbladder Cancer Chile Working Group,
Carmen Gloria Aguayo, Sergio Baez, Alfonso Dı́az, Héctor Molina, Carolina Miranda, Claudia
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389(6648):251–260, 1997.
119. Gina Arents and Evangelos N Moudrianakis. Topography of the histone octamer surface: repeat-
ing structural motifs utilized in the docking of nucleosomal DNA. Proceedings of the National
Academy of Sciences, 90(22):10489–10493, 11 1993.
174
Chapter 10
120. Steven W. Criscione, Yee Voan Teo, and Nicola Neretti. The Chromatin Landscape of Cellular
Senescence, 11 2016.
121. Andrew J. Bannister and Tony Kouzarides. Regulation of chromatin by histone modifications,
3 2011.
122. Katrien Vermeulen, Dirk R. Van Bockstaele, and Zwi N. Berneman. The cell cycle: a review of
regulation, deregulation and therapeutic targets in cancer. Cell Proliferation, 36(3):131–149, 6
2003.
123. Amit Deshpande, Peter Sicinski, and Philip W. Hinds. Cyclins and cdks in development and
cancer: A perspective, 4 2005.
124. Naoko Ohtani, Kimi Yamakoshi, Akiko Takahashi, and Eiji Hara. The p16INK4a-RB pathway:
Molecular link between cellular senescence and tumor suppression, 8 2004.
125. Nimrat Chatterjee and Graham C. Walker. Mechanisms of DNA damage, repair, and mutagen-
esis, 6 2017.
126. Monika Podhorecka, Andrzej Skladanowski, and Przemyslaw Bozko. H2AX phosphorylation: Its
role in DNA damage response and cancer therapy, 2010.
127. Arkady Celeste, Oscar Fernandez-Capetillo, Michael J. Kruhlak, Duane R. Pilch, David W.
Staudt, Alicia Lee, Robert F. Bonner, William M. Bonner, and André Nussenzweig. Histone
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Månberg, Tea Dodig-Crnkovic, Elisa Pin, Martin Zwahlen, Per Oksvold, Kalle von Feilitzen,
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Pascale Cossart. ISG15 counteracts Listeria monocytogenes infection. eLife, 4(AUGUST2015),
8 2015.
291. Ana Gutiérrez-Fernández, Clara Soria-Valles, Fernando G Osorio, Jesús Gutiérrez-Abril, Cecilia
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Alexander Schmidt, and Dirk Bumann. Phenotypic Variation of Salmonella in Host Tissues
Delays Eradication by Antimicrobial Chemotherapy. Cell, 158:722–733, 2014.
393. J. L. Kirkland and T. Tchkonia. Senolytic drugs: from discovery to translation, 11 2020.
394. Fiona C. Lewis-McDougall, Prashant J. Ruchaya, Eva Domenjo-Vila, Tze Shin Teoh, Larissa
Prata, Beverley J. Cottle, James E. Clark, Prakash P. Punjabi, Wael Awad, Daniele Torella,
Tamara Tchkonia, James L. Kirkland, and Georgina M. Ellison-Hughes. Aged-senescent cells
contribute to impaired heart regeneration. Aging Cell, 18(3), 6 2019.
395. Carolyn M. Roos, Bin Zhang, Allyson K. Palmer, Mikolaj B. Ogrodnik, Tamar Pirtskhalava,
Nassir M. Thalji, Michael Hagler, Diana Jurk, Leslie A. Smith, Grace Casaclang-Verzosa, Yi Zhu,
Marissa J. Schafer, Tamara Tchkonia, James L. Kirkland, and Jordan D. Miller. Chronic senolytic
treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice. Aging
Cell, 15(5):973–977, 10 2016.
396. Allyson K. Palmer, Tamara Tchkonia, Nathan K. LeBrasseur, Eduardo N. Chini, Ming Xu, and




397. Thomas Butler, C. B. Sridhar, M. K. Daga, Kamal Pathak, R. B. Pandit, Rasik Khakhria, Chan-
drashekhar N. Potkar, Michael T. Zelasky, and Raymond B. Johnson. Treatment of typhoid fever
with azithromycin versus chloramphenicol in a randomized multicentre trial in India. Journal of
Antimicrobial Chemotherapy, 44(2):243–250, 1 1999.
398. Masaki Takasugi. Emerging roles of extracellular vesicles in cellular senescence and aging, 4 2018.
399. Nathan Basisty, Abhijit Kale, Sandip Patel, Judith Campisi, and Birgit Schilling. The power of
proteomics to monitor senescence-associated secretory phenotypes and beyond: toward clinical
applications, 4 2020.
400. Emma L. James, Ryan D. Michalek, Gayani N. Pitiyage, Alice M. De Castro, Katie S. Vig-
nola, Janice Jones, Robert P. Mohney, Edward D. Karoly, Stephen S. Prime, and Eric Kenneth
Parkinson. Senescent human fibroblasts show increased glycolysis and redox homeostasis with ex-
tracellular metabolomes that overlap with those of irreparable DNA damage, aging, and disease.
Journal of Proteome Research, 14(4):1854–1871, 4 2015.
401. David C. Lowe, Tor C. Savidge, Derek Pickard, Lars Eckmann, Martin F. Kagnoff, Gordon
Dougan, and Steven N. Chatfield. Characterization of candidate live oral Salmonella typhi
vaccine strains harboring defined mutations in aroA, aroC, and htrA. Infection and Immunity,
67(2):700–707, 1999.
200
